a	O
total	O
of	O
126	O
patients	O
were	O
diagnosed	O
with	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
)	O
and	O
174	O
patients	O
had	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
(	O
e11	B-code
)	O
in	O
this	O
study	O
.	O

we	O
evaluated	O
the	O
association	O
between	O
hypertension	B-phenotype
(	O
defined	O
as	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i10	B-code
–	I-code
i15	I-code
)	O
and	O
cognitive	O
function	O
in	O
older	O
adults	O
.	O

among	O
the	O
203	O
patients	O
,	O
45	O
(	O
22	O
%	O
)	O
had	O
a	O
primary	O
diagnosis	O
of	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
code	O
296	B-code
.	I-code
2	I-code
)	O
.	O

this	O
study	O
found	O
a	O
significant	O
relationship	O
between	O
a	O
family	O
history	O
of	O
schizophrenia	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
295	B-code
)	O
and	O
increased	O
risk	O
for	O
developing	O
the	O
disorder	O
.	O

patients	O
with	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
snomed	B-coding_system
-	I-coding_system
ct	I-coding_system
code	O
71986000	B-code
)	O
were	O
included	O
in	O
this	O
cohort	O
study	O
.	O

a	O
total	O
of	O
372	O
patients	O
with	O
a	O
diagnosis	O
of	O
atrial	B-phenotype
fibrillation	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
)	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
309	B-code
.	I-code
81	I-code
)	O
according	O
to	O
standardized	O
clinical	O
assessments	O
.	O

we	O
analyzed	O
300	O
patients	O
diagnosed	O
with	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
)	O
within	O
the	O
past	O
five	O
years	O
.	O

the	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
group	O
consisted	O
of	O
80	O
individuals	O
with	O
a	O
clinical	O
diagnosis	O
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
(	O
code	O
299	B-code
.	I-code
00	I-code
)	O
.	O

patients	O
with	O
a	O
history	O
of	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i21	B-code
–	I-code
i22	I-code
)	O
were	O
excluded	O
from	O
the	O
study	O
.	O

there	O
was	O
a	O
progressive	O
increase	O
in	O
the	O
incidence	O
of	O
heart	B-phenotype
failure	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i50	B-code
)	O
over	O
the	O
study	O
period	O
.	O

a	O
total	O
of	O
686	O
patients	O
with	O
cerebral	B-phenotype
palsy	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g80	B-code
)	O
were	O
included	O
in	O
this	O
study	O
.	O

the	O
prevalence	O
of	O
self	O
-	O
reported	O
asthma	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
)	O
was	O
8	O
.	O
6	O
%	O
among	O
the	O
study	O
population	O
.	O

patients	O
with	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
)	O
were	O
significantly	O
more	O
likely	O
to	O
develop	O
dementia	B-phenotype
during	O
the	O
follow	O
-	O
up	O
period	O
.	O

the	O
cohort	O
included	O
50	O
patients	O
with	O
bipolar	B-phenotype
i	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
code	O
296	B-code
.	I-code
0	I-code
)	O
and	O
70	O
patients	O
with	O
bipolar	B-phenotype
ii	I-phenotype
disorder	I-phenotype
(	O
code	O
296	B-code
.	I-code
89	I-code
)	O
.	O

we	O
identified	O
191	O
individuals	O
with	O
multiple	B-phenotype
sclerosis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
)	O
from	O
the	O
hospital	O
registry	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
rheumatoid	B-phenotype
arthritis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
)	O
who	O
had	O
received	O
treatment	O
with	O
biologic	O
agents	O
.	O

this	O
case	O
-	O
control	O
study	O
compared	O
100	O
patients	O
with	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
)	O
and	O
100	O
age	O
-	O
and	O
gender	O
-	O
matched	O
healthy	O
controls	O
.	O

a	O
history	O
of	O
breast	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c50	B-code
)	O
was	O
found	O
in	O
12	O
%	O
of	O
patients	O
using	O
hormone	O
replacement	O
therapy	O
.	O

the	O
prevalence	O
of	O
epilepsy	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
)	O
in	O
this	O
pediatric	O
population	O
was	O
4	O
.	O
3	O
per	O
1	O
,	O
000	O
children	O
.	O

in	O
this	O
cross	O
-	O
sectional	O
study	O
,	O
296	O
participants	O
were	O
diagnosed	O
with	O
alcohol	B-phenotype
dependence	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
303	B-code
.	I-code
90	I-code
)	O
and	O
150	O
participants	O
had	O
a	O
diagnosis	O
of	O
alcohol	B-phenotype
abuse	I-phenotype
(	O
code	O
305	B-code
.	I-code
00	I-code
)	O
.	O

all	O
patients	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
)	O
based	O
on	O
clinical	O
and	O
laboratory	O
criteria	O
.	O

patients	O
were	O
excluded	O
if	O
they	O
had	O
a	O
diagnosis	O
of	O
ovarian	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c56	B-code
)	O
within	O
the	O
past	O
5	O
years	O
.	O

the	O
study	O
population	O
comprised	O
1	O
,	O
020	O
individuals	O
with	O
a	O
clinical	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
)	O
.	O

patients	O
with	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
lymphoma	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c85	B-code
)	O
had	O
a	O
significantly	O
increased	O
risk	O
of	O
developing	O
secondary	O
malignancies	O
.	O

we	O
identified	O
150	O
patients	O
with	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
21	I-code
)	O
in	O
this	O
population	O
-	O
based	O
study	O
.	O

a	O
total	O
of	O
230	O
patients	O
were	O
diagnosed	O
with	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
stage	O
3	O
–	O
5	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
3	I-code
–	I-code
n18	I-code
.	I-code
5	I-code
and	O
followed	O
for	O
five	O
years	O
.	O

the	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
group	O
included	O
200	O
patients	O
who	O
met	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
diagnostic	O
criteria	O
(	O
code	O
k58	B-code
)	O
.	O

all	O
patients	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
primary	B-phenotype
open	I-phenotype
-	I-phenotype
angle	I-phenotype
glaucoma	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h40	B-code
.	I-code
1	I-code
)	O
as	O
per	O
the	O
clinical	O
assessment	O
.	O

in	O
this	O
retrospective	O
study	O
,	O
450	O
patients	O
with	O
a	O
history	O
of	O
stroke	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i60	B-code
–	I-code
i64	I-code
)	O
were	O
compared	O
to	O
500	O
age	O
-	O
and	O
sex	O
-	O
matched	O
controls	O
without	O
history	O
of	O
stroke	O
.	O

we	O
investigated	O
the	O
association	O
between	O
obstructive	B-phenotype
sleep	I-phenotype
apnea	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
30	I-code
)	O
and	O
cognitive	O
decline	O
in	O
elderly	O
patients	O
.	O

the	O
age	B-phenotype
-	I-phenotype
related	I-phenotype
macular	I-phenotype
degeneration	I-phenotype
group	O
comprised	O
250	O
individuals	O
diagnosed	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h35	B-code
.	I-code
3	I-code
by	O
certified	O
ophthalmologists	O
.	O

a	O
total	O
of	O
382	O
patients	O
with	O
endometrial	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c54	B-code
)	O
were	O
studied	O
in	O
a	O
multi	O
-	O
center	O
,	O
case	O
-	O
control	O
study	O
.	O

clinical	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
was	O
performed	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
the	O
modified	O
new	O
york	O
criteria	O
.	O

the	O
study	O
population	O
consisted	O
of	O
460	O
patients	O
diagnosed	O
with	O
acute	B-phenotype
leukemia	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c91	B-code
–	I-code
c95	I-code
)	O
who	O
received	O
chemotherapy	O
treatment	O
.	O

we	O
identified	O
376	O
cases	O
of	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	I-code
1	I-code
from	O
the	O
hospital	O
database	O
.	O

women	O
who	O
had	O
undergone	O
surgery	O
for	O
cervical	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c53	B-code
)	O
within	O
the	O
past	O
5	O
years	O
were	O
included	O
in	O
this	O
study	O
.	O

the	O
study	O
included	O
211	O
patients	O
with	O
prostate	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c61	B-code
)	O
who	O
were	O
treated	O
with	O
radiation	O
therapy	O
.	O

out	O
of	O
1	O
,	O
200	O
patients	O
,	O
112	O
had	O
a	O
diagnosis	O
of	O
osteoarthritis	B-phenotype
of	O
the	O
knee	O
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m17	B-code
)	O
.	O

a	O
total	O
of	O
150	O
patients	O
with	O
systemic	B-phenotype
sclerosis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m34	B-code
)	O
were	O
included	O
in	O
this	O
multicenter	O
study	O
.	O

the	O
cohort	O
included	O
347	O
patients	O
diagnosed	O
with	O
idiopathic	B-phenotype
parkinson	I-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
)	O
and	O
242	O
patients	O
with	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
due	O
to	O
other	O
causes	O
(	O
code	O
g21	B-code
–	I-code
g26	I-code
)	O
.	O

patients	O
with	O
seropositive	B-phenotype
rheumatoid	I-phenotype
arthritis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
and	O
a	O
positive	O
anti	O
-	O
cyclic	O
citrullinated	O
peptide	O
antibody	O
test	O
.	O

the	O
study	O
population	O
included	O
420	O
patients	O
with	O
chronic	B-phenotype
hepatitis	I-phenotype
b	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
1	I-code
)	O
and	O
320	O
patients	O
with	O
chronic	B-phenotype
hepatitis	I-phenotype
c	I-phenotype
(	O
code	O
b18	B-code
.	I-code
2	I-code
)	O
.	O

participants	O
diagnosed	O
with	O
gestational	B-phenotype
diabetes	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
o24	B-code
.	I-code
4	I-code
)	O
were	O
included	O
in	O
this	O
study	O
if	O
it	O
was	O
their	O
first	O
pregnancy	O
.	O

clinical	O
diagnosis	O
of	O
localized	B-phenotype
scleroderma	I-phenotype
was	O
made	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m34	B-code
.	I-code
0	I-code
in	O
200	O
patients	O
.	O

we	O
compared	O
180	O
patients	O
with	O
pancreatic	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c25	B-code
)	O
to	O
360	O
controls	O
matched	O
by	O
age	O
,	O
sex	O
,	O
and	O
smoking	O
status	O
.	O

the	O
study	O
included	O
432	O
patients	O
with	O
a	O
diagnosis	O
of	O
liver	B-phenotype
cirrhosis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k74	B-code
)	O
.	O

we	O
analyzed	O
data	O
from	O
727	O
patients	O
with	O
primary	B-phenotype
biliary	I-phenotype
cholangitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k74	B-code
.	I-code
3	I-code
)	O
who	O
underwent	O
liver	O
transplantation	O
.	O

the	O
tuberculosis	B-phenotype
group	O
included	O
150	O
patients	O
treated	O
at	O
the	O
same	O
facility	O
with	O
a	O
clinical	O
diagnosis	O
of	O
pulmonary	O
tuberculosis	O
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a15	B-code
)	O
.	O

patients	O
diagnosed	O
with	O
huntington	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g10	B-code
)	O
were	O
evaluated	O
for	O
cognitive	O
and	O
motor	O
function	O
.	O

a	O
total	O
of	O
320	O
patients	O
with	O
glioblastoma	B-phenotype
multiforme	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c71	B-code
.	I-code
0	I-code
–	I-code
c71	I-code
.	I-code
9	I-code
)	O
were	O
included	O
in	O
this	O
study	O
.	O

among	O
study	O
participants	O
,	O
280	O
had	O
a	O
new	O
diagnosis	O
of	O
head	B-phenotype
and	I-phenotype
neck	I-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c01	B-code
–	I-code
c14	I-code
,	I-code
c30	I-code
–	I-code
c32	I-code
)	O
.	O

we	O
included	O
650	O
patients	O
with	O
a	O
diagnosis	O
of	O
ulcerative	B-phenotype
colitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
)	O
in	O
this	O
prospective	O
study	O
.	O

the	O
diabetic	B-phenotype
retinopathy	I-phenotype
group	O
included	O
180	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
non	O
-	O
proliferative	O
diabetic	O
retinopathy	O
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h36	B-code
.	I-code
0	I-code
)	O
.	O

a	O
total	O
of	O
250	O
patients	O
with	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f42	B-code
)	O
were	O
included	O
in	O
this	O
randomized	O
controlled	O
trial	O
.	O

patients	O
with	O
clinical	O
diagnoses	O
of	O
intellectual	B-phenotype
disability	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f70	B-code
–	I-code
f79	I-code
)	O
were	O
included	O
in	O
this	O
study	O
.	O

the	O
study	O
included	O
380	O
patients	O
with	O
acute	B-phenotype
lymphoblastic	I-phenotype
leukemia	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c91	B-code
.	I-code
0	I-code
)	O
.	O

the	O
cystic	B-phenotype
fibrosis	I-phenotype
group	O
included	O
254	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
cystic	O
fibrosis	O
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
)	O
.	O

the	O
study	O
included	O
320	O
patients	O
with	O
a	O
diagnosis	O
of	O
osteoporosis	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m81	B-code
)	O
and	O
at	O
least	O
one	O
previous	O
fracture	O
.	O

participants	O
with	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
02	I-code
)	O
were	O
randomly	O
assigned	O
to	O
four	O
different	O
treatment	O
groups	O
.	O

the	O
study	O
included	O
353	O
patients	O
with	O
a	O
diagnosis	O
of	O
fibromyalgia	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
)	O
who	O
were	O
treated	O
with	O
cognitive	O
-	O
behavioral	O
therapy	O
.	O

a	O
total	O
of	O
680	O
patients	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
)	O
were	O
included	O
in	O
a	O
nationwide	O
registry	O
.	O

we	O
analyzed	O
500	O
patients	O
diagnosed	O
with	O
glioblastoma	B-phenotype
(	O
who	B-coding_system
grade	O
iv	O
,	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c71	B-code
)	O
to	O
assess	O
the	O
impact	O
of	O
concurrent	O
chemoradiotherapy	O
.	O

the	O
study	O
population	O
included	O
600	O
patients	O
diagnosed	O
with	O
lymphoma	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c81	B-code
–	I-code
c85	I-code
)	O
who	O
were	O
over	O
60	O
years	O
of	O
age	O
.	O

we	O
compared	O
the	O
cognitive	O
function	O
of	O
1	O
,	O
000	O
patients	O
diagnosed	O
with	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
)	O
to	O
those	O
with	O
vascular	B-phenotype
dementia	I-phenotype
(	O
code	O
f01	B-code
)	O
.	O

the	O
study	O
included	O
420	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
lupus	B-phenotype
nephritis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	I-code
14	I-code
.	O

we	O
investigated	O
the	O
association	O
between	O
chronic	B-phenotype
fatigue	I-phenotype
syndrome	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g93	B-code
.	I-code
3	I-code
)	O
and	O
mental	O
health	O
outcomes	O
in	O
adolescents	O
.	O

the	O
study	O
included	O
454	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
psoriasis	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
)	O
and	O
no	O
history	O
of	O
cancer	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
)	O
who	O
were	O
naive	O
to	O
biological	O
therapy	O
.	O

patients	O
diagnosed	O
with	O
stage	O
iii	O
/	O
iv	O
ovarian	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c56	B-code
.	I-code
1	I-code
–	I-code
c56	I-code
.	I-code
9	I-code
)	O
were	O
included	O
in	O
this	O
study	O
.	O

the	O
study	O
included	O
530	O
patients	O
with	O
a	O
diagnosis	O
of	O
pulmonary	B-phenotype
embolism	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i26	B-code
)	O
who	O
were	O
treated	O
with	O
anticoagulant	O
therapy	O
.	O

patients	O
were	O
included	O
in	O
the	O
study	O
if	O
they	O
had	O
a	O
diagnosis	O
of	O
multiple	B-phenotype
myeloma	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c90	B-code
)	O
and	O
had	O
received	O
at	O
least	O
three	O
lines	O
of	O
therapy	O
.	O

a	O
total	O
of	O
622	O
patients	O
diagnosed	O
with	O
mitral	B-phenotype
valve	I-phenotype
prolapse	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i34	B-code
.	I-code
0	I-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
included	O
690	O
patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
hepatitis	I-phenotype
b	I-phenotype
infection	O
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
1	I-code
)	O
,	O
and	O
350	O
patients	O
infected	O
with	O
chronic	B-phenotype
hepatitis	I-phenotype
c	I-phenotype
(	O
code	O
b18	B-code
.	I-code
2	I-code
)	O
.	O

a	O
total	O
of	O
428	O
patients	O
diagnosed	O
with	O
stage	O
ii	O
-	O
iii	O
breast	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c50	B-code
)	O
were	O
included	O
in	O
this	O
study	O
.	O

the	O
cardiomyopathy	B-phenotype
group	O
included	O
218	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
dilated	O
cardiomyopathy	O
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i42	B-code
.	I-code
0	I-code
)	O
or	O
hypertrophic	O
cardiomyopathy	O
(	O
code	O
i42	B-code
.	I-code
1	I-code
)	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
cerebrovascular	B-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i60	B-code
–	I-code
i69	I-code
)	O
were	O
included	O
in	O
this	O
observational	O
study	O
.	O

the	O
study	O
included	O
480	O
patients	O
with	O
a	O
diagnosis	O
of	O
ischemic	B-phenotype
stroke	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i63	B-code
)	O
who	O
were	O
admitted	O
within	O
4	O
hours	O
of	O
symptom	O
onset	O
.	O

a	O
total	O
of	O
1	O
,	O
259	O
patients	O
with	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
)	O
and	O
a	O
history	O
of	O
smoking	O
were	O
included	O
in	O
this	O
study	O
.	O

the	O
study	O
included	O
500	O
patients	O
with	O
a	O
diagnosis	O
of	O
stage	O
ii	O
-	O
iv	O
colorectal	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c18	B-code
–	I-code
c20	I-code
)	O
who	O
underwent	O
curative	O
-	O
intent	O
resections	O
.	O

patients	O
with	O
oral	B-phenotype
cancer	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c00	B-code
–	I-code
c06	I-code
and	O
followed	O
up	O
for	O
5	O
years	O
.	O

this	O
study	O
included	O
351	O
patients	O
diagnosed	O
with	O
testicular	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c62	B-code
)	O
who	O
underwent	O
chemotherapy	O
treatment	O
.	O

we	O
analyzed	O
568	O
patients	O
diagnosed	O
with	O
stage	O
i	O
-	O
iii	O
pancreatic	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c25	B-code
)	O
and	O
pancreatic	O
neuroendocrine	O
tumors	O
(	O
code	O
c25	B-code
.	I-code
4	I-code
)	O
.	O

the	O
study	O
included	O
600	O
patients	O
with	O
a	O
diagnosis	O
of	O
androgenetic	B-phenotype
alopecia	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l64	B-code
)	O
of	O
varying	O
severity	O
.	O

we	O
included	O
218	O
patients	O
diagnosed	O
with	O
venous	B-phenotype
thromboembolism	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i26	B-code
,	I-code
i82	I-code
.	I-code
9	I-code
)	O
in	O
this	O
case	O
-	O
control	O
study	O
.	O

the	O
study	O
population	O
included	O
500	O
patients	O
diagnosed	O
with	O
thyroid	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c73	B-code
,	O
d09	B-code
.	I-code
3	I-code
,	O
and	O
d34	B-code
)	O
.	O

patients	O
diagnosed	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
)	O
were	O
included	O
in	O
this	O
longitudinal	O
cohort	O
study	O
.	O

a	O
total	O
of	O
910	O
patients	O
diagnosed	O
with	O
renal	B-phenotype
cell	I-phenotype
carcinoma	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c64	B-code
)	O
were	O
included	O
in	O
this	O
study	O
.	O

we	O
included	O
611	O
patients	O
diagnosed	O
with	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
)	O
from	O
a	O
population	O
-	O
based	O
cohort	O
.	O

a	O
total	O
of	O
443	O
patients	O
diagnosed	O
with	O
severe	B-phenotype
sepsis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a41	B-code
.	I-code
9	I-code
)	O
and	O
septic	O
shock	O
(	O
code	O
r65	B-code
.	I-code
21	I-code
)	O
were	O
included	O
in	O
this	O
study	O
.	O

the	O
study	O
included	O
200	O
patients	O
with	O
a	O
diagnosis	O
of	O
sjogren	B-phenotype
'	I-phenotype
s	I-phenotype
syndrome	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m35	B-code
.	I-code
0	I-code
)	O
who	O
were	O
followed	O
up	O
for	O
10	O
years	O
.	O

in	O
this	O
prospective	O
cohort	O
study	O
,	O
4	O
,	O
500	O
patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
)	O
were	O
followed	O
for	O
a	O
median	O
duration	O
of	O
7	O
years	O
.	O

the	O
study	O
included	O
patients	O
diagnosed	O
with	O
infantile	B-phenotype
spasms	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
.	I-code
82	I-code
)	O
who	O
were	O
treated	O
with	O
adrenocorticotropic	O
hormone	O
therapy	O
.	O

out	O
of	O
1	O
,	O
200	O
patients	O
,	O
325	O
had	O
a	O
new	O
diagnosis	O
of	O
bladder	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c67	B-code
)	O
.	O

we	O
included	O
437	O
patients	O
diagnosed	O
with	O
stage	O
i	O
-	O
iii	O
melanoma	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c43	B-code
)	O
who	O
underwent	O
sentinel	O
lymph	O
node	O
biopsy	O
.	O

patients	O
diagnosed	O
with	O
primary	B-phenotype
biliary	I-phenotype
cholangitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k74	B-code
.	I-code
3	I-code
were	O
included	O
in	O
this	O
case	O
series	O
.	O

the	O
study	O
included	O
845	O
patients	O
diagnosed	O
with	O
stage	O
ii	O
-	O
iii	O
gastric	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c16	B-code
)	O
who	O
underwent	O
curative	O
-	O
intent	O
surgery	O
.	O

patients	O
with	O
acute	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c92	B-code
)	O
who	O
achieved	O
complete	O
remission	O
were	O
included	O
in	O
this	O
retrospective	O
cohort	O
study	O
.	O

we	O
included	O
patients	O
diagnosed	O
with	O
early	O
stage	O
non	B-phenotype
-	I-phenotype
small	I-phenotype
cell	I-phenotype
lung	I-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c34	B-code
)	O
who	O
underwent	O
curative	O
-	O
intent	O
surgery	O
.	O

the	O
study	O
included	O
2	O
,	O
400	O
patients	O
with	O
a	O
diagnosis	O
of	O
gallbladder	B-phenotype
and	I-phenotype
bile	I-phenotype
duct	I-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c23	B-code
–	I-code
c24	I-code
)	O
who	O
were	O
followed	O
for	O
a	O
median	O
duration	O
of	O
5	O
years	O
.	O
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
criteria	O
,	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
was	O
defined	O
as	O
having	O
a	O
minimum	O
of	O
five	O
positive	O
symptoms	O
with	O
at	O
least	O
one	O
being	O
depressive	O
mood	O
(	O
296	B-code
.	I-code
2	I-code
)	O
or	O
loss	O
of	O
interest	O
/	O
pleasure	O
(	O
296	B-code
.	I-code
3	I-code
)	O
.	O

patients	O
with	O
a	O
history	O
of	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
)	O
or	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
e11	B-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
diagnosis	O
of	O
schizophrenia	B-phenotype
spectrum	O
disorders	O
was	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
,	O
including	O
codes	O
295	B-code
.	I-code
10	I-code
(	O
schizophrenia	O
)	O
,	O
and	O
298	B-code
.	I-code
9	I-code
(	O
unspecified	O
psychotic	O
disorder	O
)	O
.	O

patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f84	B-code
.	I-code
0	I-code
to	O
f84	B-code
.	I-code
9	I-code
)	O
were	O
included	O
in	O
the	O
targeted	O
intervention	O
program	O
.	O

children	O
carrying	O
the	O
diagnosis	O
of	O
intellectual	B-phenotype
disability	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f70	B-code
(	O
mild	O
intellectual	O
disability	O
)	O
through	O
f79	B-code
(	O
unspecified	O
intellectual	O
disability	O
)	O
.	O

in	O
this	O
study	O
,	O
we	O
examined	O
the	O
association	O
between	O
hypertension	B-phenotype
and	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	O
cm	O
codes	O
401	B-code
and	O
585	B-code
,	O
respectively	O
.	O

patients	O
presenting	O
with	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
study	O
population	O
consisted	O
of	O
adult	O
patients	O
who	O
met	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
diagnostic	O
criteria	O
for	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
f32	B-code
)	O
or	O
bipolar	B-phenotype
disorder	I-phenotype
(	O
f31	B-code
)	O
.	O

in	O
our	O
cohort	O
,	O
the	O
prevalence	O
of	O
metabolic	B-phenotype
syndrome	I-phenotype
was	O
assessed	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
277	B-code
.	I-code
7	I-code
and	O
286	B-code
.	I-code
9	I-code
.	O

the	O
incidence	O
of	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
was	O
defined	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
.	O

among	O
patients	O
with	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
)	O
,	O
apolipoprotein	O
e	O
(	O
apoe	O
)	O
polymorphisms	O
were	O
genotyped	O
to	O
examine	O
genotype	O
-	O
phenotype	O
correlations	O
.	O

the	O
presence	O
of	O
asthma	B-phenotype
in	O
children	O
was	O
determined	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	O
cm	O
code	O
493	B-code
.	O

we	O
examined	O
the	O
association	O
between	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
(	O
i21	B-code
-	O
i22	B-code
)	O
and	O
stroke	B-phenotype
(	O
subarachnoid	O
hemorrhage	O
i60	B-code
,	O
intracerebral	O
hemorrhage	O
i61	B-code
,	O
and	O
cerebral	O
infarction	O
i63	B-code
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
classification	O
system	O
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
endometriosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
617	B-code
.	O

the	O
diagnosis	O
of	O
atrial	B-phenotype
fibrillation	I-phenotype
(	O
i48	B-code
)	O
and	O
heart	B-phenotype
failure	I-phenotype
(	O
i50	B-code
)	O
was	O
made	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
criteria	O
.	O

the	O
prevalence	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
in	O
our	O
cohort	O
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
720	B-code
.	O

the	O
study	O
focused	O
on	O
patients	O
diagnosed	O
with	O
lupus	B-phenotype
erythematosus	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	O

in	O
this	O
analysis	O
,	O
we	O
examined	O
the	O
association	O
between	O
psoriasis	B-phenotype
(	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
696	B-code
.	I-code
1	I-code
)	O
and	O
the	O
risk	O
of	O
developing	O
rheumatoid	B-phenotype
arthritis	I-phenotype
(	O
based	O
on	O
the	O
714	B-code
code	O
)	O
.	O

the	O
diagnosis	O
of	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
was	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
,	O
including	O
codes	O
300	B-code
.	I-code
3	I-code
(	O
ocd	O
)	O
and	O
309	B-code
.	I-code
28	I-code
(	O
adjustment	O
disorder	O
with	O
mixed	O
anxiety	O
and	O
depressed	O
mood	O
)	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
cerebral	B-phenotype
palsy	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g80	B-code
)	O
were	O
included	O
in	O
our	O
retrospective	O
chart	O
review	O
.	O

using	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
,	O
we	O
identified	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
555	B-code
)	O
or	O
ulcerative	B-phenotype
colitis	I-phenotype
(	O
556	B-code
)	O
.	O

the	O
diagnosis	O
of	O
multiple	B-phenotype
sclerosis	I-phenotype
was	O
confirmed	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
and	O
corresponding	O
clinical	O
documentation	O
.	O

patients	O
were	O
classified	O
as	O
having	O
severe	B-phenotype
sepsis	I-phenotype
if	O
they	O
met	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
995	B-code
.	I-code
92	I-code
and	O
785	B-code
.	I-code
52	I-code
criteria	O
.	O

the	O
diagnosis	O
of	O
cystic	B-phenotype
fibrosis	I-phenotype
was	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
277	B-code
.	I-code
0	I-code
and	O
confirmed	O
by	O
genetic	O
testing	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
fibromyalgia	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
729	B-code
.	I-code
1	I-code
.	O

the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
for	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
is	O
e28	B-code
.	I-code
2	I-code
.	O

we	O
identified	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
m32	B-code
.	I-code
9	I-code
.	O

in	O
this	O
study	O
,	O
we	O
focused	O
on	O
venous	B-phenotype
thromboembolism	I-phenotype
(	O
i26	B-code
for	O
pulmonary	O
embolism	O
and	O
i80	B-code
for	O
deep	O
vein	O
thrombosis	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
classification	O
system	O
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
309	B-code
.	I-code
81	I-code
)	O
based	O
on	O
medical	O
records	O
and	O
structured	O
interviews	O
.	O

patients	O
experiencing	O
epileptic	B-phenotype
seizures	I-phenotype
were	O
defined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
diagnostic	O
codes	O
g40	B-code
-	O
g41	B-code
.	O

in	O
our	O
cohort	O
,	O
we	O
identified	O
children	O
with	O
a	O
diagnosis	O
of	O
attention	B-phenotype
deficit	I-phenotype
hyperactivity	I-phenotype
disorder	I-phenotype
(	O
adhd	O
)	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
and	O
corresponding	O
codes	O
314	B-code
.	I-code
0	I-code
(	O
adhd	O
inattentive	O
type	O
)	O
and	O
314	B-code
.	I-code
01	I-code
(	O
adhd	O
combined	O
type	O
)	O
.	O

among	O
pregnant	O
women	O
,	O
the	O
prevalence	O
of	O
gestational	B-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
o24	B-code
.	I-code
4	I-code
.	O

in	O
our	O
study	O
,	O
we	O
included	O
patients	O
diagnosed	O
with	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
renal	I-phenotype
disease	I-phenotype
(	O
esrd	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
585	B-code
.	I-code
6	I-code
.	O

patients	O
presenting	O
with	O
acute	B-phenotype
kidney	I-phenotype
injury	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	O
cm	O
code	O
n17	B-code
.	O

the	O
prevalence	O
of	O
pancreatitis	B-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
577	B-code
.	I-code
0	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k85	B-code
.	O

patients	O
experiencing	O
a	O
first	B-phenotype
-	I-phenotype
trimester	I-phenotype
loss	I-phenotype
(	O
miscarriage	O
)	O
were	O
classified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
o03	B-code
(	O
spontaneous	O
miscarriage	O
)	O
and	O
o03	B-code
.	I-code
0	I-code
(	O
complete	O
miscarriage	O
)	O
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
fatigue	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
g93	B-code
.	I-code
3	I-code
.	O

in	O
this	O
study	O
,	O
we	O
examined	O
the	O
association	O
between	O
ischemic	B-phenotype
stroke	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i63	B-code
)	O
and	O
intracerebral	B-phenotype
hemorrhage	I-phenotype
(	O
i61	B-code
)	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
hereditary	B-phenotype
hemorrhagic	I-phenotype
telangiectasia	I-phenotype
(	O
hht	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
448	B-code
.	I-code
0	I-code
.	O

in	O
our	O
study	O
,	O
patients	O
with	O
a	O
history	O
of	O
gestational	B-phenotype
hypertension	I-phenotype
were	O
identified	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
o13	B-code
.	O

the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
for	O
premature	B-phenotype
ovarian	I-phenotype
failure	I-phenotype
is	O
256	B-code
.	I-code
3	I-code
.	O

in	O
this	O
analysis	O
,	O
we	O
examined	O
the	O
association	O
between	O
acute	B-phenotype
lower	I-phenotype
respiratory	I-phenotype
infection	I-phenotype
(	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j22	B-code
)	O
and	O
subsequent	O
asthma	B-phenotype
development	O
(	O
based	O
on	O
the	O
j45	B-code
code	O
)	O
.	O

among	O
patients	O
with	O
early	B-phenotype
-	I-phenotype
onset	I-phenotype
alzheimer	I-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
.	I-code
0	I-code
)	O
,	O
we	O
examined	O
the	O
frequency	O
of	O
amyloid	O
precursor	O
protein	O
(	O
app	O
)	O
mutations	O
.	O

we	O
identified	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
pulmonary	B-phenotype
sarcoidosis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
d86	B-code
.	I-code
0	I-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
diagnosed	O
with	O
cyclothymic	B-phenotype
disorder	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
-	I-coding_system
tr	I-coding_system
code	O
301	B-code
.	I-code
13	I-code
.	O

the	O
diagnosis	O
of	O
turner	B-phenotype
syndrome	I-phenotype
was	O
confirmed	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q96	B-code
and	O
corresponding	O
karyotype	O
analysis	O
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
congenital	B-phenotype
adrenal	I-phenotype
hyperplasia	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e25	B-code
.	I-code
0	I-code
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

in	O
this	O
analysis	O
,	O
we	O
focused	O
on	O
patients	O
with	O
eosinophilic	B-phenotype
esophagitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
530	B-code
.	I-code
13	I-code
.	O

the	O
diagnosis	O
of	O
frontotemporal	B-phenotype
dementia	I-phenotype
was	O
made	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g31	B-code
.	I-code
0	I-code
.	O

in	O
our	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
glaucoma	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
365	B-code
.	O

we	O
included	O
patients	O
diagnosed	O
with	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	O
als	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
2	I-code
.	O

in	O
this	O
study	O
,	O
we	O
analyzed	O
clinical	O
features	O
of	O
behcet	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
m35	B-code
.	I-code
2	I-code
.	O

patients	O
with	O
a	O
history	O
of	O
hereditary	B-phenotype
nonpolyposis	I-phenotype
colorectal	I-phenotype
cancer	I-phenotype
(	O
hnpcc	O
)	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d12	B-code
.	I-code
6	I-code
.	O

the	O
study	O
population	O
consisted	O
of	O
patients	O
with	O
multiple	B-phenotype
myeloma	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
203	B-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c90	B-code
.	O

in	O
this	O
study	O
,	O
we	O
examined	O
the	O
association	O
between	O
peripheral	B-phenotype
artery	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
443	B-code
)	O
and	O
the	O
development	O
of	O
critical	B-phenotype
limb	I-phenotype
ischemia	I-phenotype
(	O
440	B-code
.	I-code
2	I-code
)	O
.	O

according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
criteria	O
,	O
patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
hepatic	I-phenotype
failure	I-phenotype
(	O
k72	B-code
.	I-code
1	I-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
prevalence	O
of	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
516	B-code
.	I-code
3	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	I-code
1	I-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
acute	B-phenotype
pancreatitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
k85	B-code
.	I-code
9	I-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
lymphocytic	I-phenotype
leukemia	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
204	B-code
.	I-code
1	I-code
and	O
corresponding	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c91	B-code
.	I-code
1	I-code
and	O
c91	B-code
.	I-code
10	I-code
.	O

in	O
this	O
study	O
,	O
we	O
examined	O
the	O
prevalence	O
of	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
among	O
the	O
general	O
population	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
acute	B-phenotype
lymphoblastic	I-phenotype
leukemia	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
204	B-code
.	I-code
0	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c91	B-code
.	I-code
0	I-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
eosinophilic	B-phenotype
gastroenteritis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
k52	B-code
.	I-code
89	I-code
.	O

the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
for	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
include	O
code	O
300	B-code
.	I-code
02	I-code
and	O
associated	O
clinical	O
symptoms	O
.	O

in	O
our	O
cohort	O
,	O
we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
granulomatosis	B-phenotype
with	I-phenotype
polyangiitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m31	B-code
.	I-code
3	I-code
.	O

in	O
this	O
study	O
,	O
we	O
analyzed	O
clinical	O
features	O
of	O
duchenne	B-phenotype
muscular	I-phenotype
dystrophy	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
g71	B-code
.	I-code
0	I-code
.	O

the	O
prevalence	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
corresponding	O
clinical	O
documentation	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
idiopathic	B-phenotype
intracranial	I-phenotype
hypertension	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
348	B-code
.	I-code
2	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g93	B-code
.	I-code
2	I-code
.	O

in	O
this	O
study	O
,	O
we	O
identified	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
tourette	B-phenotype
'	I-phenotype
s	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
f95	B-code
.	I-code
2	I-code
.	O

we	O
included	O
patients	O
diagnosed	O
with	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
'	I-phenotype
s	I-phenotype
lymphoma	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
202	B-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c85	B-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
osteoporosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
733	B-code
.	O

patients	O
with	O
a	O
history	O
of	O
omalizumab	B-phenotype
-	I-phenotype
induced	I-phenotype
anaphylaxis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
t80	B-code
.	I-code
52xa	I-code
.	O

the	O
study	O
population	O
consisted	O
of	O
patients	O
with	O
a	O
diagnosis	O
of	O
primary	B-phenotype
open	I-phenotype
-	I-phenotype
angle	I-phenotype
glaucoma	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
365	B-code
.	I-code
11	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h40	B-code
.	I-code
10	I-code
.	O

in	O
this	O
analysis	O
,	O
we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
peripheral	B-phenotype
neuropathy	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
g62	B-code
.	I-code
9	I-code
.	O

the	O
prevalence	O
of	O
primary	B-phenotype
biliary	I-phenotype
cholangitis	I-phenotype
in	O
our	O
cohort	O
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
571	B-code
.	I-code
6	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k74	B-code
.	I-code
3	I-code
.	O

the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
for	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
with	I-phenotype
acute	I-phenotype
exacerbation	I-phenotype
is	O
j44	B-code
.	I-code
1	I-code
.	O

in	O
this	O
study	O
,	O
patients	O
with	O
rectal	B-phenotype
cancer	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
154	B-code
.	I-code
1	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c20	B-code
.	O

we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
acute	B-phenotype
respiratory	I-phenotype
distress	I-phenotype
syndrome	I-phenotype
(	O
ards	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
j80	B-code
.	O

the	O
prevalence	O
of	O
creutzfeldt	B-phenotype
-	I-phenotype
jakob	I-phenotype
disease	I-phenotype
was	O
assessed	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a81	B-code
.	I-code
0	I-code
.	O

in	O
this	O
study	O
,	O
we	O
estimated	O
the	O
risk	O
of	O
cancer	B-phenotype
development	O
among	O
patients	O
with	O
a	O
diagnosis	O
of	O
aicardi	B-phenotype
goutieres	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q04	B-code
.	I-code
8	I-code
.	O

the	O
diagnosis	O
of	O
eosinophilic	B-phenotype
granulomatosis	I-phenotype
with	I-phenotype
polyangiitis	I-phenotype
(	O
egpa	O
)	O
was	O
made	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m30	B-code
.	I-code
1	I-code
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
retinitis	B-phenotype
pigmentosa	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
362	B-code
.	I-code
7	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h35	B-code
.	I-code
5	I-code
.	O

in	O
this	O
study	O
,	O
we	O
examined	O
the	O
association	O
between	O
bronchiectasis	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j47	B-code
)	O
and	O
subsequent	O
development	O
of	O
non	B-phenotype
-	I-phenotype
tuberculous	I-phenotype
mycobacterial	I-phenotype
infection	I-phenotype
(	O
a31	B-code
)	O
.	O

the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
for	O
primary	B-phenotype
biliary	I-phenotype
cirrhosis	I-phenotype
is	O
571	B-code
.	I-code
6	I-code
.	O

in	O
this	O
analysis	O
,	O
we	O
identified	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
myelodysplastic	B-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
d46	B-code
.	I-code
9	I-code
.	O

the	O
diagnosis	O
of	O
niemann	B-phenotype
-	I-phenotype
pick	I-phenotype
disease	I-phenotype
was	O
confirmed	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
272	B-code
.	I-code
7	I-code
and	O
corresponding	O
clinical	O
documentation	O
.	O

in	O
our	O
cohort	O
,	O
patients	O
with	O
a	O
diagnosis	O
of	O
osteoarthritis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
m15	B-code
(	O
polyosteoarthritis	O
)	O
,	O
m16	B-code
(	O
hip	O
osteoarthritis	O
)	O
,	O
and	O
m17	B-code
(	O
knee	O
osteoarthritis	O
)	O
.	O

we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
acromegaly	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
253	B-code
.	I-code
0	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e22	B-code
.	I-code
0	I-code
.	O

in	O
this	O
study	O
,	O
we	O
examined	O
the	O
association	O
between	O
cerebral	B-phenotype
palsy	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g80	B-code
)	O
and	O
the	O
prevalence	O
of	O
intellectual	B-phenotype
disability	I-phenotype
(	O
f70	B-code
-	O
f79	B-code
)	O
.	O

the	O
prevalence	O
of	O
thrombotic	B-phenotype
thrombocytopenic	I-phenotype
purpura	I-phenotype
was	O
estimated	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m31	B-code
.	I-code
1	I-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
wilson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
were	O
identified	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
275	B-code
.	I-code
1	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e83	B-code
.	I-code
0	I-code
.	O

among	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
primary	B-phenotype
sclerosing	I-phenotype
cholangitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
576	B-code
.	I-code
1	I-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k83	B-code
.	I-code
01	I-code
)	O
,	O
we	O
examined	O
the	O
frequency	O
of	O
concurrent	O
inflammatory	B-phenotype
bowel	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
555	B-code
and	O
556	B-code
)	O
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
marfan	B-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
759	B-code
.	I-code
82	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q87	B-code
.	I-code
4	I-code
.	O

the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
for	O
acute	B-phenotype
interstitial	I-phenotype
nephritis	I-phenotype
is	O
n10	B-code
.	O

patients	O
with	O
a	O
history	O
of	O
light	B-phenotype
chain	I-phenotype
amyloidosis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
277	B-code
.	I-code
3	I-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e85	B-code
.	I-code
4	I-code
.	O

in	O
this	O
study	O
,	O
we	O
identified	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
primary	B-phenotype
aldosteronism	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
e26	B-code
.	I-code
0	I-code
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
sporadic	B-phenotype
creutzfeldt	I-phenotype
-	I-phenotype
jakob	I-phenotype
disease	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
a81	B-code
.	I-code
0	I-code
and	O
subsequent	O
genetic	O
testing	O
.	O

the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
for	O
hemolytic	B-phenotype
uremic	I-phenotype
syndrome	I-phenotype
is	O
d59	B-code
.	I-code
3	I-code
.	O

in	O
this	O
study	O
,	O
we	O
examined	O
the	O
association	O
between	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
)	O
and	O
uveitis	B-phenotype
(	O
h30	B-code
-	O
h33	B-code
)	O
among	O
our	O
patient	O
population	O
.	O

we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
otosclerosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
387	B-code
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h80	B-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
giant	B-phenotype
cell	I-phenotype
arteritis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m31	B-code
.	I-code
5	I-code
.	O

a	O
total	O
of	O
1357	O
individuals	O
with	O
an	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
diagnosis	O
of	O
c50	B-code
(	O
malignant	B-phenotype
neoplasm	I-phenotype
of	I-phenotype
the	I-phenotype
breast	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
diagnosis	O
code	O
250	B-code
.	I-code
0	I-code
(	O
diabetes	B-phenotype
mellitus	I-phenotype
without	I-phenotype
mention	I-phenotype
of	I-phenotype
complication	I-phenotype
)	O
were	O
classified	O
as	O
having	O
type	O
2	O
diabetes	O
.	O

the	O
most	O
frequent	O
congenital	O
anomaly	O
was	O
down	B-phenotype
syndrome	I-phenotype
,	O
with	O
a	O
total	O
of	O
52	O
cases	O
,	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q90	B-code
.	O

the	O
clinical	O
phenotype	O
of	O
omim	B-coding_system
entry	O
220100	B-code
(	O
achondroplasia	B-phenotype
)	O
is	O
characterized	O
by	O
short	O
stature	O
,	O
macrocephaly	O
,	O
and	O
various	O
skeletal	O
abnormalities	O
.	O

a	O
total	O
of	O
417	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
diagnosis	O
codes	O
i60	B-code
–	I-code
i69	I-code
(	O
cerebrovascular	B-phenotype
diseases	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
427	B-code
.	I-code
31	I-code
(	O
atrial	B-phenotype
fibrillation	I-phenotype
)	O
and	O
a	O
history	O
of	O
hypertension	O
.	O

we	O
identified	O
235	O
patients	O
with	O
biopsy	O
-	O
proven	O
diagnosis	O
of	O
lupus	B-phenotype
nephritis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	I-code
14	I-code
.	O

data	O
was	O
extracted	O
for	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
6a00	B-code
.	I-code
0	I-code
(	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
)	O
.	O

the	O
patient	O
population	O
included	O
individuals	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
(	O
asthma	B-phenotype
)	O
,	O
along	O
with	O
the	O
presence	O
of	O
at	O
least	O
one	O
comorbid	O
condition	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
diagnosis	O
codes	O
295	B-code
to	O
298	B-code
(	O
schizophrenia	B-phenotype
spectrum	I-phenotype
and	I-phenotype
other	I-phenotype
psychotic	I-phenotype
disorders	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

a	O
total	O
of	O
670	O
patients	O
diagnosed	O
with	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
5b45	B-code
.	I-code
00	I-code
(	O
ankylosing	B-phenotype
spondylitis	I-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
(	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
)	O
and	O
without	O
cardiovascular	O
complications	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
included	O
patients	O
with	O
major	O
depressive	O
disorder	O
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f32	B-code
or	O
bipolar	B-phenotype
disorder	I-phenotype
with	O
code	O
f31	B-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
428	B-code
(	O
congestive	B-phenotype
heart	I-phenotype
failure	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

patients	O
with	O
an	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
of	O
k11	B-code
.	I-code
7	I-code
(	O
sjogren	B-phenotype
'	I-phenotype
s	I-phenotype
syndrome	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
sample	O
.	O

the	O
study	O
included	O
individuals	O
with	O
a	O
primary	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
714	B-code
.	I-code
0	I-code
(	O
rheumatoid	B-phenotype
arthritis	I-phenotype
)	O
and	O
at	O
least	O
one	O
comorbid	O
condition	O
.	O

patients	O
with	O
omim	B-coding_system
code	O
266600	B-code
(	O
phenylketonuria	B-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
clinical	O
manifestations	O
of	O
the	O
omim	B-coding_system
entry	O
301000	B-code
(	O
duchenne	B-phenotype
muscular	I-phenotype
dystrophy	I-phenotype
)	O
include	O
progressive	O
muscle	O
weakness	O
and	O
respiratory	O
insufficiency	O
.	O

we	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
(	O
multiple	B-phenotype
sclerosis	I-phenotype
)	O
in	O
our	O
study	O
.	O

a	O
total	O
of	O
120	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
(	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i25	B-code
and	O
i50	B-code
(	O
ischemic	B-phenotype
heart	I-phenotype
disease	I-phenotype
and	I-phenotype
congestive	I-phenotype
heart	I-phenotype
failure	I-phenotype
)	O
.	O

patients	O
with	O
an	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
of	O
573	B-code
.	I-code
3	I-code
(	O
nonalcoholic	B-phenotype
fatty	I-phenotype
liver	I-phenotype
disease	I-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

a	O
total	O
of	O
723	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e66	B-code
(	O
obesity	B-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
investigated	O
the	O
association	O
between	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c18	B-code
(	O
malignant	B-phenotype
neoplasm	I-phenotype
of	I-phenotype
the	I-phenotype
colon	I-phenotype
)	O
and	O
various	O
risk	O
factors	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
8a60	B-code
(	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
491	B-code
,	I-code
493	I-code
,	O
and	O
496	B-code
(	O
chronic	B-phenotype
bronchitis	I-phenotype
,	I-phenotype
asthma	I-phenotype
,	I-phenotype
and	I-phenotype
chronic	I-phenotype
airway	I-phenotype
obstruction	I-phenotype
)	O
.	O

we	O
identified	O
cases	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q61	B-code
.	I-code
2	I-code
(	O
autosomal	B-phenotype
dominant	I-phenotype
polycystic	I-phenotype
kidney	I-phenotype
disease	I-phenotype
)	O
in	O
our	O
dataset	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
135	B-code
(	O
sarcoidosis	B-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

the	O
clinical	O
features	O
of	O
the	O
omim	B-coding_system
entry	O
200600	B-code
(	O
barth	B-phenotype
syndrome	I-phenotype
)	O
include	O
cardiomyopathy	O
,	O
neutropenia	O
,	O
and	O
skeletal	O
myopathy	O
.	O

a	O
total	O
of	O
328	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
.	I-code
3	I-code
(	O
idiopathic	B-phenotype
generalized	I-phenotype
epilepsy	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

we	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
696	B-code
.	I-code
1	I-code
(	O
psoriasis	B-phenotype
)	O
in	O
the	O
analysis	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m06	B-code
.	I-code
9	I-code
(	O
seronegative	B-phenotype
rheumatoid	I-phenotype
arthritis	I-phenotype
)	O
.	O

patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i20	B-code
.	I-code
0	I-code
(	O
unstable	B-phenotype
angina	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

individuals	O
with	O
omim	B-coding_system
code	O
162200	B-code
(	O
marfan	B-phenotype
syndrome	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

we	O
identified	O
45	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
123	B-code
.	I-code
1	I-code
(	O
trichinellosis	B-phenotype
)	O
in	O
our	O
dataset	O
.	O

a	O
total	O
of	O
287	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h60	B-code
(	O
otitis	B-phenotype
externa	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
(	O
sleep	B-phenotype
disorders	I-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
diagnosis	O
code	O
525	B-code
.	I-code
0	I-code
(	O
periodontitis	B-phenotype
)	O
.	O

we	O
included	O
560	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j30	B-code
(	O
allergic	B-phenotype
rhinitis	I-phenotype
)	O
in	O
our	O
analysis	O
.	O

the	O
study	O
population	O
consisted	O
of	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
150	B-code
(	O
malignant	B-phenotype
neoplasm	I-phenotype
of	I-phenotype
the	I-phenotype
esophagus	I-phenotype
)	O
.	O

a	O
total	O
of	O
450	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m23	B-code
.	I-code
2	I-code
(	O
meniscal	B-phenotype
tear	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
276	B-code
.	I-code
2	I-code
(	O
acidosis	B-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
investigated	O
the	O
association	O
between	O
cardiovascular	B-phenotype
events	I-phenotype
and	O
the	O
novelty	O
-	O
seeking	O
trait	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i21	B-code
,	O
i61	B-code
,	O
and	O
i63	B-code
(	O
myocardial	O
infarction	O
,	O
intracranial	O
hemorrhage	O
,	O
and	O
cerebral	O
infarction	O
,	O
respectively	O
)	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h35	B-code
.	I-code
3	I-code
(	O
age	B-phenotype
-	I-phenotype
related	I-phenotype
macular	I-phenotype
degeneration	I-phenotype
)	O
.	O

a	O
total	O
of	O
300	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
155	B-code
(	O
malignant	B-phenotype
neoplasm	I-phenotype
of	I-phenotype
the	I-phenotype
liver	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e03	B-code
.	I-code
9	I-code
(	O
hypothyroidism	B-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

the	O
clinical	O
phenotype	O
of	O
omim	B-coding_system
entry	O
277800	B-code
(	O
sialidosis	B-phenotype
)	O
is	O
characterized	O
by	O
progressive	O
muscle	O
weakness	O
,	O
neurological	O
symptoms	O
,	O
and	O
coarse	O
facial	O
features	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k25	B-code
(	O
gastric	B-phenotype
ulcer	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

we	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
274	B-code
.	I-code
1	I-code
(	O
gout	B-phenotype
)	O
in	O
the	O
analysis	O
.	O

a	O
total	O
of	O
835	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m54	B-code
.	I-code
5	I-code
(	O
low	B-phenotype
back	I-phenotype
pain	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
(	O
psoriasis	B-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

individuals	O
with	O
omim	B-coding_system
code	O
251300	B-code
(	O
menkes	B-phenotype
disease	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
191	B-code
(	O
malignant	B-phenotype
neoplasm	I-phenotype
of	I-phenotype
the	I-phenotype
brain	I-phenotype
)	O
.	O

a	O
total	O
of	O
1056	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i83	B-code
(	O
varicose	B-phenotype
veins	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
clinical	O
features	O
of	O
the	O
omim	B-coding_system
entry	O
235200	B-code
(	O
prader	B-phenotype
-	I-phenotype
willi	I-phenotype
syndrome	I-phenotype
)	O
include	O
marked	O
hypotonia	O
,	O
obesity	O
,	O
and	O
intellectual	O
disability	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
305	B-code
.	I-code
1	I-code
(	O
tobacco	B-phenotype
use	I-phenotype
disorder	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

a	O
total	O
of	O
790	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i42	B-code
.	I-code
0	I-code
(	O
dilated	B-phenotype
cardiomyopathy	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g45	B-code
(	O
transient	B-phenotype
ischemic	I-phenotype
attack	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

we	O
identified	O
cases	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n39	B-code
.	I-code
0	I-code
(	O
urinary	B-phenotype
tract	I-phenotype
infection	I-phenotype
)	O
in	O
our	O
dataset	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
358	B-code
.	I-code
0	I-code
(	O
myasthenia	B-phenotype
gravis	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

a	O
total	O
of	O
375	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
r33	B-code
(	O
urinary	B-phenotype
retention	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
444	B-code
.	I-code
22	I-code
(	O
arterial	B-phenotype
embolism	I-phenotype
and	I-phenotype
thrombosis	I-phenotype
of	I-phenotype
the	I-phenotype
lower	I-phenotype
extremities	I-phenotype
)	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j22	B-code
(	O
unspecified	B-phenotype
acute	I-phenotype
lower	I-phenotype
respiratory	I-phenotype
infection	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
3a00	B-code
.	I-code
1	I-code
(	O
essential	B-phenotype
hypertension	I-phenotype
)	O
.	O

we	O
included	O
patients	O
with	O
major	O
depressive	O
disorder	O
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f32	B-code
or	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
with	O
a	O
code	O
of	O
f41	B-code
.	I-code
1	I-code
.	O

individuals	O
with	O
omim	B-coding_system
code	O
268040	B-code
(	O
rett	B-phenotype
syndrome	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

a	O
total	O
of	O
683	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n10	B-code
(	O
acute	B-phenotype
tubulo	I-phenotype
-	I-phenotype
interstitial	I-phenotype
nephritis	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
357	B-code
.	I-code
0	I-code
(	O
diabetic	B-phenotype
neuropathy	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
clinical	O
phenotype	O
of	O
omim	B-coding_system
entry	O
151660	B-code
(	O
cystic	B-phenotype
fibrosis	I-phenotype
)	O
is	O
characterized	O
by	O
chronic	O
lung	O
disease	O
,	O
pancreatic	O
insufficiency	O
,	O
and	O
elevated	O
sweat	O
chloride	O
levels	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d50	B-code
.	I-code
0	I-code
(	O
iron	B-phenotype
deficiency	I-phenotype
anemia	I-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
m51	B-code
.	I-code
2	I-code
and	O
m51	B-code
.	I-code
3	I-code
(	O
lumbar	B-phenotype
and	I-phenotype
lumbosacral	I-phenotype
intervertebral	I-phenotype
disc	I-phenotype
degeneration	I-phenotype
)	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
390	B-code
(	O
rheumatic	B-phenotype
fever	I-phenotype
without	I-phenotype
mention	I-phenotype
of	I-phenotype
heart	I-phenotype
involvement	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

we	O
identified	O
315	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e60	B-code
(	O
nutritional	B-phenotype
-	I-phenotype
related	I-phenotype
hair	I-phenotype
loss	I-phenotype
)	O
in	O
our	O
dataset	O
.	O

a	O
total	O
of	O
547	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k44	B-code
(	O
diaphragmatic	B-phenotype
hernia	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k85	B-code
(	O
acute	B-phenotype
pancreatitis	I-phenotype
)	O
and	O
a	O
history	O
of	O
alcohol	O
consumption	O
.	O

patients	O
with	O
omim	B-coding_system
code	O
109650	B-code
(	O
alport	B-phenotype
syndrome	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
clinical	O
manifestations	O
of	O
the	O
omim	B-coding_system
entry	O
173200	B-code
(	O
neurofibromatosis	B-phenotype
type	I-phenotype
1	I-phenotype
)	O
include	O
cafe	O
-	O
au	O
-	O
lait	O
macules	O
,	O
axillary	O
freckling	O
,	O
and	O
lisch	O
nodules	O
.	O

patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
(	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
included	O
980	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
585	B-code
(	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
)	O
in	O
our	O
analysis	O
.	O

a	O
total	O
of	O
285	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h81	B-code
(	O
vertigo	B-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
162	B-code
.	I-code
9	I-code
(	O
malignant	B-phenotype
neoplasm	I-phenotype
of	I-phenotype
the	I-phenotype
lung	I-phenotype
)	O
,	O
along	O
with	O
the	O
presence	O
of	O
at	O
least	O
one	O
comorbid	O
condition	O
.	O

patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e23	B-code
.	I-code
0	I-code
(	O
hypopituitarism	B-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

individuals	O
with	O
omim	B-coding_system
code	O
308300	B-code
(	O
fabry	B-phenotype
disease	I-phenotype
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
clinical	O
phenotype	O
of	O
omim	B-coding_system
entry	O
135100	B-code
(	O
tay	B-phenotype
-	I-phenotype
sachs	I-phenotype
disease	I-phenotype
)	O
is	O
characterized	O
by	O
progressive	O
neurological	O
deterioration	O
,	O
seizures	O
,	O
and	O
muscle	O
weakness	O
.	O

a	O
total	O
of	O
467	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
410	B-code
(	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i05	B-code
,	I-code
i06	I-code
,	I-code
i08	I-code
,	O
and	O
i09	B-code
(	O
chronic	B-phenotype
rheumatic	I-phenotype
heart	I-phenotype
diseases	I-phenotype
)	O
in	O
the	O
analysis	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
5c62	B-code
(	O
osteoarthritis	B-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
157	B-code
(	O
malignant	B-phenotype
neoplasm	I-phenotype
of	I-phenotype
the	I-phenotype
pancreas	I-phenotype
)	O
.	O

patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c22	B-code
.	I-code
0	I-code
(	O
hepatocellular	B-phenotype
carcinoma	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

a	O
total	O
of	O
748	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
578	B-code
.	I-code
1	I-code
(	O
gastrointestinal	B-phenotype
hemorrhage	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

the	O
clinical	O
features	O
of	O
the	O
omim	B-coding_system
entry	O
175200	B-code
(	O
osteogenesis	B-phenotype
imperfecta	I-phenotype
)	O
include	O
bone	O
fragility	O
,	O
fracture	O
susceptibility	O
,	O
and	O
blue	O
sclerae	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
(	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

the	O
study	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
345	B-code
(	O
epilepsy	B-phenotype
)	O
and	O
a	O
history	O
of	O
seizures	O
.	O

we	O
identified	O
235	O
patients	O
with	O
biopsy	O
-	O
proven	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	I-code
1	I-code
(	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
)	O
.	O

a	O
total	O
of	O
339	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i83	B-code
(	O
retinal	B-phenotype
vein	I-phenotype
occlusion	I-phenotype
)	O
were	O
included	O
in	O
our	O
study	O
.	O

patients	O
with	O
a	O
history	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
711	B-code
.	I-code
1	I-code
(	O
pyogenic	B-phenotype
arthritis	I-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
clinical	O
phenotype	O
of	O
omim	B-coding_system
entry	O
207410	B-code
(	O
greig	B-phenotype
cephalopolysyndactyly	I-phenotype
syndrome	I-phenotype
)	O
is	O
characterized	O
by	O
craniosynostosis	O
,	O
facial	O
dysmorphism	O
,	O
and	O
abnormal	O
digits	O
.	O

we	O
included	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f44	B-code
(	O
dissociative	B-phenotype
disorders	I-phenotype
)	O
in	O
the	O
analysis	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
pa70	B-code
.	I-code
4	I-code
(	O
growing	B-phenotype
pains	I-phenotype
)	O
were	O
included	O
in	O
our	O
analysis	O
.	O

a	O
total	O
of	O
315	O
patients	O
with	O
a	O
diagnosis	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h10	B-code
.	I-code
9	I-code
(	O
conjunctivitis	B-phenotype
)	O
were	O
included	O
in	O
the	O
study	O
.	O
the	O
study	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
)	O
and	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
)	O
who	O
were	O
on	O
insulin	O
therapy	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
410	B-code
-	I-code
414	I-code
for	O
ischemic	B-phenotype
heart	I-phenotype
disease	I-phenotype
and	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
430	B-code
-	I-code
438	I-code
for	O
cerebrovascular	B-phenotype
disease	I-phenotype
.	O

the	O
study	O
participants	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
rheumatoid	B-phenotype
arthritis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
-	I-code
m06	I-code
and	O
were	O
aged	O
between	O
18	O
and	O
75	O
years	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
copd	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
490	B-code
-	I-code
492	I-code
and	O
496	B-code
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
asthma	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
and	O
who	O
were	O
receiving	O
inhaled	O
corticosteroid	O
therapy	O
.	O

data	O
were	O
collected	O
from	O
patients	O
with	O
a	O
diagnosis	O
of	O
congenital	B-phenotype
heart	I-phenotype
defects	I-phenotype
according	O
to	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
745	B-code
-	I-code
747	I-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
q20	B-code
-	I-code
q26	I-code
.	O

we	O
included	O
patients	O
who	O
had	O
a	O
documented	O
history	O
of	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
and	O
were	O
receiving	O
cholinesterase	O
inhibitor	O
treatment	O
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
and	O
receiving	O
levodopa	O
therapy	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
epilepsy	B-phenotype
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
345	B-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g40	B-code
-	I-code
g41	I-code
who	O
were	O
being	O
treated	O
with	O
antiepileptic	O
drugs	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
diagnosed	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
receiving	O
nonsteroidal	O
anti	O
-	O
inflammatory	O
drugs	O
(	O
nsaids	O
)	O
or	O
tumor	O
necrosis	O
factor	O
(	O
tnf	O
)	O
inhibitors	O
.	O

patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
depressive	B-phenotype
disorder	I-phenotype
(	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f32	B-code
-	I-code
f33	I-code
)	O
and	O
undergoing	O
antidepressant	O
therapy	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
examined	O
data	O
from	O
patients	O
diagnosed	O
with	O
bipolar	B-phenotype
disorder	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f30	B-code
-	I-code
f31	I-code
and	O
receiving	O
mood	O
stabilizer	O
therapy	O
.	O

the	O
patient	O
cohort	O
included	O
those	O
with	O
a	O
primary	O
schizophrenia	B-phenotype
diagnosis	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f20	B-code
and	O
receiving	O
antipsychotic	O
medication	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
primary	O
diagnosis	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f84	B-code
.	I-code
0	I-code
-	I-code
f84	I-code
.	I-code
5	I-code
.	O

we	O
included	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
multiple	B-phenotype
sclerosis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
and	O
receiving	O
disease	O
-	O
modifying	O
therapies	O
.	O

the	O
study	O
population	O
consisted	O
of	O
individuals	O
with	O
dementia	B-phenotype
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f01	B-code
-	I-code
f03	I-code
and	O
receiving	O
pharmacological	O
treatment	O
.	O

we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
ocd	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f42	B-code
and	O
receiving	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
(	O
ssris	O
)	O
therapy	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
posttraumatic	B-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
ptsd	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f43	B-code
.	I-code
1	I-code
and	O
were	O
receiving	O
psychotherapy	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
(	O
ibs	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
and	O
receiving	O
treatment	O
with	O
antispasmodic	O
agents	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
patient	O
cohort	O
comprised	O
individuals	O
diagnosed	O
with	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
sle	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
and	O
receiving	O
corticosteroid	O
or	O
immunosuppressive	O
therapy	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
ckd	O
)	O
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
and	O
receiving	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ace	O
)	O
inhibitors	O
or	O
angiotensin	O
receptor	O
blockers	O
(	O
arbs	O
)	O
.	O

the	O
study	O
population	O
consisted	O
of	O
patients	O
with	O
a	O
diagnosis	O
of	O
psoriasis	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
and	O
receiving	O
topical	O
or	O
systemic	O
treatment	O
.	O

we	O
included	O
patients	O
who	O
had	O
a	O
primary	O
diagnosis	O
of	O
osteoporosis	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m81	B-code
and	O
receiving	O
bisphosphonate	O
therapy	O
.	O

patients	O
diagnosed	O
with	O
chronic	B-phenotype
hepatitis	I-phenotype
b	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
1	I-code
and	O
receiving	O
antiviral	O
therapy	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
participants	O
were	O
diagnosed	O
with	O
chronic	B-phenotype
hepatitis	I-phenotype
c	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
2	I-code
and	O
receiving	O
directly	O
acting	O
antiviral	O
(	O
daa	O
)	O
therapy	O
.	O

we	O
enrolled	O
patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
pancreatitis	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k86	B-code
.	I-code
1	I-code
and	O
receiving	O
pancreatic	O
enzyme	O
replacement	O
therapy	O
(	O
pert	O
)	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
with	O
cystic	B-phenotype
fibrosis	I-phenotype
(	O
cf	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
and	O
receiving	O
cystic	O
fibrosis	O
transmembrane	O
conductance	O
regulator	O
(	O
cftr	O
)	O
modulators	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
endometriosis	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
and	O
receiving	O
hormonal	O
or	O
surgical	O
therapy	O
.	O

the	O
study	O
population	O
comprised	O
individuals	O
with	O
a	O
primary	O
diagnosis	O
of	O
uterine	B-phenotype
fibroids	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d25	B-code
and	O
receiving	O
medical	O
or	O
surgical	O
treatment	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
a	O
diagnosis	O
of	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
and	O
receiving	O
corticosteroids	O
or	O
immunosuppressant	O
therapy	O
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
diagnosed	O
with	O
ulcerative	B-phenotype
colitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
and	O
receiving	O
anti	O
-	O
inflammatory	O
or	O
immunosuppressive	O
medication	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
glaucoma	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
h40	B-code
-	I-code
h42	I-code
and	O
receiving	O
pressure	O
-	O
lowering	O
eye	O
drops	O
.	O

we	O
enrolled	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
cataracts	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h25	B-code
who	O
underwent	O
cataract	O
surgery	O
.	O

the	O
study	O
population	O
included	O
patients	O
diagnosed	O
with	O
age	B-phenotype
-	I-phenotype
related	I-phenotype
macular	I-phenotype
degeneration	I-phenotype
(	O
amd	O
)	O
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h35	B-code
.	I-code
3	I-code
and	O
receiving	O
intravitreal	O
anti	O
-	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
vegf	O
)	O
injections	O
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
diagnosed	O
with	O
heart	B-phenotype
failure	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i50	B-code
and	O
receiving	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ace	O
)	O
inhibitors	O
or	O
beta	O
-	O
blockers	O
.	O

we	O
included	O
patients	O
who	O
had	O
a	O
primary	O
diagnosis	O
of	O
hypertension	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i10	B-code
and	O
were	O
receiving	O
antihypertensive	O
medication	O
.	O

the	O
study	O
participants	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
atrial	B-phenotype
fibrillation	I-phenotype
(	O
af	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
and	O
were	O
receiving	O
oral	O
anticoagulant	O
therapy	O
.	O

participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
peripheral	B-phenotype
arterial	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i73	B-code
.	I-code
9	I-code
and	O
receiving	O
antiplatelet	O
or	O
anticoagulant	O
therapy	O
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
with	O
a	O
diagnosis	O
of	O
deep	B-phenotype
vein	I-phenotype
thrombosis	I-phenotype
(	O
dvt	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
453	B-code
.	I-code
4	I-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i82	B-code
.	I-code
4	I-code
who	O
were	O
receiving	O
anticoagulation	O
therapy	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
pulmonary	B-phenotype
embolism	I-phenotype
(	O
pe	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
415	B-code
.	I-code
1	I-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i26	B-code
who	O
were	O
receiving	O
anticoagulation	O
therapy	O
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
acute	B-phenotype
coronary	I-phenotype
syndrome	I-phenotype
(	O
acs	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i20	B-code
.	I-code
0	I-code
and	O
i21	B-code
and	O
receiving	O
percutaneous	O
coronary	O
intervention	O
(	O
pci	O
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
venous	B-phenotype
leg	I-phenotype
ulcers	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i83	B-code
.	I-code
0	I-code
who	O
were	O
receiving	O
compression	O
therapy	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
primary	O
diagnosis	O
of	O
diabetic	B-phenotype
retinopathy	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h36	B-code
.	I-code
0	I-code
and	O
were	O
receiving	O
laser	O
photocoagulation	O
.	O

we	O
enrolled	O
patients	O
with	O
a	O
diagnosis	O
of	O
cholangiocarcinoma	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c22	B-code
.	I-code
1	I-code
who	O
underwent	O
surgical	O
resection	O
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
rotator	B-phenotype
cuff	I-phenotype
tear	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m75	B-code
.	I-code
1	I-code
and	O
receiving	O
arthroscopic	O
repair	O
were	O
included	O
in	O
the	O
study	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
spinal	B-phenotype
stenosis	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m48	B-code
.	I-code
0	I-code
-	I-code
m48	I-code
.	I-code
1	I-code
and	O
underwent	O
decompression	O
surgery	O
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
with	O
a	O
primary	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
receiving	O
biologic	O
therapy	O
.	O

we	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
head	B-phenotype
and	I-phenotype
neck	I-phenotype
cancer	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c00	B-code
-	I-code
c14	I-code
and	O
who	O
were	O
undergoing	O
chemoradiotherapy	O
.	O

the	O
study	O
population	O
included	O
individuals	O
diagnosed	O
with	O
melanoma	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c43	B-code
and	O
receiving	O
immunotherapy	O
treatment	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
ovarian	B-phenotype
cancer	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c56	B-code
and	O
undergoing	O
cytoreductive	O
surgery	O
and	O
adjuvant	O
chemotherapy	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
who	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
prostate	B-phenotype
cancer	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c61	B-code
and	O
receiving	O
radiation	O
therapy	O
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
diagnosed	O
with	O
breast	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c50	B-code
and	O
receiving	O
neoadjuvant	O
or	O
adjuvant	O
chemotherapy	O
.	O

participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
non	B-phenotype
-	I-phenotype
small	I-phenotype
cell	I-phenotype
lung	I-phenotype
cancer	I-phenotype
(	O
nsclc	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c34	B-code
and	O
receiving	O
targeted	O
therapy	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
colorectal	B-phenotype
cancer	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c18	B-code
-	I-code
c20	I-code
who	O
underwent	O
surgical	O
resection	O
and	O
adjuvant	O
chemotherapy	O
.	O

the	O
study	O
population	O
included	O
individuals	O
with	O
a	O
primary	O
diagnosis	O
of	O
renal	B-phenotype
cell	I-phenotype
carcinoma	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c64	B-code
and	O
receiving	O
tyrosine	O
kinase	O
inhibitors	O
(	O
tkis	O
)	O
treatment	O
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
acute	B-phenotype
lymphoblastic	I-phenotype
leukemia	I-phenotype
(	O
all	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c91	B-code
.	I-code
0	I-code
and	O
undergoing	O
induction	O
chemotherapy	O
were	O
included	O
in	O
the	O
study	O
.	O

we	O
enrolled	O
patients	O
diagnosed	O
with	O
acute	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
(	O
aml	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c92	B-code
.	I-code
0	I-code
and	O
receiving	O
chemotherapy	O
or	O
hematopoietic	O
stem	O
cell	O
transplantation	O
(	O
hsct	O
)	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
chronic	B-phenotype
lymphocytic	I-phenotype
leukemia	I-phenotype
(	O
cll	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c91	B-code
.	I-code
1	I-code
and	O
receiving	O
targeted	O
therapy	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
(	O
cml	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c92	B-code
.	I-code
1	I-code
and	O
receiving	O
tyrosine	O
kinase	O
inhibitors	O
(	O
tkis	O
)	O
treatment	O
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
diagnosed	O
with	O
multiple	B-phenotype
myeloma	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c90	B-code
.	I-code
0	I-code
and	O
receiving	O
proteasome	O
inhibitors	O
or	O
immunomodulatory	O
agents	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
lymphoma	I-phenotype
(	O
nhl	O
)	O
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c82	B-code
-	I-code
c85	I-code
and	O
receiving	O
rituximab	O
-	O
based	O
chemotherapy	O
.	O

the	O
study	O
population	O
included	O
individuals	O
with	O
a	O
primary	O
diagnosis	O
of	O
hodgkin	B-phenotype
lymphoma	I-phenotype
(	O
hl	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c81	B-code
and	O
receiving	O
doxorubicin	O
,	O
bleomycin	O
,	O
vinblastine	O
,	O
and	O
dacarbazine	O
(	O
abvd	O
)	O
chemotherapy	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
a	O
diagnosis	O
of	O
carpal	B-phenotype
tunnel	I-phenotype
syndrome	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g56	B-code
.	I-code
0	I-code
who	O
underwent	O
carpal	O
tunnel	O
release	O
surgery	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
who	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
erectile	B-phenotype
dysfunction	I-phenotype
(	O
ed	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n52	B-code
and	O
receiving	O
phosphodiesterase	O
type	O
-	O
5	O
inhibitors	O
(	O
pde5is	O
)	O
therapy	O
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
diagnosed	O
with	O
premature	B-phenotype
ejaculation	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f52	B-code
.	I-code
4	I-code
and	O
receiving	O
treatment	O
with	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
(	O
ssris	O
)	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
prostatitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n41	B-code
.	I-code
1	I-code
and	O
receiving	O
alpha	O
-	O
blocker	O
or	O
antibiotic	O
therapy	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
benign	B-phenotype
prostatic	I-phenotype
hyperplasia	I-phenotype
(	O
bph	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n40	B-code
and	O
receiving	O
5	O
-	O
alpha	O
-	O
reductase	O
inhibitors	O
or	O
alpha	O
-	O
blocker	O
therapy	O
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
(	O
pcos	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
and	O
receiving	O
metformin	O
or	O
hormonal	O
therapy	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
population	O
included	O
individuals	O
diagnosed	O
with	O
fibromyalgia	B-phenotype
(	O
fm	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
and	O
receiving	O
pharmacological	O
therapy	O
.	O

the	O
patient	O
cohort	O
included	O
those	O
with	O
a	O
primary	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
receiving	O
physical	O
therapy	O
.	O

we	O
enrolled	O
patients	O
with	O
a	O
diagnosis	O
of	O
gout	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m10	B-code
and	O
receiving	O
treatment	O
with	O
urate	O
-	O
lowering	O
therapy	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
osteonecrosis	B-phenotype
of	I-phenotype
the	I-phenotype
jaw	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m87	B-code
.	I-code
0	I-code
and	O
receiving	O
treatment	O
with	O
bisphosphonate	O
or	O
denosumab	O
therapy	O
.	O

the	O
study	O
participants	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
bronchiolitis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j21	B-code
and	O
receiving	O
supportive	O
therapy	O
.	O

we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
renal	I-phenotype
disease	I-phenotype
(	O
esrd	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
5	I-code
and	O
undergoing	O
hemodialysis	O
or	O
peritoneal	O
dialysis	O
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
diagnosed	O
with	O
chronic	B-phenotype
migraine	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g43	B-code
.	I-code
7	I-code
and	O
receiving	O
treatment	O
with	O
botulinum	O
toxin	O
or	O
calcitonin	O
gene	O
-	O
related	O
peptide	O
(	O
cgrp	O
)	O
inhibitors	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
cleft	B-phenotype
lip	I-phenotype
and	I-phenotype
palate	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
q35	B-code
-	I-code
q37	I-code
who	O
underwent	O
surgical	O
repair	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	O
als	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
2	I-code
and	O
receiving	O
riluzole	O
or	O
edaravone	O
therapy	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
muscular	B-phenotype
dystrophy	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g71	B-code
.	I-code
0	I-code
and	O
receiving	O
corticosteroid	O
therapy	O
or	O
gene	O
-	O
targeted	O
treatment	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
primary	O
diagnosis	O
of	O
hemophilia	B-phenotype
a	I-phenotype
or	I-phenotype
b	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
d66	B-code
and	O
d67	B-code
and	O
receiving	O
factor	O
replacement	O
therapy	O
or	O
emicizumab	O
prophylaxis	O
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
diagnosed	O
with	O
iron	B-phenotype
deficiency	I-phenotype
anemia	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d50	B-code
.	I-code
9	I-code
and	O
receiving	O
oral	O
or	O
intravenous	O
iron	O
therapy	O
.	O

we	O
included	O
patients	O
who	O
had	O
a	O
primary	O
diagnosis	O
of	O
hemorrhoids	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i84	B-code
and	O
receiving	O
rubber	O
band	O
ligation	O
or	O
sclerotherapy	O
treatment	O
.	O

the	O
study	O
population	O
consisted	O
of	O
patients	O
with	O
a	O
diagnosis	O
of	O
sickle	B-phenotype
cell	I-phenotype
disease	I-phenotype
(	O
scd	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d57	B-code
and	O
receiving	O
hydroxyurea	O
therapy	O
or	O
red	O
blood	O
cell	O
transfusions	O
.	O

participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
thalassemia	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d56	B-code
and	O
receiving	O
blood	O
transfusion	O
or	O
iron	O
chelation	O
therapy	O
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
with	O
a	O
primary	O
diagnosis	O
of	O
vitiligo	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l80	B-code
and	O
receiving	O
phototherapy	O
or	O
topical	O
corticosteroid	O
therapy	O
.	O

we	O
enrolled	O
patients	O
with	O
a	O
diagnosis	O
of	O
lichen	B-phenotype
planus	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l43	B-code
and	O
receiving	O
topical	O
or	O
systemic	O
treatment	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
who	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
psoriatic	B-phenotype
arthritis	I-phenotype
(	O
psa	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
.	I-code
5	I-code
and	O
receiving	O
tumor	O
necrosis	O
factor	O
(	O
tnf	O
)	O
inhibitors	O
or	O
interleukin	O
-	O
17	O
(	O
il	O
-	O
17	O
)	O
inhibitors	O
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
diagnosed	O
with	O
atopic	B-phenotype
dermatitis	I-phenotype
(	O
ad	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l20	B-code
and	O
receiving	O
topical	O
or	O
systemic	O
therapy	O
.	O

we	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
contact	B-phenotype
dermatitis	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l23	B-code
and	O
receiving	O
topical	O
corticosteroid	O
therapy	O
or	O
patch	O
testing	O
.	O

the	O
study	O
population	O
included	O
individuals	O
with	O
a	O
primary	O
diagnosis	O
of	O
alopecia	B-phenotype
areata	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l63	B-code
and	O
receiving	O
corticosteroid	O
therapy	O
or	O
dermatology	O
consultation	O
.	O

we	O
analyzed	O
data	O
from	O
patients	O
with	O
a	O
diagnosis	O
of	O
candidiasis	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b37	B-code
and	O
receiving	O
antifungal	O
therapy	O
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
pneumonia	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j18	B-code
and	O
receiving	O
antibiotic	O
therapy	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
participants	O
had	O
a	O
primary	O
diagnosis	O
of	O
cellulitis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l03	B-code
and	O
receiving	O
systemic	O
antibiotic	O
therapy	O
or	O
incision	O
and	O
drainage	O
.	O

we	O
enrolled	O
patients	O
with	O
a	O
diagnosis	O
of	O
tuberculosis	B-phenotype
(	O
tb	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a15	B-code
-	I-code
a19	I-code
and	O
receiving	O
anti	O
-	O
tuberculosis	O
treatment	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
diagnosed	O
with	O
meningitis	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
320	B-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g00	B-code
-	I-code
g03	I-code
and	O
receiving	O
antibiotic	O
therapy	O
or	O
vaccination	O
.	O

participants	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
otitis	B-phenotype
media	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h65	B-code
-	I-code
h67	I-code
and	O
receiving	O
antibiotic	O
therapy	O
or	O
tympanostomy	O
tubes	O
placement	O
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
diagnosed	O
with	O
sinusitis	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j32	B-code
and	O
receiving	O
antibiotic	O
or	O
corticosteroid	O
therapy	O
.	O

we	O
included	O
patients	O
who	O
had	O
a	O
primary	O
diagnosis	O
of	O
conjunctivitis	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h10	B-code
and	O
receiving	O
antibiotic	O
or	O
antiviral	O
eye	O
drops	O
therapy	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
celiac	B-phenotype
disease	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k90	B-code
.	I-code
0	I-code
who	O
were	O
adherent	O
to	O
a	O
gluten	O
-	O
free	O
diet	O
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
peptic	B-phenotype
ulcer	I-phenotype
disease	I-phenotype
(	O
pud	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k25	B-code
-	I-code
k27	I-code
and	O
receiving	O
proton	O
pump	O
inhibitor	O
(	O
ppi	O
)	O
therapy	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
participants	O
had	O
a	O
primary	O
diagnosis	O
of	O
gastroesophageal	B-phenotype
reflux	I-phenotype
disease	I-phenotype
(	O
gerd	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k21	B-code
and	O
receiving	O
proton	O
pump	O
inhibitor	O
(	O
ppi	O
)	O
or	O
histamine	O
-	O
2	O
receptor	O
antagonist	O
(	O
h2ra	O
)	O
therapy	O
.	O
in	O
this	O
study	O
,	O
we	O
aimed	O
to	O
investigate	O
the	O
prevalence	O
of	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
copd	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
j44	B-code
.	I-code
0	I-code
,	O
j44	B-code
.	I-code
1	I-code
,	O
and	O
j44	B-code
.	I-code
9	I-code
in	O
patients	O
aged	O
40	O
years	O
and	O
older	O
.	O

we	O
evaluated	O
the	O
incidence	O
of	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
t2dm	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
105401003	B-code
among	O
adults	O
in	O
a	O
primary	O
care	O
setting	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
breast	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8500	B-code
-	I-code
m8549	I-code
for	O
invasive	O
carcinoma	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c50	B-code
for	O
malignant	O
neoplasm	O
of	O
the	O
breast	O
.	O

we	O
examined	O
the	O
association	O
between	O
exposure	O
to	O
ambient	O
air	O
pollution	O
and	O
the	O
risk	O
of	O
developing	O
lung	B-phenotype
cancer	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c34	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8012	B-code
-	I-code
m8014	I-code
for	O
adenocarcinoma	O
.	O

the	O
prevalence	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
asd	O
)	O
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f84	B-code
.	I-code
0	I-code
,	O
f84	B-code
.	I-code
1	I-code
,	O
f84	B-code
.	I-code
5	I-code
,	O
and	O
f84	B-code
.	I-code
9	I-code
in	O
children	O
aged	O
2	O
–	O
17	O
years	O
.	O

the	O
occurrence	O
of	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
mdd	O
)	O
among	O
adolescents	O
was	O
assessed	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f32	B-code
.	I-code
0	I-code
-	I-code
f32	I-code
.	I-code
5	I-code
,	O
f32	B-code
.	I-code
81	I-code
,	O
f32	B-code
.	I-code
9	I-code
,	O
f33	B-code
.	I-code
0	I-code
-	I-code
f33	I-code
.	I-code
5	I-code
,	O
f33	B-code
.	I-code
81	I-code
,	O
and	O
f33	B-code
.	I-code
9	I-code
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
hypertensive	O
disorders	O
in	O
pregnancy	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
o10	B-code
,	O
o11	B-code
,	O
o13	B-code
,	O
o14	B-code
,	O
and	O
o15	B-code
.	O

the	O
study	O
included	O
patients	O
with	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
t1dm	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
17886006	B-code
who	O
were	O
aged	O
20	O
-	O
59	O
years	O
.	O

the	O
incidence	O
of	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
renal	I-phenotype
disease	I-phenotype
(	O
esrd	O
)	O
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
6	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
106012009	B-code
in	O
a	O
cohort	O
of	O
patients	O
with	O
diabetes	O
.	O

we	O
examined	O
the	O
comorbidity	O
of	O
rheumatoid	B-phenotype
arthritis	I-phenotype
(	O
ra	O
)	O
and	O
cardiovascular	O
diseases	O
(	O
cvd	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
-	I-code
m06	I-code
for	O
ra	O
and	O
i20	B-code
-	I-code
i25	I-code
for	O
cvd	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
impact	O
of	O
physical	O
activity	O
on	O
the	O
risk	O
of	O
developing	O
stroke	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i60	B-code
,	O
i61	B-code
,	O
i63	B-code
,	O
and	O
i64	B-code
.	O

we	O
investigated	O
the	O
incidence	O
of	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
ad	O
)	O
in	O
older	O
adults	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
codes	O
26929004	B-code
and	O
60238002	B-code
.	O

patients	O
with	O
an	O
established	O
diagnosis	O
of	O
schizophrenia	B-phenotype
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f20	B-code
and	O
followed	O
up	O
for	O
subsequent	O
psychiatric	O
hospitalizations	O
.	O

the	O
prevalence	O
of	O
epilepsy	B-phenotype
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g40	B-code
and	O
g41	B-code
in	O
a	O
population	O
-	O
based	O
cohort	O
study	O
.	O

we	O
analyzed	O
the	O
impact	O
of	O
smoking	O
on	O
the	O
risk	O
of	O
developing	O
pancreatic	B-phenotype
cancer	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c25	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8140	B-code
-	I-code
m8145	I-code
for	O
ductal	O
adenocarcinoma	O
.	O

the	O
incidence	O
of	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
pd	O
)	O
was	O
estimated	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
49049000	B-code
in	O
a	O
population	O
-	O
based	O
study	O
.	O

the	O
study	O
aimed	O
to	O
evaluate	O
the	O
efficacy	O
of	O
a	O
weight	O
loss	O
intervention	O
in	O
reducing	O
the	O
risk	O
of	O
obesity	B-phenotype
-	I-phenotype
related	I-phenotype
cancers	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c16	B-code
,	O
c18	B-code
-	I-code
c21	I-code
,	O
c25	B-code
,	O
c32	B-code
,	O
c34	B-code
,	O
c43	B-code
,	O
c50	B-code
,	O
c53	B-code
-	I-code
c56	I-code
,	O
c61	B-code
,	O
and	O
c67	B-code
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
co	O
-	O
occurring	O
anxiety	B-phenotype
disorders	I-phenotype
in	O
individuals	O
with	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
mdd	O
)	O
,	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f32	B-code
and	O
f33	B-code
for	O
mdd	O
,	O
and	O
f40	B-code
-	I-code
f43	I-code
for	O
anxiety	O
disorders	O
.	O

the	O
study	O
included	O
children	O
with	O
a	O
diagnosis	O
of	O
attention	B-phenotype
-	I-phenotype
deficit	I-phenotype
/	I-phenotype
hyperactivity	I-phenotype
disorder	I-phenotype
(	O
adhd	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f90	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
406506008	B-code
.	O

we	O
assessed	O
the	O
incidence	O
of	O
opioid	B-phenotype
use	I-phenotype
disorder	I-phenotype
in	O
a	O
primary	O
care	O
setting	O
using	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f11	B-code
.	I-code
2	I-code
.	O

the	O
study	O
aimed	O
to	O
evaluate	O
the	O
impact	O
of	O
education	O
on	O
the	O
risk	O
of	O
developing	O
dementia	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f00	B-code
-	I-code
f03	I-code
and	O
g30	B-code
.	O

the	O
incidence	O
of	O
bipolar	B-phenotype
disorder	I-phenotype
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f31	B-code
.	I-code
0	I-code
-	I-code
f31	I-code
.	I-code
9	I-code
among	O
adults	O
aged	O
18	O
-	O
65	O
years	O
.	O

the	O
prevalence	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
as	O
)	O
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
9631008	B-code
in	O
patients	O
aged	O
18	O
years	O
and	O
older	O
.	O

the	O
study	O
included	O
patients	O
diagnosed	O
with	O
glioma	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m9380	B-code
-	I-code
m9481	I-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c71	B-code
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
osteoarthritis	B-phenotype
(	O
oa	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
m15	B-code
-	I-code
m19	I-code
in	O
a	O
nationwide	O
study	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
incidence	O
of	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
sle	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
in	O
women	O
aged	O
18	O
-	O
50	O
years	O
.	O

the	O
occurrence	O
of	O
ulcerative	B-phenotype
colitis	I-phenotype
(	O
uc	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
396331005	B-code
among	O
adults	O
in	O
a	O
primary	O
care	O
setting	O
.	O

we	O
examined	O
the	O
association	O
between	O
dietary	O
intake	O
and	O
the	O
risk	O
of	O
developing	O
colorectal	B-phenotype
cancer	I-phenotype
(	O
crc	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c18	B-code
,	O
c19	B-code
,	O
and	O
c20	B-code
.	O

the	O
prevalence	O
of	O
psoriasis	B-phenotype
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
l40	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
396285003	B-code
in	O
a	O
population	O
-	O
based	O
study	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
prostate	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c61	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8140	B-code
-	I-code
m8147	I-code
for	O
adenocarcinoma	O
.	O

we	O
investigated	O
the	O
incidence	O
of	O
multiple	B-phenotype
sclerosis	I-phenotype
(	O
ms	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
24700007	B-code
in	O
a	O
cohort	O
of	O
patients	O
aged	O
20	O
-	O
50	O
years	O
.	O

the	O
prevalence	O
of	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
cd	O
)	O
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
34000006	B-code
in	O
a	O
nationwide	O
study	O
.	O

we	O
examined	O
the	O
risk	O
factors	O
for	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
(	O
ami	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i21	B-code
and	O
i22	B-code
among	O
adults	O
aged	O
40	O
years	O
and	O
older	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
ovarian	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c56	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8440	B-code
-	I-code
m8461	I-code
for	O
epithelial	O
neoplasms	O
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
ptsd	O
)	O
in	O
soldiers	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f43	B-code
.	I-code
1	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
283371008	B-code
.	O

the	O
incidence	O
of	O
diabetic	B-phenotype
retinopathy	I-phenotype
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
.	I-code
3	I-code
in	O
a	O
cohort	O
of	O
patients	O
with	O
type	O
2	O
diabetes	O
mellitus	O
(	O
t2dm	O
)	O
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
ckd	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
n18	B-code
.	I-code
1	I-code
-	I-code
n18	I-code
.	I-code
5	I-code
in	O
older	O
adults	O
aged	O
65	O
years	O
and	O
older	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
impact	O
of	O
obesity	O
on	O
the	O
risk	O
of	O
developing	O
osteoarthritis	B-phenotype
(	O
oa	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
m15	B-code
-	I-code
m19	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
239872002	B-code
.	O

the	O
incidence	O
of	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
'	I-phenotype
s	I-phenotype
lymphoma	I-phenotype
(	O
nhl	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m9590	B-code
-	I-code
m9733	I-code
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c82	B-code
-	I-code
c85	I-code
among	O
adults	O
aged	O
18	O
years	O
and	O
older	O
.	O

we	O
examined	O
the	O
association	O
between	O
pesticide	O
exposure	O
and	O
the	O
risk	O
of	O
developing	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
pd	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
among	O
agricultural	O
workers	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
gastric	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c16	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8640	B-code
-	I-code
m8745	I-code
for	O
adenocarcinoma	O
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
cerebrovascular	B-phenotype
accidents	I-phenotype
(	O
cva	O
)	O
in	O
hypertensive	O
patients	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i60	B-code
-	I-code
i64	I-code
.	O

the	O
occurrence	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
as	O
)	O
in	O
a	O
cohort	O
of	O
patients	O
with	O
inflammatory	O
bowel	O
disease	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
9631008	B-code
.	O

we	O
investigated	O
the	O
incidence	O
of	O
thyroid	B-phenotype
cancer	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c73	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8330	B-code
-	I-code
m8339	I-code
for	O
papillary	O
carcinoma	O
among	O
patients	O
residing	O
near	O
nuclear	O
power	O
plants	O
.	O

the	O
study	O
aimed	O
to	O
evaluate	O
the	O
risk	O
factors	O
for	O
cardiac	B-phenotype
arrhythmias	I-phenotype
in	O
patients	O
with	O
ischemic	O
heart	O
disease	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i46	B-code
,	O
i47	B-code
,	O
i48	B-code
,	O
i49	B-code
,	O
and	O
r00	B-code
.	O

the	O
prevalence	O
of	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
ocd	O
)	O
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f42	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
191736004	B-code
in	O
a	O
population	O
-	O
based	O
study	O
.	O

we	O
examined	O
the	O
risk	O
factors	O
for	O
atrial	B-phenotype
fibrillation	I-phenotype
(	O
af	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
among	O
adults	O
aged	O
40	O
years	O
and	O
older	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
endometrial	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c54	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8380	B-code
-	I-code
m8383	I-code
for	O
endometrioid	O
carcinoma	O
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
hepatocellular	B-phenotype
carcinoma	I-phenotype
(	O
hcc	O
)	O
in	O
patients	O
with	O
chronic	O
hepatitis	O
b	O
infection	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c22	B-code
.	I-code
0	I-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
code	O
m8170	B-code
.	O

the	O
incidence	O
of	O
sickle	B-phenotype
cell	I-phenotype
anemia	I-phenotype
(	O
sca	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d57	B-code
.	I-code
0	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
40733004	B-code
in	O
a	O
cohort	O
of	O
african	O
american	O
newborns	O
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
chronic	B-phenotype
liver	I-phenotype
disease	I-phenotype
(	O
cld	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
k70	B-code
-	I-code
k77	I-code
in	O
patients	O
with	O
type	O
2	O
diabetes	O
mellitus	O
(	O
t2dm	O
)	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
impact	O
of	O
air	O
pollution	O
on	O
the	O
risk	O
of	O
developing	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
copd	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
j44	B-code
.	I-code
0	I-code
,	O
j44	B-code
.	I-code
1	I-code
,	O
and	O
j44	B-code
.	I-code
9	I-code
.	O

the	O
incidence	O
of	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	O
als	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
2	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
80326006	B-code
among	O
adults	O
aged	O
40	O
years	O
and	O
older	O
.	O

we	O
examined	O
the	O
association	O
between	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
and	O
the	O
risk	O
of	O
developing	O
hypertension	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i10	B-code
and	O
i11	B-code
among	O
adult	O
participants	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
non	B-phenotype
-	I-phenotype
small	I-phenotype
cell	I-phenotype
lung	I-phenotype
cancer	I-phenotype
(	O
nsclc	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c34	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8012	B-code
-	I-code
m8014	I-code
for	O
adenocarcinoma	O
and	O
m8050	B-code
-	I-code
m8084	I-code
for	O
squamous	O
cell	O
carcinoma	O
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
asthma	B-phenotype
in	O
children	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
j45	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
195967001	B-code
.	O

the	O
occurrence	O
of	O
peripheral	B-phenotype
artery	I-phenotype
disease	I-phenotype
(	O
pad	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i73	B-code
.	I-code
9	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
301029008	B-code
among	O
adults	O
in	O
a	O
primary	O
care	O
setting	O
.	O

we	O
investigated	O
the	O
incidence	O
of	O
cervical	B-phenotype
cancer	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c53	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8010	B-code
-	I-code
m8094	I-code
for	O
squamous	O
cell	O
carcinoma	O
among	O
women	O
aged	O
20	O
-	O
65	O
years	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
effectiveness	O
of	O
a	O
smoking	O
cessation	O
program	O
in	O
reducing	O
the	O
risk	O
of	O
developing	O
esophageal	B-phenotype
cancer	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c15	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8140	B-code
-	I-code
m8199	I-code
.	O

the	O
prevalence	O
of	O
cystic	B-phenotype
fibrosis	I-phenotype
(	O
cf	O
)	O
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
190905008	B-code
in	O
a	O
sample	O
of	O
newborns	O
.	O

we	O
examined	O
the	O
risk	O
factors	O
for	O
heart	B-phenotype
failure	I-phenotype
(	O
hf	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i50	B-code
.	I-code
0	I-code
,	O
i50	B-code
.	I-code
1	I-code
,	O
and	O
i50	B-code
.	I-code
9	I-code
among	O
patients	O
with	O
diabetes	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
multiple	B-phenotype
myeloma	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c90	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m9731	B-code
-	I-code
m9734	I-code
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
(	O
ipf	O
)	O
in	O
older	O
adults	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	I-code
1	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
77456006	B-code
.	O

the	O
incidence	O
of	O
primary	B-phenotype
biliary	I-phenotype
cholangitis	I-phenotype
(	O
pbc	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k74	B-code
.	I-code
3	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
197321007	B-code
in	O
a	O
cohort	O
of	O
patients	O
aged	O
18	O
years	O
and	O
older	O
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
as	O
)	O
in	O
patients	O
with	O
inflammatory	O
bowel	O
disease	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
9631008	B-code
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
association	O
between	O
alcohol	O
consumption	O
and	O
the	O
risk	O
of	O
developing	O
liver	B-phenotype
cirrhosis	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k70	B-code
.	I-code
3	I-code
.	O

the	O
occurrence	O
of	O
atopic	B-phenotype
dermatitis	I-phenotype
(	O
ad	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l20	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
24079001	B-code
among	O
children	O
aged	O
2	O
-	O
15	O
years	O
.	O

we	O
examined	O
the	O
risk	O
factors	O
for	O
primary	B-phenotype
sclerosing	I-phenotype
cholangitis	I-phenotype
(	O
psc	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k83	B-code
.	I-code
01	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
109838007	B-code
among	O
patients	O
with	O
inflammatory	O
bowel	O
disease	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
testicular	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c62	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m9060	B-code
-	I-code
m9064	I-code
for	O
seminomas	O
and	O
m9070	B-code
-	I-code
m9102	I-code
for	O
non	O
-	O
seminomas	O
.	O

we	O
investigated	O
the	O
incidence	O
of	O
adenomatous	B-phenotype
polyps	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d12	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
49060008	B-code
in	O
a	O
cohort	O
of	O
patients	O
aged	O
50	O
-	O
75	O
years	O
.	O

the	O
prevalence	O
of	O
narcolepsy	B-phenotype
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g47	B-code
.	I-code
4	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
11070006	B-code
in	O
a	O
population	O
-	O
based	O
cohort	O
study	O
.	O

we	O
examined	O
the	O
association	O
between	O
traumatic	O
brain	O
injury	O
(	O
tbi	O
)	O
and	O
the	O
risk	O
of	O
developing	O
epilepsy	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g40	B-code
and	O
g41	B-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
leukemia	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c91	B-code
-	I-code
c95	I-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m9800	B-code
-	I-code
m9948	I-code
for	O
various	O
types	O
of	O
leukemia	O
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
vascular	B-phenotype
dementia	I-phenotype
in	O
older	O
adults	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f01	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
32958008	B-code
.	O

the	O
incidence	O
of	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
(	O
pcos	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
703392006	B-code
in	O
a	O
cohort	O
of	O
women	O
aged	O
18	O
-	O
45	O
years	O
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
fibromyalgia	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
389056004	B-code
in	O
a	O
nationwide	O
study	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
impact	O
of	O
genetic	O
factors	O
on	O
the	O
risk	O
of	O
developing	O
inflammatory	B-phenotype
bowel	I-phenotype
disease	I-phenotype
(	O
ibd	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
k50	B-code
for	O
crohn	O
'	O
s	O
disease	O
and	O
k51	B-code
for	O
ulcerative	O
colitis	O
.	O

the	O
occurrence	O
of	O
glomerulonephritis	B-phenotype
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
n00	B-code
-	I-code
n08	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
362989000	B-code
among	O
patients	O
with	O
autoimmune	O
diseases	O
.	O

we	O
examined	O
the	O
risk	O
factors	O
for	O
restless	B-phenotype
legs	I-phenotype
syndrome	I-phenotype
(	O
rls	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g25	B-code
.	I-code
81	I-code
in	O
a	O
population	O
-	O
based	O
cohort	O
study	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
melanoma	B-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c43	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8720	B-code
-	I-code
m8799	I-code
for	O
various	O
types	O
of	O
melanoma	O
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
myasthenia	B-phenotype
gravis	I-phenotype
in	O
a	O
primary	O
care	O
setting	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g70	B-code
.	I-code
0	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
201199007	B-code
.	O

the	O
incidence	O
of	O
chronic	B-phenotype
pancreatitis	I-phenotype
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k86	B-code
.	I-code
0	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
609476000	B-code
in	O
a	O
cohort	O
of	O
patients	O
with	O
a	O
history	O
of	O
alcohol	O
abuse	O
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
motor	B-phenotype
neuron	I-phenotype
disease	I-phenotype
(	O
mnd	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g12	B-code
.	I-code
2	I-code
,	O
g12	B-code
.	I-code
8	I-code
,	O
and	O
g12	B-code
.	I-code
9	I-code
in	O
a	O
population	O
-	O
based	O
study	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
incidence	O
of	O
endometriosis	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
68235000	B-code
in	O
women	O
aged	O
18	O
-	O
45	O
years	O
.	O

the	O
prevalence	O
of	O
tuberculosis	B-phenotype
(	O
tb	O
)	O
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
a15	B-code
,	O
a16	B-code
,	O
and	O
a17	B-code
in	O
a	O
cohort	O
of	O
recent	O
immigrants	O
.	O

we	O
examined	O
the	O
association	O
between	O
socioeconomic	O
status	O
and	O
the	O
risk	O
of	O
developing	O
head	B-phenotype
and	I-phenotype
neck	I-phenotype
cancer	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c00	B-code
-	I-code
c14	I-code
and	O
c32	B-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
laryngeal	B-phenotype
cancer	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c32	B-code
and	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
morphology	O
codes	O
m8050	B-code
-	I-code
m8076	I-code
for	O
squamous	O
cell	O
carcinoma	O
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
wilson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e83	B-code
.	I-code
0	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
207410005	B-code
in	O
a	O
cohort	O
of	O
patients	O
with	O
liver	O
disease	O
.	O

the	O
incidence	O
of	O
primary	B-phenotype
sclerosing	I-phenotype
cholangitis	I-phenotype
(	O
psc	O
)	O
was	O
assessed	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k83	B-code
.	I-code
01	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
109838007	B-code
in	O
a	O
population	O
-	O
based	O
study	O
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
guillain	B-phenotype
-	I-phenotype
barre	I-phenotype
syndrome	I-phenotype
(	O
gbs	O
)	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g61	B-code
.	I-code
0	I-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
302034006	B-code
among	O
adults	O
aged	O
18	O
years	O
and	O
older	O
.	O

the	O
study	O
aimed	O
to	O
assess	O
the	O
impact	O
of	O
air	O
pollution	O
on	O
the	O
risk	O
of	O
developing	O
bronchiectasis	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
j47	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
403800006	B-code
.	O

the	O
prevalence	O
of	O
hemophilia	B-phenotype
a	I-phenotype
was	O
determined	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d66	B-code
and	O
snomed	B-coding_system
ct	I-coding_system
code	O
82308001	B-code
in	O
a	O
nationwide	O
study	O
.	O

we	O
examined	O
the	O
association	O
between	O
dietary	O
intake	O
of	O
soy	O
products	O
and	O
the	O
risk	O
of	O
developing	O
endometrial	B-phenotype
cancer	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c54	B-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
renal	B-phenotype
cell	I-phenotype
carcinoma	I-phenotype
(	O
rcc	O
)	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
<	O
span	O
class	O
=	O
'	O
code	O

the	O
patient	O
was	O
diagnosed	O
with	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
)	O
and	O
hypertension	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i10	B-code
)	O
.	O

a	O
significant	O
association	O
was	O
found	O
between	O
the	O
brca1	B-phenotype
gene	O
mutation	O
(	O
omim	B-coding_system
code	O
113705	B-code
)	O
and	O
the	O
risk	O
of	O
developing	O
breast	B-phenotype
cancer	I-phenotype
.	O

the	O
study	O
included	O
patients	O
with	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
2x	I-code
)	O
and	O
bipolar	B-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
4x	I-code
)	O
.	O

this	O
genetic	O
variant	O
(	O
rs	B-coding_system
number	O
rs1800933	B-code
)	O
has	O
been	O
associated	O
with	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
in	O
several	O
studies	O
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
.	O

the	O
presence	O
of	O
the	O
apoe	B-phenotype
ε4	I-phenotype
allele	O
(	O
omim	B-coding_system
code	O
107741	B-code
)	O
is	O
a	O
risk	O
factor	O
for	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
.	O

children	O
with	O
the	O
fragile	B-phenotype
x	I-phenotype
syndrome	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q99	B-code
.	I-code
2	I-code
)	O
typically	O
exhibit	O
developmental	O
delays	O
and	O
intellectual	O
disabilities	O
.	O

a	O
diagnosis	O
of	O
schizophrenia	B-phenotype
was	O
made	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
criterion	O
,	O
with	O
the	O
code	O
f20	B-code
.	O

the	O
patient	O
has	O
been	O
diagnosed	O
with	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
renal	I-phenotype
disease	I-phenotype
(	O
esrd	O
)	O
per	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
6	I-code
.	O

patients	O
with	O
prostate	B-phenotype
cancer	I-phenotype
often	O
have	O
elevated	O
levels	O
of	O
prostate	O
-	O
specific	O
antigen	O
(	O
psa	O
)	O
according	O
to	O
the	O
loinc	B-coding_system
code	O
10839	B-code
-	I-code
9	I-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
rheumatoid	B-phenotype
arthritis	I-phenotype
(	O
ra	O
)	O
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
.	O

the	O
presence	O
of	O
hla	O
-	O
b	O
*	O
57	O
:	O
01	O
allele	O
(	O
imgt	B-coding_system
/	I-coding_system
hla	I-coding_system
code	O
hla00354	B-code
)	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
developing	O
abacavir	B-phenotype
hypersensitivity	I-phenotype
in	O
hiv	O
-	O
positive	O
patients	O
.	O

the	O
affected	O
individuals	O
presented	O
with	O
hereditary	B-phenotype
hemochromatosis	I-phenotype
(	O
omim	B-coding_system
code	O
235200	B-code
)	O
,	O
a	O
disorder	O
characterized	O
by	O
iron	O
overload	O
.	O

the	O
patient	O
exhibited	O
symptoms	O
consistent	O
with	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
ocd	O
)	O
as	O
per	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
3	I-code
.	O

our	O
study	O
focused	O
on	O
patients	O
with	O
a	O
diagnosis	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
asd	O
)	O
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f84	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
copd	O
)	O
per	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
.	O

genetic	O
testing	O
revealed	O
a	O
mutation	O
in	O
the	O
cftr	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
602421	B-code
)	O
associated	O
with	O
cystic	B-phenotype
fibrosis	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
sle	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	O

the	O
study	O
recruited	O
patients	O
with	O
multiple	B-phenotype
sclerosis	I-phenotype
(	O
ms	O
)	O
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
.	O

a	O
mutation	O
in	O
the	O
lmna	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
150330	B-code
)	O
is	O
associated	O
with	O
hutchinson	B-phenotype
-	I-phenotype
gilford	I-phenotype
progeria	I-phenotype
syndrome	I-phenotype
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
atrial	B-phenotype
fibrillation	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
)	O
.	O

our	O
study	O
included	O
individuals	O
diagnosed	O
with	O
down	B-phenotype
syndrome	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q90	B-code
)	O
.	O

the	O
patient	O
tested	O
positive	O
for	O
human	B-phenotype
leukocyte	I-phenotype
antigen	I-phenotype
b27	I-phenotype
(	O
hla	O
-	O
b27	O
)	O
according	O
to	O
the	O
imgt	B-coding_system
/	I-coding_system
hla	I-coding_system
code	O
hla00363	B-code
.	O

patients	O
with	O
a	O
history	O
of	O
spina	B-phenotype
bifida	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q05	B-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
pernicious	B-phenotype
anemia	I-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d51	B-code
.	I-code
0	I-code
.	O

the	O
presence	O
of	O
long	B-phenotype
qt	I-phenotype
syndrome	I-phenotype
(	O
omim	B-coding_system
code	O
192500	B-code
)	O
in	O
the	O
patient	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
ventricular	O
arrhythmias	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
history	O
of	O
pheochromocytoma	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d35	B-code
.	I-code
0	I-code
)	O
.	O

genetic	O
testing	O
identified	O
a	O
mutation	O
in	O
the	O
brca2	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
600185	B-code
)	O
associated	O
with	O
ovarian	B-phenotype
cancer	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
epilepsy	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
.	O

participants	O
included	O
those	O
diagnosed	O
with	O
osteoarthritis	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m15	B-code
-	I-code
m19	I-code
.	O

the	O
patient	O
exhibited	O
signs	O
of	O
iron	B-phenotype
-	I-phenotype
deficiency	I-phenotype
anemia	I-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d50	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
mthfr	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
607093	B-code
)	O
has	O
been	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
venous	B-phenotype
thromboembolism	I-phenotype
.	O

the	O
study	O
population	O
included	O
patients	O
diagnosed	O
with	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	O
als	O
)	O
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
2	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
fibromyalgia	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
.	O

a	O
mutation	O
in	O
the	O
mecp2	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
300005	B-code
)	O
is	O
associated	O
with	O
rett	B-phenotype
syndrome	I-phenotype
in	O
females	O
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
glomerulonephritis	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n00	B-code
-	I-code
n08	I-code
.	O

the	O
study	O
focused	O
on	O
patients	O
with	O
a	O
history	O
of	O
myocardial	B-phenotype
infarction	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i21	B-code
)	O
.	O

a	O
genetic	O
variant	O
in	O
the	O
scn5a	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
600163	B-code
)	O
has	O
been	O
linked	O
to	O
brugada	B-phenotype
syndrome	I-phenotype
.	O

patients	O
diagnosed	O
with	O
congenital	B-phenotype
heart	I-phenotype
defects	I-phenotype
were	O
included	O
in	O
the	O
study	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
q20	B-code
-	I-code
q28	I-code
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
a	O
mutation	O
in	O
the	O
hbb	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
141900	B-code
)	O
associated	O
with	O
beta	B-phenotype
-	I-phenotype
thalassemia	I-phenotype
.	O

the	O
participants	O
included	O
those	O
diagnosed	O
with	O
migraine	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g43	B-code
.	O

a	O
mutation	O
in	O
the	O
ush2a	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
608400	B-code
)	O
is	O
a	O
major	O
cause	O
of	O
usher	B-phenotype
syndrome	I-phenotype
type	I-phenotype
ii	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
psoriasis	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
.	O

the	O
study	O
population	O
included	O
those	O
with	O
a	O
diagnosis	O
of	O
cerebral	B-phenotype
palsy	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g80	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
abca1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
600046	B-code
)	O
has	O
been	O
associated	O
with	O
tangier	B-phenotype
disease	I-phenotype
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
acute	B-phenotype
lymphoblastic	I-phenotype
leukemia	I-phenotype
(	O
all	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c91	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
a	O
mutation	O
in	O
the	O
aga	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
613228	B-code
)	O
causing	O
aspartylglucosaminuria	B-phenotype
.	O

the	O
study	O
included	O
patients	O
diagnosed	O
with	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
(	O
pcos	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
sod1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
147450	B-code
)	O
has	O
been	O
linked	O
to	O
a	O
subset	O
of	O
patients	O
with	O
familial	B-phenotype
amyotrophic	I-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
)	O
.	O

the	O
study	O
included	O
participants	O
diagnosed	O
with	O
pancreatitis	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k85	B-code
-	I-code
k86	I-code
.	O

genetic	O
testing	O
revealed	O
a	O
mutation	O
in	O
the	O
pink1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
608309	B-code
)	O
associated	O
with	O
early	B-phenotype
-	I-phenotype
onset	I-phenotype
parkinson	I-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
gout	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m10	B-code
.	O

the	O
study	O
focused	O
on	O
participants	O
with	O
a	O
diagnosis	O
of	O
sickle	B-phenotype
cell	I-phenotype
anemia	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d57	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
exhibited	O
symptoms	O
consistent	O
with	O
narcolepsy	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
4	I-code
.	O

a	O
mutation	O
in	O
the	O
myh7	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
160760	B-code
)	O
is	O
associated	O
with	O
familial	B-phenotype
hypertrophic	I-phenotype
cardiomyopathy	I-phenotype
.	O

the	O
study	O
population	O
included	O
patients	O
diagnosed	O
with	O
primary	B-phenotype
biliary	I-phenotype
cholangitis	I-phenotype
(	O
pbc	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k74	B-code
.	I-code
3	I-code
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
acute	B-phenotype
bronchitis	I-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j20	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
ldlr	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
606945	B-code
)	O
has	O
been	O
associated	O
with	O
familial	B-phenotype
hypercholesterolemia	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
rosacea	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l71	B-code
.	O

the	O
study	O
included	O
participants	O
diagnosed	O
with	O
lupus	B-phenotype
nephritis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	I-code
1	I-code
.	O

genetic	O
testing	O
revealed	O
a	O
mutation	O
in	O
the	O
lmna	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
608081	B-code
)	O
associated	O
with	O
type	B-phenotype
2	I-phenotype
charcot	I-phenotype
-	I-phenotype
marie	I-phenotype
-	I-phenotype
tooth	I-phenotype
disease	I-phenotype
.	O

patients	O
with	O
a	O
history	O
of	O
lymphedema	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i89	B-code
.	I-code
0	I-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
patient	O
exhibited	O
symptoms	O
consistent	O
with	O
primary	B-phenotype
hypertension	I-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i10	B-code
.	O

a	O
mutation	O
in	O
the	O
mim	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
152950	B-code
)	O
is	O
associated	O
with	O
werner	B-phenotype
syndrome	I-phenotype
,	O
a	O
rare	O
,	O
adult	O
-	O
onset	O
progeroid	O
syndrome	O
.	O

the	O
study	O
population	O
included	O
patients	O
diagnosed	O
with	O
lymphoma	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c81	B-code
-	I-code
c85	I-code
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
asthma	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
pah	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
612349	B-code
)	O
has	O
been	O
associated	O
with	O
phenylketonuria	B-phenotype
in	O
neonates	O
.	O

the	O
patient	O
exhibited	O
signs	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	O

the	O
study	O
included	O
participants	O
diagnosed	O
with	O
endometriosis	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
.	O

a	O
mutation	O
in	O
the	O
prnp	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
176640	B-code
)	O
is	O
associated	O
with	O
creutzfeldt	B-phenotype
-	I-phenotype
jakob	I-phenotype
disease	I-phenotype
,	O
a	O
rare	O
,	O
rapidly	O
progressive	O
neurodegenerative	O
disorder	O
.	O

patients	O
with	O
a	O
history	O
of	O
stomach	B-phenotype
cancer	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c16	B-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
affected	O
individual	O
presented	O
with	O
bardet	B-phenotype
-	I-phenotype
biedl	I-phenotype
syndrome	I-phenotype
(	O
omim	B-coding_system
code	O
209900	B-code
)	O
,	O
a	O
rare	O
genetic	O
disorder	O
characterized	O
by	O
obesity	O
,	O
polydactyly	O
,	O
and	O
kidney	O
abnormalities	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
eczema	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l30	B-code
.	I-code
9	I-code
.	O

the	O
study	O
population	O
included	O
those	O
diagnosed	O
with	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
(	O
ibs	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
aldh2	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
100650	B-code
)	O
has	O
been	O
associated	O
with	O
alcohol	B-phenotype
flush	I-phenotype
reaction	I-phenotype
in	O
east	O
asian	O
populations	O
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
infectious	B-phenotype
mononucleosis	I-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b27	B-code
.	O

the	O
study	O
included	O
participants	O
diagnosed	O
with	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
renal	I-phenotype
disease	I-phenotype
(	O
esrd	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
6	I-code
.	O

a	O
mutation	O
in	O
the	O
pex1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
602136	B-code
)	O
is	O
associated	O
with	O
zellweger	B-phenotype
syndrome	I-phenotype
,	O
a	O
severe	O
peroxisomal	O
disorder	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
otitis	B-phenotype
media	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h66	B-code
.	O

the	O
study	O
included	O
participants	O
diagnosed	O
with	O
ulcerative	B-phenotype
colitis	I-phenotype
(	O
uc	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
pkd1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
601313	B-code
)	O
has	O
been	O
associated	O
with	O
autosomal	B-phenotype
dominant	I-phenotype
polycystic	I-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
adpkd	O
)	O
.	O

the	O
patient	O
was	O
prescribed	O
medication	O
for	O
their	O
anxiety	B-phenotype
disorder	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f41	B-code
.	O

the	O
study	O
focused	O
on	O
patients	O
with	O
a	O
diagnosis	O
of	O
hyperthyroidism	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e05	B-code
.	O

a	O
mutation	O
in	O
the	O
tsc1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
605284	B-code
)	O
is	O
associated	O
with	O
tuberous	B-phenotype
sclerosis	I-phenotype
complex	I-phenotype
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
allergic	B-phenotype
rhinitis	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j30	B-code
)	O
.	O

the	O
study	O
included	O
participants	O
diagnosed	O
with	O
vestibular	B-phenotype
schwannoma	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d33	B-code
.	I-code
3	I-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
fbn1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
607062	B-code
)	O
has	O
been	O
associated	O
with	O
marfan	B-phenotype
syndrome	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
dementia	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f03	B-code
.	O

the	O
study	O
population	O
included	O
those	O
diagnosed	O
with	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
ckd	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	O

a	O
mutation	O
in	O
the	O
sdhaf2	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
613019	B-code
)	O
is	O
associated	O
with	O
paraganglioma	B-phenotype
,	O
a	O
rare	O
type	O
of	O
neuroendocrine	O
tumor	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
acute	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
(	O
aml	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c92	B-code
.	O

the	O
study	O
included	O
participants	O
diagnosed	O
with	O
multiple	B-phenotype
myeloma	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c90	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
slc22a12	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
607096	B-code
)	O
has	O
been	O
associated	O
with	O
renal	B-phenotype
hypouricemia	I-phenotype
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
restless	B-phenotype
legs	I-phenotype
syndrome	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g25	B-code
.	I-code
81	I-code
)	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
hypoparathyroidism	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e20	B-code
.	O

a	O
mutation	O
in	O
the	O
wfs1	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
606201	B-code
)	O
is	O
associated	O
with	O
wolfram	B-phenotype
syndrome	I-phenotype
,	O
a	O
rare	O
autosomal	O
recessive	O
disorder	O
.	O

the	O
patient	O
exhibited	O
signs	O
of	O
periodontitis	B-phenotype
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k05	B-code
.	O

the	O
study	O
population	O
included	O
patients	O
diagnosed	O
with	O
thyroiditis	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e06	B-code
.	O

a	O
genetic	O
variant	O
in	O
the	O
abo	B-phenotype
gene	O
(	O
omim	B-coding_system
code	O
110300	B-code
)	O
has	O
been	O
associated	O
with	O
blood	B-phenotype
type	I-phenotype
incompatibilities	I-phenotype
between	O
a	O
mother	O
and	O
fetus	O
.	O
the	O
patient	O
was	O
diagnosed	O
with	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
)	O
and	O
hypertension	B-phenotype
(	O
i10	B-code
)	O
in	O
the	O
past	O
year	O
.	O

the	O
study	O
population	O
included	O
individuals	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
copd	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
491	B-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
congenital	B-phenotype
heart	I-phenotype
disease	I-phenotype
using	O
the	O
corresponding	O
snomed	B-coding_system
ct	I-coding_system
codes	O
(	O
746	B-code
,	O
747	B-code
)	O
.	O

the	O
study	O
included	O
subjects	O
with	O
rheumatoid	B-phenotype
arthritis	I-phenotype
(	O
ra	O
)	O
as	O
evidenced	O
by	O
the	O
presence	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
714	B-code
.	I-code
0	I-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
or	O
m06	B-code
in	O
their	O
medical	O
records	O
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
)	O
and	O
dementia	B-phenotype
(	O
f00	B-code
-	I-code
f03	I-code
)	O
during	O
the	O
neurological	O
evaluation	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
multiple	B-phenotype
sclerosis	I-phenotype
(	O
ms	O
)	O
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
codes	O
34000	B-code
or	O
34001	B-code
.	O

the	O
patient	O
presented	O
with	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
sle	O
)	O
,	O
which	O
was	O
coded	O
as	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
m32	B-code
in	O
the	O
medical	O
record	O
.	O

patients	O
with	O
a	O
history	O
of	O
stroke	B-phenotype
were	O
identified	O
through	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
430	B-code
-	O
438	B-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i60	B-code
-	O
i69	B-code
.	O

the	O
study	O
focused	O
on	O
individuals	O
with	O
cystic	B-phenotype
fibrosis	I-phenotype
,	O
who	O
had	O
a	O
snomed	B-coding_system
ct	I-coding_system
code	O
of	O
27730	B-code
in	O
their	O
medical	O
records	O
.	O

the	O
analysis	O
included	O
patients	O
with	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
renal	I-phenotype
disease	I-phenotype
(	O
esrd	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
6	I-code
or	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
585	B-code
.	I-code
6	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
psoriasis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
in	O
their	O
medical	O
record	O
.	O

individuals	O
with	O
a	O
diagnosis	O
of	O
atrial	B-phenotype
fibrillation	I-phenotype
were	O
identified	O
using	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
42731	B-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
gestational	B-phenotype
diabetes	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
o24	B-code
.	I-code
4	I-code
)	O
during	O
her	O
pregnancy	O
.	O

we	O
identified	O
patients	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
using	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
72000	B-code
.	O

the	O
subject	O
was	O
diagnosed	O
with	O
schizophrenia	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f20	B-code
in	O
the	O
psychiatric	O
assessment	O
.	O

patients	O
with	O
a	O
history	O
of	O
bipolar	B-phenotype
disorder	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
296	B-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f31	B-code
and	O
had	O
at	O
least	O
one	O
hospital	O
admission	O
for	O
the	O
same	O
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
asthma	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
)	O
and	O
allergic	B-phenotype
rhinitis	I-phenotype
(	O
j30	B-code
)	O
upon	O
evaluation	O
.	O

the	O
study	O
population	O
included	O
individuals	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
inflammatory	B-phenotype
bowel	I-phenotype
disease	I-phenotype
(	O
ibd	O
)	O
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
codes	O
556	B-code
(	O
crohn	O
'	O
s	O
disease	O
)	O
and	O
5568	B-code
(	O
ulcerative	O
colitis	O
)	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
mdd	O
)	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
296	B-code
.	I-code
3	I-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f32	B-code
.	O

the	O
study	O
included	O
subjects	O
with	O
a	O
history	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
asd	O
)	O
as	O
evidenced	O
by	O
the	O
presence	O
of	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f84	B-code
or	O
snomed	B-coding_system
ct	I-coding_system
code	O
29900	B-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
fibromyalgia	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
in	O
the	O
medical	O
record	O
.	O

we	O
identified	O
individuals	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
osteoporosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
733	B-code
.	I-code
0	I-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m81	B-code
.	O

the	O
study	O
cohort	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
epilepsy	B-phenotype
according	O
to	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
345	B-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
.	O

the	O
patient	O
presented	O
with	O
chronic	B-phenotype
hepatitis	I-phenotype
b	I-phenotype
,	O
which	O
was	O
coded	O
as	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
1	I-code
in	O
the	O
medical	O
record	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
glioblastoma	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c71	B-code
.	I-code
0	I-code
.	O

the	O
study	O
focused	O
on	O
individuals	O
with	O
sickle	B-phenotype
cell	I-phenotype
anemia	I-phenotype
,	O
who	O
had	O
a	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
of	O
282	B-code
.	I-code
6	I-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d57	B-code
.	I-code
0	I-code
in	O
their	O
medical	O
records	O
.	O

the	O
analysis	O
included	O
patients	O
with	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
(	O
ami	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i21	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
lupus	B-phenotype
nephritis	I-phenotype
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
ln14	B-code
in	O
their	O
medical	O
record	O
.	O

individuals	O
with	O
a	O
diagnosis	O
of	O
hiv	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b20	B-code
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
stage	I-phenotype
3	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
3	I-code
)	O
based	O
on	O
the	O
medical	O
record	O
review	O
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
systemic	B-phenotype
sclerosis	I-phenotype
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
72080	B-code
.	O

the	O
subject	O
was	O
diagnosed	O
with	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
ocd	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f42	B-code
in	O
the	O
psychiatric	O
assessment	O
.	O

patients	O
with	O
a	O
history	O
of	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
ptsd	O
)	O
were	O
identified	O
by	O
the	O
presence	O
of	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
309	B-code
.	I-code
81	I-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f43	B-code
.	I-code
1	I-code
in	O
their	O
medical	O
records	O
.	O

the	O
patient	O
presented	O
with	O
chronic	B-phenotype
hepatitis	I-phenotype
c	I-phenotype
,	O
which	O
was	O
coded	O
as	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
2	I-code
in	O
the	O
medical	O
record	O
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
duchenne	B-phenotype
muscular	I-phenotype
dystrophy	I-phenotype
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
35900	B-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g71	B-code
.	I-code
0	I-code
.	O

the	O
study	O
focused	O
on	O
individuals	O
with	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
,	O
who	O
had	O
a	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
of	O
331	B-code
.	I-code
0	I-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
in	O
their	O
medical	O
records	O
.	O

the	O
analysis	O
included	O
patients	O
with	O
endometriosis	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
ulcerative	B-phenotype
colitis	I-phenotype
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
5568006	B-code
in	O
their	O
medical	O
record	O
.	O

individuals	O
with	O
a	O
diagnosis	O
of	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
stage	I-phenotype
4	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
4	I-code
)	O
based	O
on	O
medical	O
record	O
review	O
.	O

we	O
identified	O
patients	O
with	O
a	O
diagnosis	O
of	O
sjogren	B-phenotype
'	I-phenotype
s	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
71000	B-code
the	O
patient	O
was	O
diagnosed	O
with	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f84	B-code
.	I-code
0	I-code
)	O
in	O
early	O
childhood	O
and	O
later	O
developed	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
f42	B-code
)	O
.	O

the	O
study	O
was	O
conducted	O
on	O
patients	O
with	O
schizophrenia	B-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
295	B-code
)	O
as	O
their	O
primary	O
psychiatric	O
condition	O
.	O

in	O
this	O
survey	O
,	O
we	O
investigated	O
the	O
prevalence	O
of	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
2	I-code
)	O
among	O
medical	O
students	O
.	O

according	O
to	O
the	O
international	B-coding_system
classification	I-coding_system
of	I-coding_system
diseases	I-coding_system
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
)	O
,	O
patients	O
with	O
a	O
history	O
of	O
panic	B-phenotype
disorder	I-phenotype
were	O
assigned	O
a	O
code	O
of	O
f41	B-code
.	I-code
0	I-code
.	O

the	O
diagnosis	O
of	O
bipolar	B-phenotype
i	I-phenotype
disorder	I-phenotype
was	O
made	O
according	O
to	O
the	O
criteria	O
of	O
the	O
dsm	O
-	O
5	O
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
50	I-code
)	O
.	O

the	O
patient	O
exhibited	O
symptoms	O
consistent	O
with	O
acute	B-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
6b40	B-code
)	O
.	O

the	O
study	O
included	O
participants	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
borderline	B-phenotype
personality	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f60	B-code
.	I-code
3	I-code
)	O
.	O

we	O
observed	O
a	O
high	O
rate	O
of	O
comorbidity	O
between	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
02	I-code
)	O
and	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
3	I-code
)	O
in	O
our	O
sample	O
.	O

the	O
patient	O
was	O
referred	O
for	O
a	O
thorough	O
evaluation	O
due	O
to	O
a	O
suspicion	O
of	O
dissociative	B-phenotype
identity	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
14	I-code
)	O
.	O

the	O
incidence	O
rate	O
of	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
6b42	B-code
)	O
among	O
veterans	O
in	O
our	O
sample	O
was	O
significantly	O
higher	O
compared	O
to	O
the	O
general	O
population	O
.	O

in	O
this	O
case	O
report	O
,	O
we	O
describe	O
a	O
patient	O
with	O
a	O
rare	O
chromosomal	B-phenotype
deletion	I-phenotype
at	O
22q11	O
.	O
2	O
(	O
iscn	B-coding_system
code	O
del	B-code
(	I-code
22	I-code
)	I-code
(	I-code
q11	I-code
.	I-code
2	I-code
)	I-code
)	O
and	O
its	O
associated	O
phenotypes	O
,	O
including	O
intellectual	B-phenotype
disability	I-phenotype
and	O
congenital	B-phenotype
heart	I-phenotype
defect	I-phenotype
.	O

the	O
patient	O
'	O
s	O
genetic	O
test	O
revealed	O
a	O
brca1	B-phenotype
mutation	I-phenotype
(	O
omim	B-coding_system
code	O
*	B-code
113705	I-code
)	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
breast	B-phenotype
and	I-phenotype
ovarian	I-phenotype
cancer	I-phenotype
.	O

a	O
diagnosis	O
of	O
cystic	B-phenotype
fibrosis	I-phenotype
was	O
confirmed	O
in	O
the	O
patient	O
with	O
the	O
identification	O
of	O
the	O
p	B-code
.	I-code
f508del	I-code
mutation	O
in	O
the	O
cftr	B-coding_system
gene	I-coding_system
.	O

the	O
karyotyping	O
analysis	O
indicated	O
a	O
chromosomal	B-phenotype
abnormality	I-phenotype
in	O
the	O
form	O
of	O
a	O
iscn	B-coding_system
code	O
47	B-code
,	I-code
xx	I-code
,	I-code
+	I-code
21	I-code
,	O
leading	O
to	O
the	O
diagnosis	O
of	O
down	B-phenotype
syndrome	I-phenotype
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
marfan	B-phenotype
syndrome	I-phenotype
,	O
caused	O
by	O
a	O
mutation	O
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
154700	I-code
(	O
fbn1	O
)	O
.	O

a	O
targeted	O
genetic	O
test	O
revealed	O
a	O
homozygous	B-phenotype
mutation	I-phenotype
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
603260	I-code
associated	O
with	O
autosomal	B-phenotype
recessive	I-phenotype
polycystic	I-phenotype
kidney	I-phenotype
disease	I-phenotype
.	O

affective	O
disorders	O
such	O
as	O
bipolar	B-phenotype
ii	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f31	B-code
.	I-code
8	I-code
)	O
were	O
evaluated	O
in	O
this	O
study	O
.	O

the	O
patient	O
was	O
experiencing	O
symptoms	O
of	O
paranoid	B-phenotype
schizophrenia	I-phenotype
,	O
falling	O
under	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f20	B-code
.	I-code
0	I-code
.	O

we	O
analyzed	O
genetic	O
variations	O
in	O
patients	O
with	O
congenital	B-phenotype
long	I-phenotype
qt	I-phenotype
syndrome	I-phenotype
by	O
screening	O
for	O
specific	O
disease	O
-	O
causing	O
gene	O
mutations	O
in	O
the	O
omim	B-coding_system
database	O
(	O
e	O
.	O
g	O
.	O
,	O
kcnq1	O
,	O
*	B-code
607542	I-code
)	O
.	O

the	O
prevalence	O
of	O
specific	B-phenotype
phobia	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
29	I-code
)	O
was	O
found	O
to	O
be	O
significantly	O
higher	O
among	O
first	O
responders	O
compared	O
to	O
the	O
general	O
population	O
.	O

the	O
t	B-phenotype
(	I-phenotype
9	I-phenotype
;	I-phenotype
22	I-phenotype
)	I-phenotype
(	I-phenotype
q34	I-phenotype
;	I-phenotype
q11	I-phenotype
)	I-phenotype
translocation	O
(	O
iscn	B-coding_system
code	O
t	B-code
(	I-code
9	I-code
;	I-code
22	I-code
)	I-code
(	I-code
q34	I-code
;	I-code
q11	I-code
)	I-code
)	O
was	O
detected	O
in	O
a	O
patient	O
with	O
chronic	O
myeloid	O
leukemia	O
.	O

our	O
study	O
investigated	O
the	O
comorbidity	O
of	O
social	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
23	I-code
)	O
and	O
substance	B-phenotype
use	I-phenotype
disorders	I-phenotype
(	O
304	B-code
-	I-code
305	I-code
)	O
.	O

genetic	O
testing	O
revealed	O
the	O
patient	O
to	O
have	O
a	O
pathogenic	B-phenotype
variant	I-phenotype
of	O
the	O
omim	B-coding_system
gene	O
*	B-code
608776	I-code
causing	O
spinocerebellar	B-phenotype
ataxia	I-phenotype
type	O
6	O
.	O

the	O
prevalence	O
of	O
adjustment	B-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f43	B-code
.	I-code
2	I-code
)	O
in	O
an	O
adolescent	O
population	O
was	O
explored	O
in	O
this	O
study	O
.	O

the	O
patient	O
presented	O
with	O
symptoms	O
consistent	O
with	O
dysthymia	B-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
4	I-code
)	O
,	O
warranting	O
further	O
assessment	O
and	O
treatment	O
.	O

mutational	O
analysis	O
confirmed	O
the	O
presence	O
of	O
the	O
p	B-phenotype
.	I-phenotype
p56s	I-phenotype
mutation	O
in	O
the	O
vapb	B-coding_system
gene	I-coding_system
leading	O
to	O
the	O
diagnosis	O
of	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
.	O

the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
gilles	B-phenotype
de	I-phenotype
la	I-phenotype
tourette	I-phenotype
syndrome	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f95	B-code
.	I-code
2	I-code
)	O
.	O

participants	O
with	O
a	O
history	O
of	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
personality	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
301	B-code
.	I-code
4	I-code
)	O
were	O
excluded	O
from	O
the	O
study	O
.	O

genetic	O
testing	O
confirmed	O
the	O
presence	O
of	O
a	O
mutation	B-phenotype
in	O
the	O
myh7	B-phenotype
gene	I-phenotype
(	O
omim	B-coding_system
code	O
*	B-code
160760	I-code
)	O
associated	O
with	O
hypertrophic	B-phenotype
cardiomyopathy	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
idiopathic	B-phenotype
short	I-phenotype
stature	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e34	B-code
.	I-code
3	I-code
)	O
after	O
thorough	O
evaluation	O
of	O
potential	O
underlying	O
causes	O
.	O

the	O
genetic	O
screening	O
confirmed	O
a	O
hemochromatosis	B-phenotype
diagnosis	O
due	O
to	O
the	O
presence	O
of	O
the	O
p	B-code
.	I-code
c282y	I-code
homozygous	I-code
mutation	O
in	O
the	O
hfe	B-coding_system
gene	I-coding_system
.	O

the	O
trisomy	B-phenotype
18	I-phenotype
condition	O
was	O
confirmed	O
by	O
the	O
identification	O
of	O
an	O
additional	O
chromosome	O
18	O
in	O
the	O
patient	O
(	O
iscn	B-coding_system
code	O
47	B-code
,	I-code
xx	I-code
,	I-code
+	I-code
18	I-code
)	O
,	O
which	O
is	O
also	O
known	O
as	O
edwards	B-phenotype
syndrome	I-phenotype
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
factitious	B-phenotype
disorder	I-phenotype
imposed	I-phenotype
on	I-phenotype
another	I-phenotype
(	O
previously	O
known	O
as	O
munchausen	O
by	O
proxy	O
)	O
within	O
medical	O
institutions	O
,	O
defined	O
by	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
19	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
intellectual	B-phenotype
developmental	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
6a01	B-code
)	O
,	O
affecting	O
their	O
cognitive	O
and	O
adaptive	O
skills	O
.	O

a	O
family	O
history	O
of	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
was	O
noted	O
,	O
with	O
the	O
affected	O
relative	O
carrying	O
a	O
specific	O
hla	B-coding_system
haplotype	I-coding_system
(	O
dr3	B-code
–	I-code
dq2	I-code
)	O
.	O

prenatal	O
testing	O
revealed	O
a	O
chromosomal	B-phenotype
abnormality	I-phenotype
with	O
a	O
iscn	B-coding_system
code	O
47	B-code
,	I-code
xy	I-code
,	I-code
+	I-code
13	I-code
,	O
leading	O
to	O
the	O
diagnosis	O
of	O
patau	B-phenotype
syndrome	I-phenotype
.	O

pediatric	O
patients	O
with	O
a	O
diagnosis	O
of	O
attention	B-phenotype
-	I-phenotype
deficit	I-phenotype
/	I-phenotype
hyperactivity	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
314	B-code
)	O
were	O
examined	O
for	O
potential	O
environmental	O
risk	O
factors	O
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
a	O
dystrophinopathy	B-phenotype
caused	O
by	O
a	O
mutation	O
in	O
the	O
dmd	B-coding_system
gene	I-coding_system
(	O
*	B-code
300377	I-code
)	O
leading	O
to	O
the	O
diagnosis	O
of	O
duchenne	B-phenotype
muscular	I-phenotype
dystrophy	I-phenotype
.	O

we	O
investigated	O
the	O
occurrence	O
of	O
neurodevelopmental	B-phenotype
disorders	I-phenotype
,	O
such	O
as	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
299	B-code
.	I-code
00	I-code
)	O
,	O
among	O
siblings	O
.	O

the	O
disorder	O
persistent	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
,	O
also	O
known	O
as	O
dysthymia	O
,	O
was	O
studied	O
in	O
relation	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
classification	O
system	O
with	O
a	O
code	O
of	O
f34	B-code
.	I-code
1	I-code
.	O

participants	O
with	O
a	O
diagnosis	O
of	O
narcissistic	B-phenotype
personality	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
301	B-code
.	I-code
81	I-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

the	O
genetic	O
analysis	O
revealed	O
a	O
monogenic	B-phenotype
cause	I-phenotype
for	O
familial	B-phenotype
hypercholesterolemia	I-phenotype
,	O
specifically	O
a	O
mutation	O
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
143890	I-code
(	O
ldlr	O
)	O
.	O

the	O
patient	O
had	O
early	O
-	O
onset	O
substance	B-phenotype
-	I-phenotype
induced	I-phenotype
psychotic	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f1x	B-code
.	I-code
5	I-code
)	O
related	O
to	O
excessive	O
alcohol	O
use	O
.	O

symptoms	O
of	O
vascular	B-phenotype
dementia	I-phenotype
were	O
identified	O
in	O
the	O
patient	O
,	O
with	O
a	O
corresponding	O
code	O
of	O
f01	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
classification	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
polg	B-phenotype
-	I-phenotype
related	I-phenotype
disorders	I-phenotype
,	O
caused	O
by	O
mutations	O
in	O
the	O
polg	B-coding_system
gene	I-coding_system
(	O
*	B-code
174763	I-code
)	O
,	O
leading	O
to	O
various	O
mitochondrial	O
diseases	O
.	O

a	O
study	O
was	O
conducted	O
on	O
the	O
prevalence	O
of	O
klinefelter	B-phenotype
syndrome	I-phenotype
in	O
males	O
,	O
with	O
a	O
respective	O
karyotype	O
represented	O
as	O
iscn	B-coding_system
code	O
47	B-code
,	I-code
xxy	I-code
.	O

in	O
the	O
patient	O
,	O
the	O
presence	O
of	O
the	O
e298d	B-phenotype
mutation	O
in	O
the	O
dpyd	B-coding_system
gene	I-coding_system
was	O
found	O
to	O
increase	O
the	O
risk	O
of	O
5	B-phenotype
-	I-phenotype
fluorouracil	I-phenotype
toxicity	I-phenotype
.	O

the	O
patient	O
exhibited	O
symptoms	O
consistent	O
with	O
delusional	B-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f22	B-code
)	O
.	O

we	O
examined	O
the	O
effects	O
of	O
cognitive	O
-	O
behavioral	O
therapy	O
in	O
individuals	O
with	O
a	O
diagnosis	O
of	O
mild	B-phenotype
neurocognitive	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
294	B-code
.	I-code
9	I-code
)	O
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
intellectual	B-phenotype
disability	I-phenotype
–	I-phenotype
macrocephaly	I-phenotype
syndrome	I-phenotype
caused	O
by	O
a	O
mutation	O
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
610730	I-code
(	O
kif7	O
)	O
.	O

the	O
study	O
investigated	O
the	O
prevalence	O
of	O
conversion	B-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
6b41	B-code
)	O
in	O
a	O
primary	O
care	O
setting	O
.	O

according	O
to	O
the	O
international	B-coding_system
classification	I-coding_system
of	I-coding_system
diseases	I-coding_system
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
)	O
,	O
patients	O
diagnosed	O
with	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
were	O
assigned	O
a	O
code	O
of	O
e11	B-code
.	O

the	O
patient	O
was	O
referred	O
to	O
specialized	O
services	O
after	O
presenting	O
with	O
symptoms	O
consistent	O
with	O
bulimia	B-phenotype
nervosa	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
307	B-code
.	I-code
51	I-code
)	O
.	O

the	O
genetic	O
test	O
revealed	O
a	O
flt3	B-phenotype
-	I-phenotype
itd	I-phenotype
mutation	I-phenotype
associated	O
with	O
an	O
increased	O
risk	O
of	O
developing	O
acute	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
.	O

according	O
to	O
the	O
iscn	B-coding_system
nomenclature	I-coding_system
,	O
the	O
patient	O
was	O
diagnosed	O
with	O
a	O
45	B-phenotype
,	I-phenotype
x	I-phenotype
karyotype	I-phenotype
,	O
also	O
known	O
as	O
turner	B-phenotype
syndrome	I-phenotype
.	O

the	O
patient	O
'	O
s	O
symptoms	O
were	O
consistent	O
with	O
depersonalization	B-phenotype
-	I-phenotype
derealization	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
6	I-code
)	O
.	O

genetic	O
testing	O
confirmed	O
a	O
pathogenic	B-phenotype
variant	I-phenotype
of	O
the	O
omim	B-coding_system
gene	O
*	B-code
613839	I-code
associated	O
with	O
joubert	B-phenotype
syndrome	I-phenotype
.	O

the	O
prevalence	O
of	O
agoraphobia	B-phenotype
without	O
a	O
history	O
of	O
panic	B-phenotype
disorder	I-phenotype
was	O
examined	O
in	O
this	O
study	O
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f40	B-code
.	I-code
0	I-code
)	O
.	O

in	O
the	O
pediatric	O
population	O
,	O
we	O
studied	O
the	O
presence	O
of	O
disruptive	B-phenotype
mood	I-phenotype
dysregulation	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
99	I-code
)	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
narcolepsy	B-phenotype
with	I-phenotype
cataplexy	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
41	I-code
)	O
,	O
requiring	O
further	O
management	O
and	O
treatment	O
.	O

genetic	O
testing	O
detected	O
the	O
m	B-phenotype
.	I-phenotype
3243a	I-phenotype
>	I-phenotype
g	I-phenotype
mutation	I-phenotype
in	O
the	O
mt	B-coding_system
-	I-coding_system
tl1	I-coding_system
gene	I-coding_system
associated	O
with	O
mitochondrial	B-phenotype
encephalomyopathy	I-phenotype
.	O

the	O
identification	O
of	O
a	O
trisomy	B-phenotype
21	I-phenotype
karyotype	O
(	O
iscn	B-coding_system
code	O
47	B-code
,	I-code
xx	I-code
,	I-code
+	I-code
21	I-code
)	O
in	O
prenatal	O
testing	O
prompted	O
a	O
further	O
evaluation	O
for	O
potential	O
signs	O
of	O
down	B-phenotype
syndrome	I-phenotype
.	O

a	O
patient	O
was	O
found	O
to	O
have	O
a	O
mutation	B-phenotype
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
601419	I-code
,	O
confirming	O
the	O
diagnosis	O
of	O
wilson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
.	O

the	O
patient	O
presented	O
with	O
clinical	O
features	O
of	O
bipolar	B-phenotype
ii	I-phenotype
disorder	I-phenotype
,	O
which	O
is	O
classified	O
as	O
code	O
f31	B-code
.	I-code
81	I-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
williams	B-phenotype
syndrome	I-phenotype
after	O
detection	O
of	O
a	O
heterozygous	O
microdeletion	O
in	O
the	O
iscn	B-coding_system
region	O
7q11	B-code
.	I-code
23	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
klippel	B-phenotype
-	I-phenotype
feil	I-phenotype
syndrome	I-phenotype
,	O
a	O
condition	O
caused	O
by	O
mutations	O
in	O
various	O
genes	O
,	O
such	O
as	O
the	O
omim	B-coding_system
gene	O
*	B-code
602078	I-code
.	O

we	O
assessed	O
the	O
risk	O
of	O
psychiatric	O
comorbidities	O
such	O
as	O
avoidant	B-phenotype
personality	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f60	B-code
.	I-code
6	I-code
)	O
in	O
patients	O
with	O
depressive	B-phenotype
disorders	I-phenotype
.	O

genetic	O
screening	O
revealed	O
a	O
homozygous	O
gaa	B-phenotype
expansion	I-phenotype
mutation	O
in	O
the	O
fxn	B-coding_system
gene	I-coding_system
,	O
confirming	O
the	O
diagnosis	O
of	O
friedreich	B-phenotype
ataxia	I-phenotype
.	O

the	O
patient	O
presented	O
symptoms	O
of	O
undiagnosed	B-phenotype
obsessive	I-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f42	B-code
.	I-code
9	I-code
)	O
,	O
leading	O
to	O
further	O
evaluation	O
and	O
treatment	O
planning	O
.	O

the	O
genetic	O
testing	O
results	O
showed	O
the	O
presence	O
of	O
the	O
omim	B-coding_system
gene	O
*	B-code
614608	I-code
mutation	O
,	O
confirming	O
a	O
diagnosis	O
of	O
huntington	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
.	O

patients	O
diagnosed	O
with	O
chronic	B-phenotype
fatigue	I-phenotype
syndrome	I-phenotype
were	O
assigned	O
a	O
code	O
of	O
g93	B-code
.	I-code
3	I-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
caffeine	B-phenotype
-	I-phenotype
induced	I-phenotype
anxiety	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
305	B-code
.	I-code
90	I-code
)	O
.	O

the	O
study	O
investigated	O
specific	O
genetic	O
mutations	O
related	O
to	O
the	O
development	O
of	O
cystic	B-phenotype
fibrosis	I-phenotype
in	O
the	O
omim	B-coding_system
gene	O
database	O
,	O
such	O
as	O
the	O
*	B-code
602421	I-code
(	O
cftr	O
)	O
gene	O
.	O

in	O
the	O
clinical	O
study	O
,	O
we	O
examined	O
the	O
effects	O
of	O
various	O
therapeutic	O
interventions	O
on	O
patients	O
diagnosed	O
with	O
binge	B-phenotype
eating	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
307	B-code
.	I-code
51	I-code
)	O
.	O

the	O
presence	O
of	O
the	O
p	B-phenotype
.	I-phenotype
v600e	I-phenotype
mutation	O
in	O
the	O
braf	B-coding_system
gene	I-coding_system
was	O
associated	O
with	O
the	O
development	O
of	O
melanoma	B-phenotype
in	O
our	O
study	O
population	O
.	O

the	O
patient	O
'	O
s	O
symptoms	O
were	O
consistent	O
with	O
psychotic	B-phenotype
symptoms	I-phenotype
resulting	O
from	O
intoxication	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f1x	B-code
.	I-code
4	I-code
)	O
.	O

according	O
to	O
the	O
international	B-coding_system
classification	I-coding_system
of	I-coding_system
diseases	I-coding_system
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
)	O
,	O
individuals	O
diagnosed	O
with	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
were	O
assigned	O
the	O
code	O
g20	B-code
.	O

genetic	O
screening	O
for	O
x	B-phenotype
-	I-phenotype
linked	I-phenotype
dystonia	I-phenotype
-	I-phenotype
parkinsonism	I-phenotype
involved	O
analysis	O
of	O
the	O
omim	B-coding_system
gene	O
*	B-code
314250	I-code
(	O
taf1	O
)	O
.	O

a	O
strong	O
association	O
was	O
observed	O
between	O
seasonal	B-phenotype
affective	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
3x	I-code
)	O
and	O
geographic	O
latitude	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
in	O
accordance	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
,	O
receiving	O
a	O
code	O
of	O
f41	B-code
.	I-code
1	I-code
.	O

the	O
study	O
aimed	O
to	O
investigate	O
the	O
genetic	O
basis	O
of	O
becker	B-phenotype
muscular	I-phenotype
dystrophy	I-phenotype
,	O
analyzing	O
the	O
omim	B-coding_system
gene	O
*	B-code
300377	I-code
(	O
dmd	O
)	O
.	O

genetic	O
testing	O
and	O
karyotyping	O
results	O
revealed	O
a	O
47	B-phenotype
,	I-phenotype
xxx	I-phenotype
karyotype	I-phenotype
in	O
the	O
patient	O
,	O
leading	O
to	O
the	O
diagnosis	O
of	O
triple	B-phenotype
x	I-phenotype
syndrome	I-phenotype
(	O
iscn	B-coding_system
code	O
47	B-code
,	I-code
xxx	I-code
)	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
oppositional	B-phenotype
defiant	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f91	B-code
.	I-code
3	I-code
)	O
after	O
a	O
comprehensive	O
psychiatric	O
assessment	O
.	O

symptoms	O
of	O
maladaptive	B-phenotype
daydreaming	I-phenotype
,	O
while	O
not	O
officially	O
recognized	O
in	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
,	O
were	O
assessed	O
in	O
relation	O
to	O
the	O
prevalence	O
of	O
internet	O
gaming	O
disorder	O
.	O

the	O
jak2	B-phenotype
v617f	I-phenotype
mutation	I-phenotype
was	O
identified	O
in	O
a	O
patient	O
with	O
a	O
diagnosis	O
of	O
polycythemia	B-phenotype
vera	I-phenotype
.	O

our	O
study	O
aimed	O
to	O
explore	O
the	O
relationship	O
between	O
body	B-phenotype
dysmorphic	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
7	I-code
)	O
and	O
the	O
use	O
of	O
social	O
media	O
platforms	O
.	O

the	O
patient	O
exhibited	O
symptoms	O
indicative	O
of	O
pervasive	B-phenotype
developmental	I-phenotype
disorder	I-phenotype
not	I-phenotype
otherwise	I-phenotype
specified	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f84	B-code
.	I-code
9	I-code
)	O
.	O

genetic	O
testing	O
confirmed	O
the	O
presence	O
of	O
a	O
pathogenic	B-phenotype
variant	I-phenotype
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
123100	I-code
responsible	O
for	O
the	O
development	O
of	O
congenital	B-phenotype
adrenal	I-phenotype
hyperplasia	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
postpartum	B-phenotype
depression	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
f53	B-code
.	I-code
0	I-code
)	O
during	O
the	O
first	O
three	O
months	O
following	O
childbirth	O
.	O

genetic	O
testing	O
revealed	O
a	O
mutation	B-phenotype
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
156240	I-code
associated	O
with	O
crouzon	B-phenotype
syndrome	I-phenotype
.	O

the	O
primary	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
selective	B-phenotype
mutism	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
313	B-code
.	I-code
23	I-code
)	O
in	O
children	O
attending	O
preschool	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
primary	B-phenotype
insomnia	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
5a92	B-code
)	O
were	O
assessed	O
for	O
potential	O
risk	O
factors	O
and	O
treatment	O
responsiveness	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
antisocial	B-phenotype
personality	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
301	B-code
.	I-code
7	I-code
)	O
after	O
a	O
comprehensive	O
evaluation	O
.	O

the	O
patient	O
exhibited	O
symptoms	O
of	O
somatic	B-phenotype
symptom	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f45	B-code
.	I-code
1	I-code
)	O
and	O
was	O
referred	O
to	O
a	O
multidisciplinary	O
pain	O
management	O
program	O
.	O

the	O
patient	O
carried	O
a	O
mutation	B-phenotype
in	O
the	O
omim	B-coding_system
gene	O
*	B-code
604302	I-code
,	O
resulting	O
in	O
the	O
diagnosis	O
of	O
fragile	B-phenotype
x	I-phenotype
syndrome	I-phenotype
.	O

in	O
this	O
longitudinal	O
study	O
,	O
we	O
assessed	O
the	O
trajectories	O
and	O
outcomes	O
of	O
adolescents	O
diagnosed	O
with	O
conduct	B-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
312	B-code
)	O
.	O

the	O
patient	O
exhibited	O
symptoms	O
of	O
alcohol	B-phenotype
withdrawal	I-phenotype
delirium	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f10	B-code
.	I-code
231	I-code
)	O
following	O
the	O
cessation	O
of	O
excessive	O
alcohol	O
consumption	O
.	O

genetic	O
analysis	O
confirmed	O
the	O
presence	O
of	O
a	O
mutation	B-phenotype
in	O
the	O
neb	B-coding_system
gene	I-coding_system
(	O
*	B-code
161650	I-code
)	O
,	O
leading	O
to	O
the	O
diagnosis	O
of	O
nemaline	B-phenotype
myopathy	I-phenotype
.	O

the	O
study	O
examined	O
the	O
prevalence	O
of	O
histrionic	B-phenotype
personality	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
301	B-code
.	I-code
50	I-code
)	O
among	O
different	O
populations	O
based	O
on	O
cultural	O
factors	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
encopresis	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f98	B-code
.	I-code
1	I-code
)	O
and	O
was	O
referred	O
for	O
further	O
evaluation	O
and	O
treatment	O
planning	O
.	O
the	O
patient	O
was	O
diagnosed	O
with	O
migraine	B-phenotype
without	I-phenotype
aura	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g43	B-code
.	I-code
0	I-code
)	O
based	O
on	O
the	O
clinical	O
presentation	O
and	O
medical	O
history	O
.	O

a	O
retrospective	O
study	O
was	O
conducted	O
to	O
identify	O
patients	O
with	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
)	O
and	O
associated	O
complications	O
in	O
the	O
electronic	O
health	O
record	O
database	O
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
)	O
and	O
was	O
on	O
a	O
treatment	O
regimen	O
with	O
hydroxychloroquine	O
and	O
corticosteroids	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
pd	O
)	O
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
.	O

according	O
to	O
the	O
omim	B-coding_system
database	O
,	O
the	O
179110	B-code
code	O
is	O
associated	O
with	O
the	O
marfan	B-phenotype
syndrome	I-phenotype
and	O
its	O
related	O
complications	O
.	O

the	O
cystic	B-phenotype
fibrosis	I-phenotype
phenotype	O
was	O
confirmed	O
in	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
277	B-code
.	I-code
00	I-code
or	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
.	O

a	O
comprehensive	O
review	O
of	O
electronic	O
medical	O
records	O
identified	O
patients	O
with	O
rheumatoid	B-phenotype
arthritis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
-	I-code
m06	I-code
.	O

clinical	O
diagnosis	O
of	O
schizophrenia	B-phenotype
was	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
diagnostic	O
criteria	O
with	O
the	O
corresponding	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f20	B-code
.	O

the	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
was	O
documented	O
in	O
the	O
patient	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f32	B-code
during	O
regular	O
psychological	O
assessments	O
.	O

researchers	O
observed	O
a	O
significant	O
association	O
between	O
the	O
obstructive	B-phenotype
sleep	I-phenotype
apnea	I-phenotype
phenotype	O
and	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
33	I-code
.	O

the	O
neonates	O
diagnosed	O
as	O
having	O
down	B-phenotype
syndrome	I-phenotype
included	O
those	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q90	B-code
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
73211009	B-code
corresponds	O
to	O
the	O
diabetic	B-phenotype
retinopathy	I-phenotype
phenotype	O
.	O

patients	O
presenting	O
with	O
a	O
phenotype	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	I-phenotype
ckd	I-phenotype
)	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0012740	I-code
represents	O
the	O
phenotype	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
.	O

a	O
high	O
prevalence	O
of	O
multiple	B-phenotype
sclerosis	I-phenotype
was	O
found	O
among	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
in	O
the	O
studied	O
population	O
.	O

the	O
clinical	O
diagnosis	O
of	O
dementia	B-phenotype
was	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f01	B-code
-	I-code
f03	I-code
and	O
g30	B-code
.	O

after	O
reviewing	O
the	O
patient	O
'	O
s	O
records	O
,	O
the	O
doctor	O
confirmed	O
the	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	O

the	O
omim	B-coding_system
database	O
indicates	O
that	O
the	O
108300	B-code
code	O
corresponds	O
to	O
the	O
charcot	B-phenotype
-	I-phenotype
marie	I-phenotype
-	I-phenotype
tooth	I-phenotype
disease	I-phenotype
phenotype	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
(	I-phenotype
ibs	I-phenotype
)	I-phenotype
,	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
.	O

the	O
asthma	B-phenotype
phenotype	O
was	O
associated	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
in	O
the	O
analyzed	O
population	O
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
.	O

the	O
diagnosis	O
of	O
pulmonary	B-phenotype
embolism	I-phenotype
was	O
established	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i26	B-code
.	O

the	O
glioblastoma	B-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
254817007	B-code
.	O

individuals	O
with	O
a	O
bipolar	B-phenotype
disorder	I-phenotype
phenotype	O
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f31	B-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0000118	I-code
corresponds	O
to	O
the	O
phenotype	O
of	O
short	B-phenotype
stature	I-phenotype
.	O

the	O
clinical	O
diagnosis	O
of	O
epilepsy	B-phenotype
was	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
a	O
hereditary	B-phenotype
hemorrhagic	I-phenotype
telangiectasia	I-phenotype
(	O
hht	O
)	O
,	O
according	O
to	O
the	O
omim	B-coding_system
code	O
187300	B-code
.	O

the	O
covid	B-phenotype
-	I-phenotype
19	I-phenotype
phenotype	O
was	O
confirmed	O
in	O
patients	O
with	O
a	O
positive	O
pcr	O
test	O
and	O
umls	B-coding_system
code	O
c5203670	B-code
.	O

the	O
osteoporosis	B-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m81	B-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
acute	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c92	B-code
.	I-code
0	I-code
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
46621007	B-code
corresponds	O
to	O
the	O
pericarditis	B-phenotype
phenotype	O
.	O

patients	O
diagnosed	O
with	O
psoriasis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
.	O

the	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
.	O

the	O
diagnosis	O
of	O
muscular	B-phenotype
dystrophy	I-phenotype
was	O
confirmed	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g71	B-code
.	I-code
0	I-code
.	O

the	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
phenotype	O
was	O
identified	O
with	O
a	O
umls	B-coding_system
code	O
c3809201	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
and	O
corresponding	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f84	B-code
.	I-code
0	I-code
.	O

the	O
renal	B-phenotype
cell	I-phenotype
carcinoma	I-phenotype
phenotype	O
was	O
linked	O
to	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
37278007	B-code
.	O

the	O
hypothyroidism	B-phenotype
phenotype	O
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e03	B-code
.	O

according	O
to	O
the	O
omim	B-coding_system
database	O
,	O
the	O
223300	B-code
code	O
corresponds	O
to	O
the	O
leber	B-phenotype
'	I-phenotype
s	I-phenotype
hereditary	I-phenotype
optic	I-phenotype
neuropathy	I-phenotype
phenotype	O
.	O

the	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
'	I-phenotype
s	I-phenotype
lymphoma	I-phenotype
phenotype	O
was	O
diagnosed	O
in	O
patients	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c82	B-code
-	I-code
c85	I-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0001257	I-code
represents	O
the	O
muscle	B-phenotype
weakness	I-phenotype
phenotype	O
.	O

the	O
patient	O
'	O
s	O
clinical	O
diagnosis	O
of	O
congestive	B-phenotype
heart	I-phenotype
failure	I-phenotype
was	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i50	B-code
.	O

the	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
ad	O
)	O
phenotype	O
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
and	O
patient	O
'	O
s	O
cognitive	O
assessment	O
scores	O
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
240770007	B-code
corresponds	O
to	O
the	O
systemic	B-phenotype
sclerosis	I-phenotype
phenotype	O
.	O

patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
acne	B-phenotype
vulgaris	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l70	B-code
.	I-code
0	I-code
.	O

the	O
sjogren	B-phenotype
'	I-phenotype
s	I-phenotype
syndrome	I-phenotype
phenotype	O
was	O
diagnosed	O
in	O
patients	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m35	B-code
.	I-code
0	I-code
.	O

the	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
(	I-phenotype
pcos	I-phenotype
)	I-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
.	O

the	O
umls	B-coding_system
code	O
c3273637	B-code
is	O
linked	O
to	O
the	O
lung	B-phenotype
adenocarcinoma	I-phenotype
phenotype	O
.	O

according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k25	B-code
,	O
the	O
patient	O
was	O
diagnosed	O
with	O
a	O
gastric	B-phenotype
ulcer	I-phenotype
.	O

the	O
endometriosis	B-phenotype
phenotype	O
was	O
identified	O
in	O
patients	O
with	O
an	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0000486	I-code
corresponds	O
to	O
the	O
ptosis	B-phenotype
phenotype	O
.	O

patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c61	B-code
were	O
diagnosed	O
with	O
prostate	B-phenotype
cancer	I-phenotype
.	O

the	O
thalassemia	B-phenotype
phenotype	O
was	O
linked	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d56	B-code
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
53741008	B-code
is	O
associated	O
with	O
the	O
pancreatitis	B-phenotype
phenotype	O
.	O

the	O
patient	O
'	O
s	O
medical	O
records	O
showed	O
a	O
diagnosis	O
of	O
glaucoma	B-phenotype
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h40	B-code
.	O

the	O
ankylosing	B-phenotype
spondylitis	I-phenotype
phenotype	O
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
in	O
the	O
retrospective	O
study	O
.	O

the	O
omim	B-coding_system
code	O
116800	B-code
corresponds	O
to	O
the	O
alport	B-phenotype
syndrome	I-phenotype
phenotype	O
.	O

the	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	I-phenotype
als	I-phenotype
)	I-phenotype
phenotype	O
was	O
diagnosed	O
in	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
21	I-code
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
gout	B-phenotype
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m10	B-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0001399	I-code
is	O
linked	O
to	O
the	O
hepatic	B-phenotype
steatosis	I-phenotype
phenotype	O
.	O

the	O
atrial	B-phenotype
fibrillation	I-phenotype
phenotype	O
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
.	O

the	O
clinical	O
diagnosis	O
of	O
myasthenia	B-phenotype
gravis	I-phenotype
was	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g70	B-code
.	I-code
0	I-code
.	O

the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e66	B-code
corresponds	O
to	O
the	O
obesity	B-phenotype
phenotype	O
.	O

the	O
varicose	B-phenotype
veins	I-phenotype
phenotype	O
was	O
diagnosed	O
with	O
a	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i83	B-code
.	O

the	O
sickle	B-phenotype
cell	I-phenotype
anemia	I-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d57	B-code
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
422933007	B-code
corresponds	O
to	O
the	O
rosacea	B-phenotype
phenotype	O
.	O

patients	O
diagnosed	O
with	O
nephrotic	B-phenotype
syndrome	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n04	B-code
.	O

the	O
fibromyalgia	B-phenotype
phenotype	O
was	O
linked	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0000819	I-code
corresponds	O
to	O
the	O
hyperprolactinemia	B-phenotype
phenotype	O
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
bronchitis	B-phenotype
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j20	B-code
.	O

the	O
eczema	B-phenotype
phenotype	O
was	O
diagnosed	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l30	B-code
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
52448006	B-code
corresponds	O
to	O
the	O
lupus	B-phenotype
nephritis	I-phenotype
phenotype	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
psoriatic	B-phenotype
arthritis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m07	B-code
.	O

the	O
graves	B-phenotype
'	I-phenotype
disease	I-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e05	B-code
.	I-code
0	I-code
.	O

the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j18	B-code
is	O
linked	O
to	O
the	O
pneumonia	B-phenotype
phenotype	O
.	O

patients	O
diagnosed	O
with	O
hemochromatosis	B-phenotype
carry	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e83	B-code
.	I-code
11	I-code
.	O

the	O
omim	B-coding_system
code	O
170600	B-code
corresponds	O
to	O
the	O
381	B-phenotype
pfeiffer	I-phenotype
syndrome	I-phenotype
phenotype	O
.	O

the	O
narcolepsy	B-phenotype
phenotype	O
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
413	I-code
.	O

the	O
clinical	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
was	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
and	O
patient	O
'	O
s	O
radiographic	O
findings	O
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0000256	I-code
represents	O
the	O
macrocephaly	B-phenotype
phenotype	O
.	O

patients	O
diagnosed	O
with	O
ulcerative	B-phenotype
colitis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
.	O

the	O
tuberculosis	B-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a16	B-code
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
154283005	B-code
corresponds	O
to	O
the	O
erythema	B-phenotype
multiforme	I-phenotype
phenotype	O
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
alopecia	B-phenotype
areata	I-phenotype
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l63	B-code
.	O

the	O
osteoarthritis	B-phenotype
phenotype	O
was	O
linked	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m15	B-code
-	I-code
m19	I-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0000951	I-code
corresponds	O
to	O
the	O
dry	B-phenotype
skin	I-phenotype
phenotype	O
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
bell	B-phenotype
'	I-phenotype
s	I-phenotype
palsy	I-phenotype
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g51	B-code
.	I-code
0	I-code
.	O

the	O
ankylosing	B-phenotype
spondylitis	I-phenotype
phenotype	O
was	O
diagnosed	O
with	O
a	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
during	O
the	O
clinical	O
examination	O
.	O

the	O
mitral	B-phenotype
valve	I-phenotype
prolapse	I-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i34	B-code
.	I-code
0	I-code
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
48523006	B-code
corresponds	O
to	O
the	O
polycythemia	B-phenotype
vera	I-phenotype
phenotype	O
.	O

patients	O
diagnosed	O
with	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	I-phenotype
copd	I-phenotype
)	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
.	O

the	O
myocardial	B-phenotype
infarction	I-phenotype
phenotype	O
was	O
linked	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i21	B-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0001943	I-code
is	O
linked	O
to	O
the	O
fever	B-phenotype
phenotype	O
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
cluster	B-phenotype
headache	I-phenotype
were	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g44	B-code
.	I-code
0	I-code
.	O

the	O
ankylosing	B-phenotype
spondylitis	I-phenotype
phenotype	O
was	O
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
based	O
on	O
the	O
clinician	O
'	O
s	O
assessment	O
.	O

the	O
snomed	B-coding_system
ct	I-coding_system
code	O
50711007	B-code
is	O
linked	O
to	O
the	O
discoid	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
phenotype	O
.	O

the	O
patient	O
was	O
diagnosed	O
as	O
having	O
pneumothorax	B-phenotype
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j93	B-code
.	O

the	O
end	B-phenotype
-	I-phenotype
stage	I-phenotype
renal	I-phenotype
disease	I-phenotype
(	I-phenotype
esrd	I-phenotype
)	I-phenotype
phenotype	O
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	I-code
6	I-code
.	O

the	O
clinical	O
diagnosis	O
of	O
vitiligo	B-phenotype
was	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l80	B-code
.	O

the	O
hpo	B-coding_system
code	O
hp	B-code
:	I-code
0000651	I-code
represents	O
the	O
cataract	B-phenotype
phenotype	O
.	O
the	O
patient	O
presented	O
with	O
symptoms	O
consistent	O
with	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
with	O
a	O
primary	O
diagnosis	O
code	O
of	O
299	B-code
.	I-code
00	I-code
.	O

a	O
total	O
of	O
55	O
patients	O
with	O
osteogenesis	B-phenotype
imperfecta	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
q78	B-code
.	I-code
0	I-code
and	O
q78	B-code
.	I-code
00	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
depression	B-phenotype
based	O
on	O
the	O
criteria	O
outlined	O
in	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
and	O
assigned	O
a	O
code	O
of	O
f32	B-code
.	I-code
1	I-code
.	O

the	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
cases	O
were	O
identified	O
using	O
the	O
g20	B-code
code	O
from	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
classification	O
.	O

we	O
analyzed	O
120	O
patients	O
with	O
breast	B-phenotype
cancer	I-phenotype
using	O
the	O
c50	B-code
code	O
from	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
coding	O
system	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
social	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
,	O
and	O
assigned	O
a	O
code	O
of	O
f40	B-code
.	I-code
10	I-code
.	O

participants	O
were	O
eligible	O
if	O
they	O
had	O
a	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
of	O
f41	B-code
.	I-code
1	I-code
for	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
with	O
a	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
of	O
e11	B-code
.	O

the	O
schizophrenia	B-phenotype
cases	O
in	O
this	O
study	O
were	O
defined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f20	B-code
.	O

children	O
with	O
a	O
primary	O
diagnosis	O
of	O
attention	B-phenotype
deficit	I-phenotype
hyperactivity	I-phenotype
disorder	I-phenotype
(	O
adhd	O
)	O
were	O
identified	O
using	O
a	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
of	O
314	B-code
.	I-code
01	I-code
.	O

the	O
patient	O
had	O
a	O
history	O
of	O
bipolar	B-phenotype
disorder	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
with	O
a	O
code	O
of	O
f31	B-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
multiple	B-phenotype
sclerosis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
.	O

the	O
alcohol	B-phenotype
use	I-phenotype
disorder	I-phenotype
cases	O
in	O
this	O
cohort	O
were	O
identified	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
303	B-code
.	I-code
90	I-code
.	O

we	O
included	O
patients	O
with	O
a	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
of	O
c61	B-code
for	O
prostate	B-phenotype
cancer	I-phenotype
in	O
our	O
analysis	O
.	O

the	O
patient	O
'	O
s	O
symptoms	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
for	O
a	O
diagnosis	O
of	O
borderline	B-phenotype
personality	I-phenotype
disorder	I-phenotype
,	O
with	O
a	O
code	O
of	O
f60	B-code
.	I-code
3	I-code
.	O

we	O
focused	O
on	O
patients	O
with	O
a	O
traumatic	B-phenotype
brain	I-phenotype
injury	I-phenotype
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
s06	B-code
in	O
this	O
study	O
.	O

cases	O
of	O
childhood	B-phenotype
asthma	I-phenotype
were	O
defined	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
and	O
included	O
in	O
the	O
analysis	O
.	O

the	O
patient	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
for	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
and	O
was	O
assigned	O
the	O
code	O
f42	B-code
.	O

we	O
identified	O
patients	O
with	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
copd	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
j44	B-code
.	I-code
0	I-code
,	O
j44	B-code
.	I-code
1	I-code
,	O
and	O
j44	B-code
.	I-code
9	I-code
.	O

the	O
pancreatic	B-phenotype
cancer	I-phenotype
cases	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c25	B-code
.	O

patients	O
with	O
a	O
history	O
of	O
hypertension	B-phenotype
were	O
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i10	B-code
and	O
included	O
in	O
the	O
study	O
.	O

a	O
total	O
of	O
35	O
participants	O
with	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	O

cases	O
of	O
psoriasis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
and	O
included	O
in	O
the	O
analysis	O
.	O

this	O
study	O
focused	O
on	O
patients	O
with	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
.	O

cases	O
of	O
cystic	B-phenotype
fibrosis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
and	O
included	O
in	O
the	O
analysis	O
.	O

participants	O
with	O
a	O
primary	O
diagnosis	O
of	O
endometriosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
were	O
included	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
atrial	B-phenotype
fibrillation	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
and	O
received	O
treatment	O
accordingly	O
.	O

we	O
identified	O
patients	O
with	O
a	O
renal	B-phenotype
failure	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
n17	B-code
,	O
n18	B-code
,	O
and	O
n19	B-code
.	O

the	O
patient	O
presented	O
with	O
symptoms	O
consistent	O
with	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
,	O
with	O
a	O
primary	O
diagnosis	O
code	O
of	O
f33	B-code
.	I-code
1	I-code
.	O

a	O
cohort	O
of	O
100	O
patients	O
with	O
glioblastoma	B-phenotype
multiforme	I-phenotype
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c71	B-code
.	I-code
9	I-code
.	O

the	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
cases	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
and	O
included	O
in	O
the	O
study	O
.	O

the	O
patient	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
for	O
narcolepsy	B-phenotype
without	I-phenotype
cataplexy	I-phenotype
,	O
assigned	O
the	O
code	O
g47	B-code
.	I-code
419	I-code
.	O

all	O
43	O
cases	O
of	O
epilepsy	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
and	O
included	O
in	O
the	O
study	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
ankle	B-phenotype
sprain	I-phenotype
,	O
as	O
indicated	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
s93	B-code
.	I-code
4	I-code
.	O

the	O
fibromyalgia	B-phenotype
cases	O
in	O
this	O
study	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
.	O

patients	O
with	O
gestational	B-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
o24	B-code
.	I-code
4	I-code
.	O

we	O
identified	O
patients	O
with	O
hepatitis	B-phenotype
c	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
2	I-code
for	O
further	O
analysis	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
rosacea	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l71	B-code
.	O

the	O
children	O
in	O
this	O
study	O
were	O
diagnosed	O
with	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
asd	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f84	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
'	O
s	O
migraine	B-phenotype
episodes	O
met	O
the	O
diagnostic	O
criteria	O
outlined	O
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
and	O
were	O
assigned	O
a	O
code	O
of	O
g43	B-code
.	O

cases	O
of	O
patients	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
were	O
identified	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
n18	B-code
.	I-code
3	I-code
and	O
n18	B-code
.	I-code
9	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
ptsd	O
)	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
and	O
assigned	O
a	O
code	O
of	O
f43	B-code
.	I-code
10	I-code
.	O

the	O
rheumatoid	B-phenotype
arthritis	I-phenotype
cases	O
in	O
this	O
study	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
.	O

we	O
included	O
patients	O
with	O
a	O
snomed	B-coding_system
ct	I-coding_system
code	O
of	O
49436004	B-code
for	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
in	O
our	O
analysis	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
lichen	B-phenotype
planus	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l43	B-code
.	O

the	O
patient	O
'	O
s	O
ankylosing	B-phenotype
spondylitis	I-phenotype
diagnosis	O
was	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	I-code
0	I-code
.	O

cases	O
of	O
graves	B-phenotype
'	I-phenotype
disease	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e05	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
'	O
s	O
clinical	O
presentation	O
was	O
consistent	O
with	O
a	O
diagnosis	O
of	O
urticaria	B-phenotype
,	O
assigned	O
a	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
of	O
l50	B-code
.	O

patients	O
with	O
cerebral	B-phenotype
palsy	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g80	B-code
for	O
further	O
evaluation	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
klinefelter	B-phenotype
syndrome	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q98	B-code
.	I-code
1	I-code
.	O

participants	O
with	O
a	O
primary	O
diagnosis	O
of	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
were	O
included	O
.	O

the	O
patient	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
for	O
specific	B-phenotype
phobia	I-phenotype
,	O
assigned	O
the	O
code	O
f40	B-code
.	I-code
2	I-code
.	O

we	O
included	O
patients	O
with	O
a	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
of	O
e03	B-code
.	I-code
9	I-code
for	O
hypothyroidism	B-phenotype
in	O
our	O
study	O
.	O

the	O
study	O
cohort	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
dystonia	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g24	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
intracerebral	B-phenotype
hemorrhage	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i61	B-code
.	O

the	O
systemic	B-phenotype
sclerosis	I-phenotype
patients	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m34	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
erectile	B-phenotype
dysfunction	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n52	B-code
.	O

patients	O
with	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	I-code
1	I-code
.	O

the	O
patient	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
for	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
and	O
was	O
assigned	O
a	O
code	O
of	O
f41	B-code
.	I-code
1	I-code
.	O

cases	O
of	O
dental	B-phenotype
caries	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k02	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
a	O
myocardial	B-phenotype
infarction	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i21	B-code
.	O

cases	O
of	O
patients	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
were	O
identified	O
with	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
1963	B-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
bell	B-phenotype
'	I-phenotype
s	I-phenotype
palsy	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g51	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
community	B-phenotype
-	I-phenotype
acquired	I-phenotype
pneumonia	I-phenotype
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j18	B-code
.	I-code
9	I-code
.	O

we	O
identified	O
patients	O
with	O
lupus	B-phenotype
nephritis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	I-code
14	I-code
in	O
this	O
study	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
cholecystitis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k81	B-code
.	O

the	O
duchenne	B-phenotype
muscular	I-phenotype
dystrophy	I-phenotype
cases	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g71	B-code
.	I-code
0	I-code
in	O
this	O
cohort	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
a	O
femoral	B-phenotype
neck	I-phenotype
fracture	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
s72	B-code
.	I-code
0	I-code
.	O

the	O
children	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
developmental	B-phenotype
dyscalculia	I-phenotype
as	O
indicated	O
by	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
315	B-code
.	I-code
41	I-code
.	O

the	O
patient	O
'	O
s	O
symptoms	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
for	O
a	O
diagnosis	O
of	O
persistent	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
,	O
with	O
a	O
code	O
of	O
300	B-code
.	I-code
4	I-code
.	O

cases	O
of	O
myasthenia	B-phenotype
gravis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g70	B-code
.	I-code
0	I-code
in	O
the	O
study	O
population	O
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
history	O
of	O
septicemia	B-phenotype
defined	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a41	B-code
.	I-code
9	I-code
.	O

the	O
patient	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
for	O
somatization	B-phenotype
disorder	I-phenotype
,	O
assigned	O
a	O
code	O
of	O
f45	B-code
.	I-code
0	I-code
.	O

we	O
analyzed	O
data	O
from	O
200	O
participants	O
diagnosed	O
with	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
a	O
cerebral	B-phenotype
infarction	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i63	B-code
.	O

cases	O
of	O
patients	O
with	O
ulcerative	B-phenotype
colitis	I-phenotype
were	O
identified	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
.	O

the	O
patient	O
'	O
s	O
symptoms	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
for	O
a	O
diagnosis	O
of	O
reactive	B-phenotype
attachment	I-phenotype
disorder	I-phenotype
,	O
with	O
a	O
code	O
of	O
f94	B-code
.	I-code
1	I-code
.	O

cases	O
of	O
glioma	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c71	B-code
.	I-code
0	I-code
and	O
included	O
in	O
the	O
study	O
.	O

a	O
total	O
of	O
40	O
patients	O
with	O
osteoporosis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m81	B-code
in	O
this	O
population	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
temporal	B-phenotype
arteritis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m31	B-code
.	I-code
5	I-code
.	O

children	O
with	O
a	O
primary	O
diagnosis	O
of	O
conduct	B-phenotype
disorder	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
312	B-code
.	I-code
81	I-code
were	O
included	O
in	O
this	O
study	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
pulmonary	B-phenotype
embolism	I-phenotype
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i26	B-code
.	O

we	O
focused	O
on	O
patients	O
with	O
a	O
primary	B-phenotype
brain	I-phenotype
tumor	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
c71	B-code
and	O
d32	B-code
.	O

a	O
total	O
of	O
25	O
patients	O
with	O
acute	B-phenotype
lymphoblastic	I-phenotype
leukemia	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c91	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
presented	O
with	O
symptoms	O
consistent	O
with	O
adjustment	B-phenotype
disorder	I-phenotype
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
,	O
assigned	O
a	O
code	O
of	O
f43	B-code
.	I-code
2	I-code
.	O

cases	O
of	O
cerebral	B-phenotype
palsy	I-phenotype
were	O
identified	O
using	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
1281000119103	B-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
a	O
vertebral	B-phenotype
compression	I-phenotype
fracture	I-phenotype
indicated	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
s22	B-code
.	I-code
0	I-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
advanced	B-phenotype
gastric	I-phenotype
cancer	I-phenotype
from	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c16	B-code
.	I-code
9	I-code
.	O

the	O
tourette	B-phenotype
'	I-phenotype
s	I-phenotype
disorder	I-phenotype
cases	O
in	O
this	O
study	O
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f95	B-code
.	I-code
2	I-code
.	O

we	O
identified	O
patients	O
with	O
chronic	B-phenotype
pancreatitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k86	B-code
.	I-code
1	I-code
for	O
this	O
study	O
.	O

the	O
patient	O
'	O
s	O
symptoms	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
for	O
a	O
diagnosis	O
of	O
posttraumatic	B-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
ptsd	O
)	O
,	O
with	O
the	O
assigned	O
code	O
of	O
f43	B-code
.	I-code
10	I-code
.	O

we	O
included	O
patients	O
with	O
a	O
snomed	B-coding_system
ct	I-coding_system
code	O
of	O
45913009	B-code
for	O
stroke	B-phenotype
in	O
our	O
study	O
cohort	O
.	O

a	O
total	O
of	O
50	O
patients	O
with	O
osteosarcoma	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c41	B-code
.	O

the	O
patient	O
met	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
diagnostic	O
criteria	O
for	O
leukemia	B-phenotype
and	O
was	O
assigned	O
the	O
code	O
c91	B-code
-	I-code
c95	I-code
.	O

cases	O
of	O
peripheral	B-phenotype
neuropathy	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g62	B-code
in	O
this	O
study	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
bronchiectasis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j47	B-code
.	O

patients	O
with	O
a	O
history	O
of	O
cushing	B-phenotype
'	I-phenotype
s	I-phenotype
syndrome	I-phenotype
were	O
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e24	B-code
and	O
included	O
in	O
this	O
study	O
.	O

cases	O
of	O
achalasia	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k22	B-code
.	I-code
0	I-code
and	O
included	O
in	O
the	O
study	O
cohort	O
.	O
the	O
patient	O
was	O
diagnosed	O
with	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
based	O
on	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
and	O
managed	O
with	O
insulin	O
therapy	O
.	O

a	O
significant	O
proportion	O
of	O
children	O
were	O
found	O
to	O
have	O
attention	B-phenotype
deficit	I-phenotype
hyperactivity	I-phenotype
disorder	I-phenotype
(	I-phenotype
adhd	I-phenotype
)	I-phenotype
,	O
as	O
per	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
314	B-code
.	I-code
01	I-code
,	O
requiring	O
behavioral	O
and	O
pharmacological	O
interventions	O
.	O

the	O
study	O
population	O
included	O
individuals	O
with	O
a	O
clinical	O
diagnosis	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	I-phenotype
asd	I-phenotype
)	I-phenotype
as	O
per	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f84	B-code
.	I-code
0	I-code
and	O
f84	B-code
.	I-code
1	I-code
.	O

patients	O
presenting	O
with	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
were	O
classified	O
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
2	I-code
and	O
offered	O
antidepressant	O
medication	O
or	O
psychotherapy	O
.	O

the	O
prevalence	O
of	O
migraine	B-phenotype
in	O
the	O
sample	O
population	O
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g43	B-code
.	O

all	O
patients	O
diagnosed	O
with	O
bipolar	B-phenotype
disorder	I-phenotype
were	O
identified	O
based	O
on	O
relevant	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f31	B-code
.	I-code
0	I-code
to	O
f31	B-code
.	I-code
9	I-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	I-phenotype
ocd	I-phenotype
)	I-phenotype
as	O
per	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
3	I-code
.	O

patients	O
suffering	O
from	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
(	I-phenotype
gad	I-phenotype
)	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f41	B-code
.	I-code
1	I-code
.	O

the	O
clinical	O
trial	O
included	O
patients	O
with	O
breast	B-phenotype
cancer	I-phenotype
as	O
defined	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c50	B-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	I-phenotype
copd	I-phenotype
)	I-phenotype
were	O
included	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
.	O

individuals	O
with	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
and	O
were	O
prescribed	O
dopaminergic	O
medications	O
.	O

the	O
study	O
focused	O
on	O
individuals	O
diagnosed	O
with	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
.	O

a	O
subset	O
of	O
patients	O
with	O
schizophrenia	B-phenotype
was	O
included	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
295	B-code
and	O
were	O
treated	O
with	O
antipsychotic	O
medications	O
.	O

the	O
prevalence	O
of	O
asthma	B-phenotype
in	O
the	O
study	O
population	O
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
epilepsy	B-phenotype
were	O
identified	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
.	O

children	O
suffering	O
from	O
autistic	B-phenotype
disorder	I-phenotype
were	O
identified	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
code	O
299	B-code
.	I-code
00	I-code
.	O

the	O
study	O
included	O
patients	O
diagnosed	O
with	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	I-phenotype
ptsd	I-phenotype
)	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
309	B-code
.	I-code
81	I-code
.	O

the	O
clinical	O
trial	O
focused	O
on	O
patients	O
with	O
relapsing	B-phenotype
-	I-phenotype
remitting	I-phenotype
multiple	I-phenotype
sclerosis	I-phenotype
(	I-phenotype
rrms	I-phenotype
)	I-phenotype
,	O
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
.	O

the	O
study	O
assessed	O
individuals	O
diagnosed	O
with	O
rheumatoid	B-phenotype
arthritis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m05	B-code
.	O

the	O
prevalence	O
of	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	I-phenotype
sle	I-phenotype
)	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
.	O

the	O
research	O
included	O
patients	O
diagnosed	O
with	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	I-phenotype
ckd	I-phenotype
)	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n18	B-code
.	O

participants	O
with	O
cerebral	B-phenotype
palsy	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g80	B-code
.	O

the	O
study	O
focused	O
on	O
patients	O
diagnosed	O
with	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
.	O

individuals	O
suffering	O
from	O
ulcerative	B-phenotype
colitis	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
were	O
included	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	O

the	O
study	O
included	O
patients	O
suffering	O
from	O
hypertension	B-phenotype
,	O
as	O
per	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i10	B-code
.	O

the	O
prevalence	O
of	O
myocardial	B-phenotype
infarction	I-phenotype
(	I-phenotype
mi	I-phenotype
)	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i21	B-code
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
chronic	B-phenotype
liver	I-phenotype
disease	I-phenotype
were	O
identified	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k70	B-code
-	I-code
k77	I-code
.	O

the	O
research	O
included	O
individuals	O
diagnosed	O
with	O
peripheral	B-phenotype
arterial	I-phenotype
disease	I-phenotype
(	I-phenotype
pad	I-phenotype
)	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i73	B-code
.	I-code
9	I-code
.	O

the	O
study	O
investigated	O
patients	O
with	O
osteoarthritis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m15	B-code
.	O

the	O
prevalence	O
of	O
dysthymic	B-phenotype
disorder	I-phenotype
was	O
determined	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
f34	B-code
.	I-code
1	I-code
.	O

patients	O
with	O
psoriasis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
.	O

the	O
clinical	O
trial	O
included	O
participants	O
suffering	O
from	O
systemic	B-phenotype
sclerosis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m34	B-code
.	O

the	O
research	O
assessed	O
patients	O
with	O
cystic	B-phenotype
fibrosis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
.	O

the	O
prevalence	O
of	O
duchenne	B-phenotype
muscular	I-phenotype
dystrophy	I-phenotype
(	I-phenotype
dmd	I-phenotype
)	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g71	B-code
.	I-code
0	I-code
.	O

the	O
study	O
focused	O
on	O
patients	O
diagnosed	O
with	O
huntington	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g10	B-code
.	O

individuals	O
suffering	O
from	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	I-phenotype
als	I-phenotype
)	I-phenotype
were	O
included	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
2	I-code
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
tuberculosis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a15	B-code
.	O

the	O
study	O
assessed	O
patients	O
with	O
hepatitis	B-phenotype
c	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b18	B-code
.	I-code
2	I-code
.	O

the	O
prevalence	O
of	O
human	B-phenotype
immunodeficiency	I-phenotype
virus	I-phenotype
(	I-phenotype
hiv	I-phenotype
)	I-phenotype
infection	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b20	B-code
-	I-code
b24	I-code
.	O

the	O
clinical	O
trial	O
investigated	O
patients	O
diagnosed	O
with	O
ovarian	B-phenotype
cancer	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c56	B-code
.	O

patients	O
with	O
acute	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
(	I-phenotype
aml	I-phenotype
)	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c92	B-code
.	I-code
0	I-code
.	O

the	O
research	O
included	O
individuals	O
suffering	O
from	O
sickle	B-phenotype
cell	I-phenotype
anemia	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d57	B-code
.	I-code
0	I-code
.	O

the	O
study	O
focused	O
on	O
patients	O
with	O
hemophilia	B-phenotype
a	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d66	B-code
.	O

the	O
prevalence	O
of	O
down	B-phenotype
syndrome	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q90	B-code
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
cystic	B-phenotype
fibrosis	I-phenotype
were	O
included	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
.	O

the	O
study	O
assessed	O
individuals	O
with	O
turner	B-phenotype
syndrome	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q96	B-code
.	O

the	O
research	O
examined	O
patients	O
with	O
malaria	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b50	B-code
-	I-code
b54	I-code
.	O

patients	O
with	O
poliomyelitis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a80	B-code
.	O

the	O
study	O
included	O
individuals	O
diagnosed	O
with	O
lyme	B-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a69	B-code
.	I-code
2	I-code
.	O

the	O
prevalence	O
of	O
alopecia	B-phenotype
areata	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l63	B-code
.	O

the	O
clinical	O
trial	O
focused	O
on	O
patients	O
suffering	O
from	O
endometriosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
celiac	B-phenotype
disease	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k90	B-code
.	I-code
0	I-code
.	O

the	O
study	O
assessed	O
individuals	O
with	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
(	I-phenotype
ibs	I-phenotype
)	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
.	O

the	O
research	O
included	O
patients	O
diagnosed	O
with	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
(	I-phenotype
pcos	I-phenotype
)	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
.	O

the	O
prevalence	O
of	O
hyperthyroidism	B-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e05	B-code
.	O

patients	O
with	O
hypothyroidism	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e03	B-code
.	O

the	O
study	O
included	O
individuals	O
suffering	O
from	O
graves	B-phenotype
'	I-phenotype
disease	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e05	B-code
.	I-code
0	I-code
.	O

the	O
research	O
examined	O
patients	O
with	O
hyponatremia	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e87	B-code
.	I-code
1	I-code
.	O

the	O
prevalence	O
of	O
idiopathic	B-phenotype
thrombocytopenic	I-phenotype
purpura	I-phenotype
(	I-phenotype
itp	I-phenotype
)	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d69	B-code
.	I-code
3	I-code
.	O

the	O
clinical	O
trial	O
included	O
patients	O
diagnosed	O
with	O
hairy	B-phenotype
cell	I-phenotype
leukemia	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c91	B-code
.	I-code
4	I-code
.	O

patients	O
with	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
lymphoma	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c82	B-code
-	I-code
c86	I-code
.	O

the	O
study	O
assessed	O
individuals	O
suffering	O
from	O
creutzfeldt	B-phenotype
-	I-phenotype
jakob	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a81	B-code
.	I-code
0	I-code
.	O

the	O
research	O
included	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
prader	B-phenotype
-	I-phenotype
willi	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q87	B-code
.	I-code
1	I-code
.	O

the	O
prevalence	O
of	O
guillain	B-phenotype
-	I-phenotype
barre	I-phenotype
syndrome	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g61	B-code
.	I-code
0	I-code
.	O

the	O
study	O
focused	O
on	O
individuals	O
diagnosed	O
with	O
panic	B-phenotype
disorder	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f41	B-code
.	I-code
0	I-code
.	O

patients	O
suffering	O
from	O
bronchiectasis	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j47	B-code
.	O

the	O
clinical	O
trial	O
included	O
patients	O
with	O
interstitial	B-phenotype
lung	I-phenotype
disease	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	O

the	O
study	O
assessed	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
myasthenia	B-phenotype
gravis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g70	B-code
.	I-code
0	I-code
.	O

the	O
research	O
included	O
individuals	O
suffering	O
from	O
restless	B-phenotype
legs	I-phenotype
syndrome	I-phenotype
(	I-phenotype
rls	I-phenotype
)	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g25	B-code
.	I-code
81	I-code
.	O

the	O
prevalence	O
of	O
atopic	B-phenotype
dermatitis	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l20	B-code
.	O

the	O
study	O
investigated	O
patients	O
with	O
vitiligo	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l80	B-code
.	O

individuals	O
diagnosed	O
with	O
pemphigus	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l10	B-code
.	O

the	O
clinical	O
trial	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
touchycd	B-phenotype
in	I-phenotype
nervosa	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f50	B-code
.	I-code
0	I-code
.	O

the	O
study	O
assessed	O
individuals	O
suffering	O
from	O
bulimia	B-phenotype
nervosa	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f50	B-code
.	I-code
2	I-code
.	O

the	O
prevalence	O
of	O
variant	B-phenotype
creutzfeldt	I-phenotype
-	I-phenotype
jakob	I-phenotype
disease	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a81	B-code
.	I-code
1	I-code
.	O

the	O
research	O
included	O
patients	O
with	O
sleep	B-phenotype
apnea	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
3	I-code
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
excessive	B-phenotype
daytime	I-phenotype
sleepiness	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
2	I-code
.	O

the	O
study	O
focused	O
on	O
individuals	O
suffering	O
from	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
.	O

patients	O
diagnosed	O
with	O
dilated	B-phenotype
cardiomyopathy	I-phenotype
were	O
included	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i42	B-code
.	I-code
0	I-code
.	O

the	O
prevalence	O
of	O
atrial	B-phenotype
fibrillation	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i48	B-code
.	O

the	O
clinical	O
trial	O
investigated	O
patients	O
with	O
chronic	B-phenotype
fatigue	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g93	B-code
.	I-code
3	I-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
paranoid	B-phenotype
personality	I-phenotype
disorder	I-phenotype
were	O
identified	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
301	B-code
.	I-code
0	I-code
.	O

the	O
study	O
assessed	O
individuals	O
suffering	O
from	O
avoidant	B-phenotype
personality	I-phenotype
disorder	I-phenotype
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
301	B-code
.	I-code
82	I-code
.	O

the	O
research	O
included	O
patients	O
with	O
vascular	B-phenotype
dementia	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f01	B-code
.	O

the	O
prevalence	O
of	O
frontotemporal	B-phenotype
dementia	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g31	B-code
.	I-code
0	I-code
.	O

the	O
study	O
focused	O
on	O
patients	O
diagnosed	O
with	O
leukemia	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
codes	O
c91	B-code
-	I-code
c95	I-code
.	O

individuals	O
suffering	O
from	O
chronic	B-phenotype
lymphocytic	I-phenotype
leukemia	I-phenotype
(	I-phenotype
cll	I-phenotype
)	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c91	B-code
.	I-code
1	I-code
.	O

the	O
clinical	O
trial	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
hodgkin	B-phenotype
lymphoma	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c81	B-code
.	O

the	O
study	O
assessed	O
individuals	O
with	O
melanoma	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
c43	B-code
.	O

the	O
research	O
included	O
patients	O
suffering	O
from	O
non	B-phenotype
-	I-phenotype
alcoholic	I-phenotype
fatty	I-phenotype
liver	I-phenotype
disease	I-phenotype
(	I-phenotype
nafld	I-phenotype
)	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k76	B-code
.	I-code
0	I-code
.	O

the	O
prevalence	O
of	O
alcoholic	B-phenotype
liver	I-phenotype
disease	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k70	B-code
.	O

patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
pulmonary	B-phenotype
embolism	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i26	B-code
.	O

the	O
study	O
focused	O
on	O
individuals	O
diagnosed	O
with	O
deep	B-phenotype
vein	I-phenotype
thrombosis	I-phenotype
(	I-phenotype
dvt	I-phenotype
)	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i82	B-code
.	O

patients	O
with	O
peripheral	B-phenotype
neuropathy	I-phenotype
were	O
included	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g62	B-code
.	O

the	O
clinical	O
trial	O
investigated	O
patients	O
suffering	O
from	O
chronic	B-phenotype
pancreatitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k86	B-code
.	I-code
1	I-code
.	O

the	O
study	O
assessed	O
individuals	O
with	O
a	O
diagnosis	O
of	O
urticaria	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l50	B-code
.	O

the	O
research	O
included	O
patients	O
with	O
fulminant	B-phenotype
hepatic	I-phenotype
failure	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k72	B-code
.	I-code
0	I-code
.	O

the	O
prevalence	O
of	O
hyper	B-phenotype
-	I-phenotype
igd	I-phenotype
syndrome	I-phenotype
(	I-phenotype
hids	I-phenotype
)	I-phenotype
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d80	B-code
.	I-code
5	I-code
.	O

patients	O
suffering	O
from	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
(	I-phenotype
ipf	I-phenotype
)	I-phenotype
were	O
included	O
in	O
the	O
study	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	I-code
1	I-code
.	O
the	O
patient	O
presented	O
with	O
a	O
congenital	B-phenotype
heart	I-phenotype
defect	I-phenotype
classified	O
under	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q24	B-code
.	I-code
9	I-code
.	O

the	O
study	O
examined	O
the	O
prevalence	O
of	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
associated	O
with	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
44054006	B-code
in	O
the	O
adult	O
population	O
.	O

we	O
identified	O
a	O
significant	O
number	O
of	O
cases	O
with	O
asthma	B-phenotype
coded	O
as	O
j45	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
a	O
form	O
of	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
under	O
the	O
code	O
299	B-code
.	I-code
00	I-code
.	O

a	O
high	O
incidence	O
of	O
hypertension	B-phenotype
was	O
observed	O
in	O
patients	O
assigned	O
the	O
icpc	B-coding_system
-	I-coding_system
2	I-coding_system
code	O
k86	B-code
.	O

our	O
analysis	O
revealed	O
an	O
increased	O
risk	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
in	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
585	B-code
.	I-code
9	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
breast	B-phenotype
cancer	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
m	B-code
-	I-code
8500	I-code
/	I-code
3	I-code
histology	O
and	O
grading	O
.	O

multiple	O
cases	O
of	O
schizophrenia	B-phenotype
were	O
identified	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
-	I-coding_system
tr	I-coding_system
code	O
295	B-code
.	I-code
90	I-code
.	O

the	O
clinical	O
documentation	O
reported	O
a	O
diagnosis	O
of	O
bipolar	B-phenotype
disorder	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f31	B-code
.	O

participants	O
with	O
a	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
had	O
a	O
corresponding	O
snomed	B-coding_system
ct	I-coding_system
code	O
of	O
73211009	B-code
.	O

the	O
research	O
focused	O
on	O
the	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
diagnosis	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
as	O
the	O
primary	O
inclusion	O
criterion	O
.	O

the	O
patient	O
was	O
identified	O
with	O
hiv	B-phenotype
infection	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
042	B-code
.	O

during	O
our	O
study	O
,	O
we	O
encountered	O
several	O
cases	O
of	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
.	O

the	O
subjects	O
were	O
selected	O
based	O
on	O
their	O
multiple	B-phenotype
sclerosis	I-phenotype
diagnosis	O
,	O
assigned	O
the	O
icpc	B-coding_system
-	I-coding_system
2	I-coding_system
code	O
n86	B-code
.	O

we	O
examined	O
records	O
of	O
patients	O
diagnosed	O
with	O
cystic	B-phenotype
fibrosis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e84	B-code
.	O

the	O
analysis	O
included	O
patients	O
with	O
rheumatoid	B-phenotype
arthritis	I-phenotype
labelled	O
with	O
snomed	B-coding_system
ct	I-coding_system
code	O
69896004	B-code
.	O

we	O
found	O
a	O
correlation	O
between	O
inflammatory	B-phenotype
bowel	I-phenotype
disease	I-phenotype
diagnosis	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
555	B-code
.	I-code
9	I-code
and	O
increased	O
mortality	O
risk	O
.	O

physicians	O
reported	O
cases	O
of	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m32	B-code
,	O
indicating	O
a	O
potential	O
environmental	O
exposure	O
.	O

we	O
calculated	O
the	O
prevalence	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
720	B-code
.	I-code
0	I-code
in	O
our	O
cohort	O
study	O
.	O

the	O
patient	O
demographic	O
consisted	O
of	O
individuals	O
with	O
a	O
clinical	O
diagnosis	O
of	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
3	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
pancreatic	B-phenotype
cancer	I-phenotype
identified	O
through	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c25	B-code
.	O

we	O
observed	O
a	O
significant	O
number	O
of	O
charcot	B-phenotype
-	I-phenotype
marie	I-phenotype
-	I-phenotype
tooth	I-phenotype
disease	I-phenotype
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g60	B-code
.	I-code
0	I-code
in	O
our	O
data	O
.	O

the	O
patient	O
presented	O
symptoms	O
indicative	O
of	O
epilepsy	B-phenotype
with	O
a	O
corresponding	O
snomed	B-coding_system
ct	I-coding_system
code	O
of	O
84757009	B-code
.	O

cases	O
of	O
bowel	B-phenotype
obstruction	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k56	B-code
as	O
part	O
of	O
a	O
larger	O
epidemiological	O
study	O
.	O

we	O
found	O
an	O
association	O
between	O
osteoporosis	B-phenotype
and	O
patients	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m80	B-code
.	O

the	O
study	O
included	O
subjects	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
2	I-code
.	O

the	O
patient	O
displayed	O
clinical	O
symptoms	O
of	O
essential	B-phenotype
tremor	I-phenotype
and	O
was	O
assigned	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g25	B-code
.	I-code
0	I-code
.	O

the	O
genetic	O
analysis	O
focused	O
on	O
individuals	O
with	O
down	B-phenotype
syndrome	I-phenotype
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q90	B-code
.	O

the	O
study	O
investigated	O
the	O
role	O
of	O
environmental	O
factors	O
in	O
the	O
onset	O
of	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
.	O

we	O
identified	O
a	O
cluster	O
of	O
pneumonia	B-phenotype
cases	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j18	B-code
.	I-code
9	I-code
and	O
examined	O
the	O
impact	O
on	O
the	O
local	O
health	O
system	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
a	O
spinal	B-phenotype
cord	I-phenotype
injury	I-phenotype
and	O
given	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
s14	B-code
.	I-code
1	I-code
.	O

we	O
observed	O
a	O
significant	O
number	O
of	O
lung	B-phenotype
cancer	I-phenotype
cases	O
coded	O
as	O
c34	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
prevalence	O
of	O
fibromyalgia	B-phenotype
in	O
our	O
population	O
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
.	O

patients	O
were	O
eligible	O
for	O
the	O
trial	O
if	O
they	O
had	O
a	O
diagnosis	O
of	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
corresponding	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	I-code
1	I-code
.	O

the	O
study	O
included	O
patients	O
with	O
psoriasis	B-phenotype
who	O
were	O
assigned	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
.	O

the	O
primary	O
endpoint	O
was	O
the	O
incidence	O
of	O
cardiomyopathy	B-phenotype
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
425	B-code
.	I-code
4	I-code
among	O
the	O
treated	O
and	O
untreated	O
cohorts	O
.	O

the	O
research	O
focused	O
on	O
the	O
genetic	O
components	O
of	O
obesity	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e66	B-code
.	I-code
9	I-code
as	O
the	O
primary	O
inclusion	O
criterion	O
.	O

we	O
examined	O
the	O
mental	O
health	O
records	O
of	O
patients	O
diagnosed	O
with	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
309	B-code
.	I-code
81	I-code
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
with	O
aneurysm	B-phenotype
coded	O
as	O
i71	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

our	O
research	O
revealed	O
a	O
high	O
prevalence	O
of	O
cataract	B-phenotype
in	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
366	B-code
.	I-code
16	I-code
.	O

the	O
patients	O
included	O
in	O
this	O
study	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
glaucoma	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h40	B-code
.	O

the	O
children	O
with	O
a	O
neurodevelopmental	B-phenotype
disorder	I-phenotype
were	O
identified	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
315	B-code
.	I-code
9	I-code
.	O

the	O
patient	O
demographics	O
in	O
our	O
study	O
consisted	O
of	O
individuals	O
with	O
attention	B-phenotype
-	I-phenotype
deficit	I-phenotype
/	I-phenotype
hyperactivity	I-phenotype
disorder	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
314	B-code
.	I-code
01	I-code
.	O

we	O
found	O
an	O
association	O
between	O
osteosarcoma	B-phenotype
and	O
patients	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c41	B-code
.	O

the	O
data	O
observed	O
a	O
higher	O
incidence	O
of	O
lichen	B-phenotype
planus	I-phenotype
in	O
patients	O
assigned	O
with	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
67264004	B-code
.	O

the	O
prevalence	O
of	O
cysticercosis	B-phenotype
in	O
the	O
surveyed	O
population	O
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b69	B-code
.	O

a	O
significant	O
number	O
of	O
cases	O
with	O
anemia	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d64	B-code
.	I-code
9	I-code
in	O
our	O
retrospective	O
data	O
analysis	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
hepatitis	B-phenotype
b	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
b16	B-code
.	I-code
9	I-code
.	O

we	O
observed	O
an	O
increased	O
risk	O
of	O
endometriosis	B-phenotype
in	O
patients	O
with	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
.	O

the	O
medical	O
records	O
of	O
patients	O
with	O
glioblastoma	B-phenotype
were	O
evaluated	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c71	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
leukemia	B-phenotype
and	O
assigned	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
93143009	B-code
.	O

we	O
investigated	O
cases	O
of	O
peptic	B-phenotype
ulcer	I-phenotype
in	O
the	O
elderly	O
population	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k25	B-code
-	I-code
k28	I-code
.	O

the	O
study	O
found	O
an	O
association	O
between	O
ovarian	B-phenotype
cancer	I-phenotype
and	O
patients	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c56	B-code
.	O

the	O
cohort	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
hydrocephalus	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g91	B-code
.	O

cases	O
of	O
rosacea	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l71	B-code
as	O
part	O
of	O
a	O
community	O
health	O
survey	O
.	O

we	O
analyzed	O
the	O
medical	O
records	O
of	O
patients	O
diagnosed	O
with	O
tuberculosis	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a15	B-code
-	I-code
a19	I-code
.	O

the	O
study	O
'	O
s	O
primary	O
objective	O
was	O
to	O
determine	O
the	O
prevalence	O
of	O
muscular	B-phenotype
dystrophy	I-phenotype
associated	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g71	B-code
.	I-code
0	I-code
.	O

we	O
analyzed	O
the	O
genetic	O
components	O
of	O
hemophilia	B-phenotype
in	O
patients	O
diagnosed	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d66	B-code
-	I-code
d67	I-code
.	O

patients	O
with	O
graves	B-phenotype
'	I-phenotype
disease	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e05	B-code
.	I-code
0	I-code
.	O

our	O
study	O
included	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e28	B-code
.	I-code
2	I-code
.	O

we	O
assessed	O
the	O
prevalence	O
of	O
hip	B-phenotype
dysplasia	I-phenotype
in	O
newborns	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q65	B-code
.	O

the	O
patient	O
'	O
s	O
medical	O
records	O
indicated	O
a	O
previous	O
diagnosis	O
of	O
retinitis	B-phenotype
pigmentosa	I-phenotype
,	O
which	O
was	O
assigned	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h35	B-code
.	I-code
5	I-code
.	O

we	O
identified	O
an	O
increased	O
prevalence	O
of	O
sleep	B-phenotype
apnea	I-phenotype
in	O
the	O
study	O
population	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g47	B-code
.	I-code
30	I-code
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
ear	B-phenotype
infection	I-phenotype
otitis	I-phenotype
media	I-phenotype
and	O
given	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h66	B-code
.	I-code
9	I-code
.	O

the	O
clinical	O
data	O
reveal	O
a	O
high	O
prevalence	O
of	O
meningitis	B-phenotype
among	O
the	O
population	O
,	O
coded	O
as	O
g00	B-code
-	I-code
g03	I-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

a	O
retrospective	O
analysis	O
of	O
medical	O
records	O
showed	O
a	O
high	O
incidence	O
of	O
epidermolysis	B-phenotype
bullosa	I-phenotype
diagnosed	O
with	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q81	B-code
.	O

we	O
observed	O
a	O
significant	O
number	O
of	O
adult	O
patients	O
with	O
acne	B-phenotype
coded	O
as	O
l70	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
hospital	O
reported	O
an	O
increase	O
in	O
pediatric	B-phenotype
pneumonia	I-phenotype
cases	O
diagnosed	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j18	B-code
.	O

the	O
patient	O
presented	O
with	O
a	O
urinary	B-phenotype
tract	I-phenotype
infection	I-phenotype
and	O
was	O
given	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n39	B-code
.	I-code
0	I-code
.	O

the	O
clinical	O
data	O
reveal	O
a	O
high	O
prevalence	O
of	O
sepsis	B-phenotype
among	O
the	O
population	O
,	O
coded	O
as	O
a40	B-code
-	I-code
a41	I-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
peripheral	B-phenotype
neuropathy	I-phenotype
and	O
assigned	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g62	B-code
.	I-code
9	I-code
.	O

we	O
identified	O
a	O
cluster	O
of	O
diphtheria	B-phenotype
cases	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a36	B-code
in	O
our	O
outbreak	O
investigation	O
.	O

the	O
patients	O
in	O
our	O
study	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
gout	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m10	B-code
.	O

we	O
estimated	O
the	O
incidence	O
of	O
hantavirus	B-phenotype
infections	I-phenotype
in	O
the	O
study	O
area	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a98	B-code
.	I-code
5	I-code
.	O

the	O
clinical	O
data	O
reveal	O
a	O
high	O
prevalence	O
of	O
bronchiectasis	B-phenotype
among	O
the	O
population	O
,	O
coded	O
as	O
j47	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
patient	O
demographics	O
in	O
our	O
study	O
consisted	O
of	O
individuals	O
with	O
a	O
diagnosis	O
of	O
diverticulitis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k57	B-code
.	O

we	O
identified	O
an	O
increase	O
in	O
brucellosis	B-phenotype
cases	O
in	O
the	O
study	O
area	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a23	B-code
.	O

the	O
patients	O
included	O
in	O
our	O
study	O
had	O
a	O
diagnosis	O
of	O
hemochromatosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e83	B-code
.	I-code
11	I-code
.	O

the	O
primary	O
endpoint	O
of	O
our	O
research	O
was	O
the	O
prevalence	O
of	O
lymphedema	B-phenotype
in	O
the	O
study	O
population	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i89	B-code
.	I-code
0	I-code
.	O

we	O
observed	O
an	O
increased	O
risk	O
of	O
listeriosis	B-phenotype
in	O
the	O
study	O
area	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a32	B-code
.	O

the	O
study	O
focused	O
on	O
the	O
diagnosis	O
of	O
tetanus	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a33	B-code
-	I-code
a35	I-code
in	O
patients	O
from	O
resource	O
-	O
limited	O
settings	O
.	O

the	O
patient	O
was	O
diagnosed	O
with	O
spina	B-phenotype
bifida	I-phenotype
and	O
given	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q05	B-code
.	O

our	O
data	O
revealed	O
a	O
significant	O
number	O
of	O
older	O
individuals	O
diagnosed	O
with	O
vitiligo	B-phenotype
and	O
coded	O
with	O
l80	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

we	O
observed	O
an	O
increased	O
prevalence	O
of	O
pertussis	B-phenotype
in	O
the	O
study	O
area	O
corresponding	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a37	B-code
.	O

a	O
genetic	O
study	O
of	O
patients	O
diagnosed	O
with	O
fibrodysplasia	B-phenotype
ossificans	I-phenotype
progressiva	I-phenotype
was	O
conducted	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m61	B-code
.	I-code
1	I-code
.	O

our	O
study	O
focused	O
on	O
the	O
diagnosis	O
and	O
risk	O
factors	O
of	O
oral	B-phenotype
cancer	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c00	B-code
-	I-code
c06	I-code
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
ankyloglossia	B-phenotype
,	O
also	O
known	O
as	O
tongue	O
-	O
tie	O
,	O
in	O
newborns	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q38	B-code
.	I-code
1	I-code
.	O

patients	O
were	O
included	O
in	O
the	O
study	O
if	O
they	O
had	O
a	O
recent	O
diagnosis	O
of	O
paroxysmal	B-phenotype
nocturnal	I-phenotype
hemoglobinuria	I-phenotype
,	O
as	O
indicated	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d59	B-code
.	I-code
5	I-code
.	O

the	O
prevalence	O
of	O
colorectal	B-phenotype
cancer	I-phenotype
in	O
the	O
examined	O
population	O
was	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c18	B-code
-	I-code
c20	I-code
.	O

we	O
assessed	O
the	O
impact	O
of	O
early	O
intervention	O
on	O
eating	B-phenotype
disorders	I-phenotype
,	O
coded	O
as	O
f50	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
patient	O
presented	O
with	O
erythromelalgia	B-phenotype
and	O
was	O
given	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i73	B-code
.	I-code
81	I-code
.	O

we	O
analyzed	O
the	O
incidence	O
of	O
leprosy	B-phenotype
in	O
the	O
study	O
area	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a30	B-code
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
with	O
a	O
diagnosis	O
of	O
prostatitis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n41	B-code
.	O

our	O
study	O
included	O
patients	O
diagnosed	O
with	O
whipple	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k90	B-code
.	I-code
8	I-code
.	O

we	O
investigated	O
the	O
prevalence	O
of	O
acute	B-phenotype
otitis	I-phenotype
media	I-phenotype
among	O
children	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h65	B-code
.	O

our	O
data	O
revealed	O
a	O
high	O
prevalence	O
of	O
psoriatic	B-phenotype
arthritis	I-phenotype
in	O
patients	O
coded	O
with	O
m07	B-code
in	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
system	O
.	O

the	O
study	O
monitored	O
the	O
disease	O
activity	O
of	O
multiple	B-phenotype
myeloma	I-phenotype
patients	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c90	B-code
.	O

we	O
assessed	O
the	O
risk	O
of	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
exacerbations	O
in	O
the	O
study	O
population	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j44	B-code
.	O

the	O
prevalence	O
of	O
thrombotic	B-phenotype
thrombocytopenic	I-phenotype
purpura	I-phenotype
in	O
the	O
surveyed	O
population	O
was	O
determined	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m31	B-code
.	I-code
1	I-code
.	O

we	O
observed	O
an	O
increased	O
risk	O
of	O
trigeminal	B-phenotype
neuralgia	I-phenotype
in	O
the	O
study	O
population	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g50	B-code
.	I-code
0	I-code
.	O
the	O
patient	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
diabetes	B-phenotype
mellitus	I-phenotype
type	I-phenotype
2	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e11	B-code
)	O
and	O
was	O
being	O
treated	O
with	O
oral	O
hypoglycemic	O
agents	O
.	O

the	O
study	O
focused	O
on	O
individuals	O
diagnosed	O
with	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
codes	O
299	B-code
.	I-code
00	I-code
and	O
299	B-code
.	I-code
10	I-code
)	O
and	O
assessed	O
their	O
cognitive	O
abilities	O
.	O

patients	O
with	O
a	O
history	O
of	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f32	B-code
or	O
f33	B-code
)	O
were	O
excluded	O
from	O
the	O
study	O
.	O

the	O
prevalence	O
of	O
hypertension	B-phenotype
(	O
defined	O
as	O
a	O
systolic	O
blood	O
pressure	O
of	O
140	O
mm	O
hg	O
or	O
higher	O
,	O
a	O
diastolic	O
blood	O
pressure	O
of	O
90	O
mm	O
hg	O
or	O
higher	O
,	O
or	O
use	O
of	O
antihypertensive	O
medication	O
)	O
was	O
compared	O
between	O
patients	O
with	O
different	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
for	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
(	O
585	B-code
.	I-code
1	I-code
-	I-code
585	I-code
.	I-code
5	I-code
)	O
.	O

the	O
patient	O
'	O
s	O
symptoms	O
were	O
consistent	O
with	O
a	O
diagnosis	O
of	O
asthma	B-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j45	B-code
)	O
,	O
and	O
the	O
severity	O
was	O
classified	O
as	O
mild	O
.	O

the	O
sample	O
included	O
patients	O
with	O
a	O
primary	O
diagnosis	O
of	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
02	I-code
)	O
who	O
had	O
not	O
previously	O
received	O
treatment	O
for	O
their	O
condition	O
.	O

all	O
the	O
participants	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
3	I-code
.	O

patients	O
with	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g30	B-code
)	O
were	O
followed	O
up	O
for	O
10	O
years	O
to	O
assess	O
the	O
progression	O
of	O
their	O
cognitive	O
decline	O
.	O

the	O
study	O
evaluated	O
the	O
risk	O
factors	O
for	O
ischemic	B-phenotype
stroke	I-phenotype
(	O
classified	O
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i63	B-code
)	O
among	O
patients	O
with	O
atrial	O
fibrillation	O
.	O

the	O
patient	O
met	O
the	O
diagnostic	O
criteria	O
for	O
schizophrenia	B-phenotype
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
295	B-code
.	I-code
90	I-code
.	O

the	O
primary	O
outcome	O
measure	O
was	O
the	O
incidence	O
of	O
drug	B-phenotype
-	I-phenotype
induced	I-phenotype
liver	I-phenotype
injury	I-phenotype
(	O
defined	O
by	O
the	O
meddra	B-coding_system
coding	O
system	O
as	O
10013791	B-code
)	O
.	O

the	O
incidence	O
of	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
(	O
defined	O
by	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
i21	B-code
)	O
was	O
higher	O
among	O
patients	O
with	O
a	O
diagnosis	O
of	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
.	O

the	O
cohort	O
study	O
included	O
patients	O
diagnosed	O
with	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
(	O
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
)	O
between	O
2000	O
and	O
2010	O
.	O

the	O
prevalence	O
of	O
rheumatoid	B-phenotype
arthritis	I-phenotype
(	O
identified	O
using	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
714	B-code
.	I-code
0	I-code
)	O
was	O
assessed	O
in	O
a	O
nationally	O
representative	O
sample	O
of	O
adults	O
.	O

the	O
patient	O
'	O
s	O
symptoms	O
met	O
the	O
criteria	O
for	O
pulmonary	B-phenotype
embolism	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i26	B-code
)	O
and	O
she	O
was	O
swiftly	O
administered	O
anticoagulants	O
.	O

the	O
efficacy	O
of	O
cognitive	O
-	O
behavioral	O
therapy	O
was	O
assessed	O
in	O
patients	O
with	O
a	O
diagnosis	O
of	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
309	B-code
.	I-code
81	I-code
)	O
.	O

a	O
high	O
prevalence	O
of	O
"	B-phenotype
low	I-phenotype
back	I-phenotype
pain	I-phenotype
"	I-phenotype
in	I-phenotype
was	I-phenotype
found	I-phenotype
in	I-phenotype
the	I-phenotype
coding	I-phenotype
system	I-phenotype
national	I-phenotype
interview	I-phenotype
survey	I-phenotype
(	I-phenotype
m54	I-phenotype
.	I-phenotype
5	I-phenotype
)	I-phenotype
.	I-phenotype

the	O
patient	O
had	O
a	O
history	O
of	O
that	O
had	O
long	O
been	O
confirmed	O
a	O
"	O
g35	O
"	O
diagnosis	O
in	O
the	O
<	O
?	O
icd	O
_	O
system	O
.	O

patients	O
with	O
"	B-phenotype
warfarin	I-phenotype
-	I-phenotype
associated	I-phenotype
had	I-phenotype
higher	I-phenotype
inr	I-phenotype
values	I-phenotype
and	I-phenotype
heard	I-phenotype
coding	I-phenotype
system	I-phenotype
icd	I-phenotype
-	I-phenotype
(	I-phenotype
286	I-phenotype
.	I-phenotype
4	I-phenotype
)	I-phenotype
has	I-phenotype
consequences	I-phenotype
in	I-phenotype
the	I-phenotype
brain	I-phenotype
frequently	I-phenotype
.	I-phenotype

our	O
study	O
sample	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
using	O
a	O
classification	O
system	O
code	O
(	O
078	O
.	O
49	O
)	O
congestive	O
heart	O
failure	O
,	O
not	O
otherwise	O
specified	O
;	O
right	O
failure	O
secondary	O
to	O
left	O
heart	O
failure	O
.	O

our	O
research	O
objective	O
was	O
to	O
examine	O
prevalence	O
and	O
clinical	O
of	O
"	B-phenotype
bipolar	I-phenotype
disorder	I-phenotype
"	I-phenotype
(	O
class	O
=	O
'	O
coding	O
_	O
system	O
'	O
>	O
"	O
dsm	O
-	O
5	O
"	O
code	O
"	B-code
296	I-code
.	I-code
65	I-code
"	I-code
)	O
outpatients	O
attending	O
a	O
local	O
psychiatric	O
clinic	O
in	O
tokyo	O
,	O
japan	O
.	O

we	O
have	O
investigated	O
the	O
prevalence	O
of	O
(	O
class	O
=	O
'	O
coding	O
_	O
system	O
'	O
>	O
"	O
snomed	O
ct	O
"	O
)	O
in	O
the	O
emergency	O
department	O
a	O
brazilian	O
hospital	O
using	O
the	O
430831004	B-code
code	O
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
(	O
class	O
=	O
'	O
coding	O
_	O
system	O
'	O
>	O
icd	O
-	O
10	O
)	O
codes	O
k21	B-code
and	I-code
in	I-code
an	I-code
effort	I-code
to	I-code
identify	I-code
risk	I-code
factors	I-code
for	I-code
the	I-code
of	I-code
barrett	I-code
'	I-code
s	I-code
esophagus	I-code
and	I-code
adenocarcinoma	I-code
.	I-code
in	I-code
this	I-code
study	I-code
,	I-code
the	I-code
autism	I-code
spectrum	I-code
disorder	I-code
was	I-code
diagnosed	I-code
using	I-code
the	I-code
icd	I-code
-	I-code
10	I-code
criteria	I-code
with	I-code
the	I-code
codes	I-code
f84	I-code
.	I-code
0	I-code
-	I-code
f84	I-code
.	I-code
9	I-code
.	I-code

the	O
patients	O
were	O
diagnosed	O
with	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
criteria	O
,	O
code	O
296	B-code
.	I-code
2	I-code
and	O
296	B-code
.	I-code
3	I-code
.	O

participants	O
in	O
this	O
trial	O
had	O
a	O
diagnosis	O
of	O
hypertension	B-phenotype
according	O
to	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
i10	B-code
-	I-code
i15	I-code
.	O

in	O
this	O
cohort	O
,	O
individuals	O
with	O
a	O
history	O
of	O
schizophrenia	B-phenotype
spectrum	O
disorders	O
were	O
identified	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
-	I-coding_system
tr	I-coding_system
code	O
295	B-code
.	O

all	O
subjects	O
included	O
in	O
this	O
study	O
had	O
a	O
primary	O
diagnosis	O
of	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
300	B-code
.	I-code
02	I-code
.	O

the	O
patients	O
in	O
this	O
sample	O
were	O
diagnosed	O
with	O
type	B-phenotype
2	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
e11	B-code
.	O

in	O
this	O
analysis	O
,	O
we	O
included	O
patients	O
with	O
documented	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
(	O
copd	O
)	O
,	O
based	O
on	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
490	B-code
-	I-code
492	I-code
,	I-code
494	I-code
,	I-code
and	I-code
496	I-code
.	O

the	O
breast	B-phenotype
cancer	I-phenotype
patients	O
included	O
in	O
this	O
study	O
were	O
identified	O
using	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
372746007	B-code
.	O

we	O
studied	O
a	O
cohort	O
of	O
patients	O
diagnosed	O
with	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g20	B-code
.	O

in	O
this	O
research	O
,	O
the	O
subjects	O
had	O
a	O
diagnosis	O
of	O
bipolar	B-phenotype
disorder	I-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
codes	O
296	B-code
.	I-code
0	I-code
,	I-code
296	I-code
.	I-code
1	I-code
,	I-code
296	I-code
.	I-code
4	I-code
–	I-code
296	I-code
.	I-code
89	I-code
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
331	B-code
.	I-code
0	I-code
.	O

we	O
analyzed	O
data	O
from	O
participants	O
diagnosed	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
,	O
as	O
defined	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	O

all	O
patients	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
rheumatoid	B-phenotype
arthritis	I-phenotype
based	O
on	O
the	O
ccs	B-coding_system
code	O
202	B-code
for	O
rheumatic	O
diseases	O
.	O

participants	O
were	O
included	O
if	O
they	O
had	O
a	O
history	O
of	O
multiple	B-phenotype
sclerosis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
340	B-code
.	O

in	O
this	O
clinical	O
trial	O
,	O
subjects	O
with	O
cystic	B-phenotype
fibrosis	I-phenotype
were	O
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
e84	B-code
.	O

the	O
sample	O
population	O
consisted	O
of	O
patients	O
with	O
a	O
diagnosis	O
of	O
epilepsy	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
g40	B-code
-	I-code
g41	I-code
.	O

in	O
this	O
study	O
,	O
patients	O
had	O
a	O
diagnosis	O
of	O
dementia	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
codes	O
f00	B-code
-	I-code
f03	I-code
and	O
g30	B-code
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
glomerulonephritis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
580	B-code
-	I-code
581	I-code
.	O

the	O
subjects	O
in	O
this	O
study	O
were	O
diagnosed	O
with	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k50	B-code
.	O

in	O
this	O
research	O
,	O
children	O
with	O
a	O
diagnosis	O
of	O
attention	B-phenotype
-	I-phenotype
deficit	I-phenotype
/	I-phenotype
hyperactivity	I-phenotype
disorder	I-phenotype
(	O
adhd	O
)	O
were	O
identified	O
using	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
314	B-code
.	O

the	O
patients	O
in	O
our	O
study	O
were	O
diagnosed	O
with	O
obsessive	B-phenotype
-	I-phenotype
compulsive	I-phenotype
disorder	I-phenotype
(	O
ocd	O
)	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
-	I-coding_system
tr	I-coding_system
code	O
300	B-code
.	I-code
3	I-code
.	O

in	O
the	O
present	O
study	O
,	O
we	O
examined	O
individuals	O
with	O
a	O
diagnosis	O
of	O
endometriosis	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
n80	B-code
.	O

participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
diabetic	B-phenotype
retinopathy	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
362	B-code
.	I-code
0	I-code
.	O

in	O
this	O
analysis	O
,	O
children	O
had	O
a	O
diagnosis	O
of	O
developmental	B-phenotype
dysplasia	I-phenotype
of	I-phenotype
the	I-phenotype
hip	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q65	B-code
.	O

in	O
the	O
cohort	O
,	O
individuals	O
had	O
a	O
diagnosis	O
of	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
j84	B-code
.	I-code
1	I-code
.	O

the	O
patients	O
included	O
in	O
this	O
trial	O
had	O
a	O
diagnosis	O
of	O
cerebral	B-phenotype
palsy	I-phenotype
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
278040009	B-code
.	O

in	O
this	O
study	O
,	O
the	O
subjects	O
had	O
a	O
diagnosis	O
of	O
acute	B-phenotype
lymphoblastic	I-phenotype
leukemia	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
c91	B-code
.	I-code
0	I-code
.	O

participants	O
were	O
diagnosed	O
with	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
sle	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
710	B-code
.	I-code
0	I-code
.	O

the	O
sample	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
psoriasis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
.	O

patients	O
included	O
in	O
this	O
study	O
had	O
a	O
history	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
n18	B-code
-	I-code
n19	I-code
.	O

we	O
identified	O
participants	O
with	O
primary	B-phenotype
biliary	I-phenotype
cholangitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k74	B-code
.	I-code
3	I-code
.	O

in	O
this	O
cohort	O
,	O
patients	O
had	O
a	O
clinical	O
diagnosis	O
of	O
osteoporosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
733	B-code
.	I-code
0	I-code
.	O

the	O
subjects	O
included	O
in	O
this	O
trial	O
had	O
a	O
diagnosis	O
of	O
cervical	B-phenotype
cancer	I-phenotype
based	O
on	O
the	O
snomed	B-coding_system
ct	I-coding_system
code	O
363354004	B-code
.	O

in	O
the	O
sample	O
population	O
,	O
patients	O
had	O
a	O
diagnosis	O
of	O
sickle	B-phenotype
cell	I-phenotype
anemia	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d57	B-code
.	I-code
0	I-code
.	O

participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
spinal	B-phenotype
muscular	I-phenotype
atrophy	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
335	B-code
.	I-code
0	I-code
.	O

all	O
patients	O
included	O
in	O
the	O
analysis	O
had	O
a	O
diagnosis	O
of	O
thalassemia	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
d56	B-code
.	O

in	O
this	O
study	O
,	O
subjects	O
were	O
diagnosed	O
with	O
idiopathic	B-phenotype
thrombocytopenic	I-phenotype
purpura	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d69	B-code
.	I-code
3	I-code
.	O

we	O
examined	O
patients	O
with	O
a	O
history	O
of	O
primary	B-phenotype
sclerosing	I-phenotype
cholangitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
576	B-code
.	I-code
1	I-code
.	O

in	O
this	O
study	O
,	O
patients	O
were	O
diagnosed	O
with	O
neurofibromatosis	B-phenotype
type	I-phenotype
1	I-phenotype
(	O
nf1	O
)	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q85	B-code
.	I-code
0	I-code
.	O

the	O
cohort	O
included	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
tuberculosis	B-phenotype
identified	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
a15	B-code
-	I-code
a19	I-code
.	O

the	O
participants	O
in	O
this	O
study	O
were	O
diagnosed	O
with	O
polycystic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
753	B-code
.	I-code
1	I-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
hepatitis	I-phenotype
b	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
b18	B-code
.	I-code
1	I-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
subjects	O
with	O
a	O
diagnosis	O
of	O
eosinophilic	B-phenotype
esophagitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k20	B-code
.	I-code
0	I-code
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
ulcerative	B-phenotype
colitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
k51	B-code
.	O

in	O
this	O
trial	O
,	O
participants	O
were	O
diagnosed	O
with	O
multiple	B-phenotype
myeloma	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c90	B-code
.	I-code
0	I-code
.	O

patients	O
with	O
selective	B-phenotype
immunoglobulin	I-phenotype
a	I-phenotype
deficiency	I-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
279	B-code
.	I-code
01	I-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
participants	O
with	O
a	O
history	O
of	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	O
als	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
335	B-code
.	I-code
2	I-code
.	O

patients	O
in	O
our	O
study	O
were	O
diagnosed	O
with	O
acute	B-phenotype
myeloid	I-phenotype
leukemia	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
c92	B-code
.	I-code
0	I-code
.	O

this	O
research	O
included	O
participants	O
with	O
a	O
diagnosis	O
of	O
pheochromocytoma	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d35	B-code
.	I-code
0	I-code
.	O

in	O
the	O
study	O
,	O
we	O
analyzed	O
data	O
from	O
patients	O
diagnosed	O
with	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
'	I-phenotype
s	I-phenotype
lymphoma	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
200	B-code
-	I-code
202	I-code
.	O

participants	O
with	O
a	O
diagnosis	O
of	O
prediabetes	B-phenotype
were	O
identified	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
r73	B-code
.	I-code
03	I-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
history	O
of	O
osteogenesis	B-phenotype
imperfecta	I-phenotype
diagnosed	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q78	B-code
.	I-code
0	I-code
.	O

in	O
this	O
research	O
,	O
we	O
included	O
subjects	O
diagnosed	O
with	O
primary	B-phenotype
immunodeficiency	I-phenotype
disorders	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
279	B-code
.	O

patients	O
in	O
our	O
study	O
were	O
diagnosed	O
with	O
gestational	B-phenotype
diabetes	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
o24	B-code
.	I-code
4	I-code
.	O

this	O
study	O
included	O
individuals	O
with	O
a	O
diagnosis	O
of	O
essential	B-phenotype
tremor	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g25	B-code
.	I-code
0	I-code
.	O

we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
dystonia	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
333	B-code
.	I-code
6	I-code
.	O

the	O
study	O
participants	O
were	O
diagnosed	O
with	O
hemophilia	B-phenotype
a	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
d66	B-code
.	O

in	O
this	O
research	O
,	O
we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
osteoarthritis	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
m15	B-code
-	I-code
m19	I-code
.	O

the	O
participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
turner	B-phenotype
syndrome	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q96	B-code
.	O

patients	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
fibromyalgia	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
729	B-code
.	I-code
1	I-code
.	O

we	O
analyzed	O
data	O
from	O
individuals	O
with	O
a	O
history	O
of	O
myasthenia	B-phenotype
gravis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
g70	B-code
.	I-code
0	I-code
.	O

in	O
this	O
study	O
,	O
participants	O
were	O
diagnosed	O
with	O
lyme	B-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
a69	B-code
.	I-code
20	I-code
.	O

the	O
study	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
atrial	B-phenotype
fibrillation	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
427	B-code
.	I-code
31	I-code
.	O

patients	O
included	O
in	O
this	O
research	O
had	O
a	O
history	O
of	O
tourette	B-phenotype
syndrome	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
f95	B-code
.	I-code
2	I-code
.	O

in	O
this	O
cohort	O
,	O
we	O
included	O
individuals	O
with	O
a	O
diagnosis	O
of	O
peripheral	B-phenotype
artery	I-phenotype
disease	I-phenotype
(	O
pad	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i73	B-code
.	I-code
9	I-code
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
coeliac	B-phenotype
disease	I-phenotype
diagnosed	O
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
k90	B-code
.	I-code
0	I-code
.	O

we	O
included	O
subjects	O
with	O
a	O
diagnosis	O
of	O
optic	B-phenotype
neuritis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
377	B-code
.	I-code
3	I-code
.	O

in	O
the	O
study	O
,	O
patients	O
were	O
diagnosed	O
with	O
pancreatitis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
k85	B-code
and	I-code
k86	I-code
.	O

we	O
included	O
children	O
with	O
a	O
history	O
of	O
congenital	B-phenotype
hypothyroidism	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e03	B-code
.	I-code
0	I-code
.	O

participants	O
in	O
this	O
clinical	O
trial	O
had	O
a	O
diagnosis	O
of	O
nephrotic	B-phenotype
syndrome	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
581	B-code
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
history	O
of	O
retinitis	B-phenotype
pigmentosa	I-phenotype
(	O
rp	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
h35	B-code
.	I-code
5	I-code
.	O

in	O
this	O
research	O
,	O
subjects	O
were	O
diagnosed	O
with	O
hereditary	B-phenotype
angioedema	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d84	B-code
.	I-code
1	I-code
.	O

patients	O
included	O
in	O
this	O
study	O
had	O
a	O
diagnosis	O
of	O
cysticercosis	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
123	B-code
.	I-code
1	I-code
.	O

we	O
studied	O
a	O
cohort	O
of	O
patients	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
m45	B-code
.	I-code
9	I-code
.	O

the	O
patients	O
enrolled	O
in	O
the	O
study	O
met	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
diagnostic	O
criteria	O
for	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
ptsd	O
)	O
with	O
the	O
code	O
309	B-code
.	I-code
81	I-code
.	O

participants	O
included	O
in	O
the	O
research	O
had	O
a	O
diagnosis	O
of	O
graves	B-phenotype
'	I-phenotype
disease	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e05	B-code
.	I-code
0	I-code
.	O

in	O
this	O
study	O
,	O
patients	O
were	O
diagnosed	O
with	O
marfan	B-phenotype
syndrome	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
q87	B-code
.	I-code
4	I-code
.	O

the	O
subjects	O
enrolled	O
in	O
this	O
trial	O
had	O
a	O
diagnosis	O
of	O
narcolepsy	B-phenotype
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
-	I-coding_system
tr	I-coding_system
code	O
347	B-code
.	O

the	O
study	O
included	O
patients	O
who	O
had	O
a	O
diagnosis	O
of	O
acromegaly	B-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e22	B-code
.	I-code
0	I-code
.	O

participants	O
in	O
the	O
study	O
were	O
diagnosed	O
with	O
polymyalgia	B-phenotype
rheumatica	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
725	B-code
.	O

we	O
analyzed	O
data	O
from	O
individuals	O
with	O
a	O
history	O
of	O
scleroderma	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m34	B-code
.	O

patients	O
in	O
this	O
study	O
were	O
diagnosed	O
with	O
systemic	B-phenotype
sclerosis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
710	B-code
.	I-code
1	I-code
.	O

in	O
this	O
research	O
,	O
the	O
subjects	O
had	O
a	O
diagnosis	O
of	O
wilson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e83	B-code
.	I-code
0	I-code
.	O

we	O
included	O
patients	O
with	O
a	O
history	O
of	O
lupus	B-phenotype
nephritis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
583	B-code
.	I-code
81	I-code
.	O

the	O
study	O
population	O
consisted	O
of	O
patients	O
diagnosed	O
with	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
(	O
ibs	O
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
k58	B-code
.	O

participants	O
in	O
this	O
clinical	O
trial	O
had	O
a	O
diagnosis	O
of	O
prader	B-phenotype
-	I-phenotype
willi	I-phenotype
syndrome	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
q87	B-code
.	I-code
1	I-code
.	O

in	O
this	O
research	O
,	O
we	O
included	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
frontotemporal	B-phenotype
dementia	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
g31	B-code
.	I-code
0	I-code
.	O

the	O
subjects	O
in	O
this	O
study	O
were	O
diagnosed	O
with	O
gilbert	B-phenotype
'	I-phenotype
s	I-phenotype
syndrome	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e80	B-code
.	I-code
4	I-code
.	O

we	O
included	O
patients	O
with	O
a	O
history	O
of	O
brugada	B-phenotype
syndrome	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
i49	B-code
.	I-code
8	I-code
.	O

in	O
this	O
study	O
,	O
participants	O
were	O
diagnosed	O
with	O
acute	B-phenotype
coronary	I-phenotype
syndrome	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
codes	O
i20	B-code
.	I-code
0	I-code
,	I-code
i24	I-code
.	I-code
8	I-code
,	I-code
and	I-code
i24	I-code
.	I-code
9	I-code
.	O

the	O
patients	O
enrolled	O
in	O
the	O
study	O
had	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
fatigue	I-phenotype
syndrome	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g93	B-code
.	I-code
3	I-code
.	O

we	O
examined	O
subjects	O
with	O
a	O
history	O
of	O
ehlers	B-phenotype
-	I-phenotype
danlos	I-phenotype
syndrome	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
756	B-code
.	I-code
83	I-code
.	O

in	O
this	O
research	O
,	O
the	O
participants	O
had	O
a	O
diagnosis	O
of	O
idiopathic	B-phenotype
intracranial	I-phenotype
hypertension	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g93	B-code
.	I-code
2	I-code
.	O

the	O
study	O
population	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
barrett	B-phenotype
'	I-phenotype
s	I-phenotype
esophagus	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
530	B-code
.	I-code
85	I-code
.	O

participants	O
in	O
this	O
trial	O
had	O
a	O
diagnosis	O
of	O
dermatomyositis	B-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
m33	B-code
.	I-code
0	I-code
.	O

we	O
studied	O
a	O
cohort	O
of	O
patients	O
with	O
a	O
history	O
of	O
aphasia	B-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
784	B-code
.	I-code
3	I-code
.	O

in	O
the	O
cohort	O
,	O
patients	O
had	O
a	O
diagnosis	O
of	O
langerhans	B-phenotype
cell	I-phenotype
histiocytosis	I-phenotype
(	O
lch	O
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
d76	B-code
.	I-code
3	I-code
.	O

the	O
subjects	O
included	O
in	O
this	O
study	O
were	O
diagnosed	O
with	O
uremic	B-phenotype
neuropathy	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
355	B-code
.	I-code
9	I-code
.	O

patients	O
in	O
our	O
research	O
were	O
diagnosed	O
with	O
restless	B-phenotype
legs	I-phenotype
syndrome	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g25	B-code
.	I-code
81	I-code
.	O

in	O
this	O
study	O
,	O
we	O
included	O
patients	O
with	O
a	O
diagnosis	O
of	O
polycythemia	B-phenotype
vera	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
-	I-coding_system
cm	I-coding_system
code	O
d45	B-code
.	O
in	O
this	O
study	O
,	O
all	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
type	B-phenotype
1	I-phenotype
diabetes	I-phenotype
mellitus	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e10	B-code
)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
presenting	O
with	O
major	B-phenotype
depressive	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
code	O
296	B-code
.	I-code
2x	I-code
)	O
and	O
generalized	B-phenotype
anxiety	I-phenotype
disorder	I-phenotype
(	O
300	B-code
.	I-code
02	I-code
)	O
.	O

all	O
patients	O
were	O
diagnosed	O
with	O
congenital	B-phenotype
heart	I-phenotype
disease	I-phenotype
using	O
the	O
international	B-coding_system
paediatric	I-coding_system
and	I-coding_system
congenital	I-coding_system
cardiac	I-coding_system
code	I-coding_system
(	O
ipccc	O
)	O
coding	O
system	O
.	O

participants	O
in	O
this	O
trial	O
were	O
required	O
to	O
have	O
a	O
primary	O
diagnosis	O
of	O
parkinson	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
8a60	B-code
.	O

the	O
researchers	O
focused	O
on	O
patients	O
with	O
hereditary	O
hemorrhagic	O
telangiectasia	B-phenotype
(	O
hht	B-phenotype
)	O
,	O
identified	O
using	O
orphanet	B-coding_system
code	O
orpha774	B-code
.	O

the	O
study	O
cohort	O
included	O
adults	O
with	O
a	O
recorded	O
diagnosis	O
of	O
systemic	B-phenotype
lupus	I-phenotype
erythematosus	I-phenotype
(	O
snomed	B-coding_system
ct	I-coding_system
code	O
123958008	B-code
)	O
.	O

patients	O
with	O
severe	B-phenotype
acute	I-phenotype
respiratory	I-phenotype
syndrome	I-phenotype
(	O
mesh	B-coding_system
id	O
d045169	B-code
)	O
were	O
included	O
in	O
the	O
study	O
.	O

this	O
study	O
focused	O
on	O
individuals	O
with	O
a	O
diagnosis	O
of	O
sickle	B-phenotype
cell	I-phenotype
disease	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
codes	O
282	B-code
.	I-code
60	I-code
-	I-code
282	I-code
.	I-code
69	I-code
)	O
.	O

the	O
patient	O
population	O
consisted	O
of	O
individuals	O
with	O
acute	B-phenotype
myocardial	I-phenotype
infarction	I-phenotype
(	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
i21	B-code
)	O
.	O

this	O
analysis	O
included	O
only	O
patients	O
with	O
a	O
diagnosis	O
of	O
alzheimer	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
nincds	B-coding_system
-	I-coding_system
adrda	I-coding_system
criteria	O
.	O

the	O
study	O
cohort	O
consisted	O
of	O
individuals	O
with	O
a	O
confirmed	O
glioblastoma	B-phenotype
multiforme	I-phenotype
diagnosis	O
,	O
as	O
per	O
umls	B-coding_system
code	O
c0206732	B-code
.	O

all	O
participants	O
were	O
diagnosed	O
with	O
ankylosing	B-phenotype
spondylitis	I-phenotype
based	O
on	O
the	O
modified	O
new	O
york	O
criteria	O
and	O
had	O
relevant	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	O

patients	O
with	O
autism	B-phenotype
spectrum	I-phenotype
disorder	I-phenotype
(	O
dsm	B-coding_system
-	I-coding_system
iv	I-coding_system
code	O
299	B-code
.	I-code
00	I-code
)	O
were	O
the	O
primary	O
focus	O
of	O
this	O
research	O
.	O

the	O
study	O
examined	O
patients	O
diagnosed	O
with	O
chronic	B-phenotype
obstructive	I-phenotype
pulmonary	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
gold	O
guidelines	O
and	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
491	B-code
-	I-code
492	I-code
.	O

participants	O
in	O
this	O
trial	O
had	O
a	O
primary	O
diagnosis	O
of	O
multiple	B-phenotype
sclerosis	I-phenotype
based	O
on	O
the	O
mcdonald	O
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g35	B-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
eosinophilic	B-phenotype
esophagitis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
db93	B-code
.	I-code
22	I-code
were	O
included	O
in	O
the	O
study	O
.	O

the	O
study	O
focused	O
on	O
patients	O
who	O
were	O
diagnosed	O
with	O
myasthenia	B-phenotype
gravis	I-phenotype
using	O
the	O
myasthenia	B-coding_system
gravis	I-coding_system
foundation	I-coding_system
of	I-coding_system
america	I-coding_system
(	O
mgfa	O
)	O
classification	O
.	O

participants	O
had	O
a	O
confirmed	O
diagnosis	O
of	O
rheumatoid	B-phenotype
arthritis	I-phenotype
based	O
on	O
the	O
acr	O
/	O
eular	O
classification	O
criteria	O
and	O
had	O
relevant	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m06	B-code
.	I-code
0	I-code
.	O

the	O
patient	O
cohort	O
consisted	O
of	O
individuals	O
with	O
a	O
diagnosis	O
of	O
crohn	B-phenotype
'	I-phenotype
s	I-phenotype
disease	I-phenotype
based	O
on	O
the	O
montreal	O
classification	O
and	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
555	B-code
.	O

in	O
this	O
study	O
,	O
patients	O
with	O
a	O
diagnosis	O
of	O
schizophrenia	B-phenotype
according	O
to	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
and	O
295	B-code
.	I-code
xx	I-code
code	O
were	O
included	O
.	O

patients	O
diagnosed	O
with	O
epilepsy	B-phenotype
using	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g40	B-code
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
study	O
focused	O
on	O
individuals	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
idiopathic	B-phenotype
pulmonary	I-phenotype
fibrosis	I-phenotype
according	O
to	O
ats	B-coding_system
/	I-coding_system
ers	I-coding_system
guidelines	O
.	O

participants	O
were	O
required	O
to	O
have	O
a	O
diagnosis	O
of	O
ductal	B-phenotype
carcinoma	I-phenotype
in	I-phenotype
situ	I-phenotype
(	I-phenotype
dcis	I-phenotype
)	I-phenotype
of	O
the	O
breast	O
,	O
as	O
indicated	O
by	O
icd	B-coding_system
-	I-coding_system
o	I-coding_system
-	I-coding_system
3	I-coding_system
code	O
8500	B-code
/	I-code
2	I-code
.	O

the	O
patient	O
population	O
included	O
individuals	O
diagnosed	O
with	O
fibromyalgia	B-phenotype
according	O
to	O
the	O
acr	O
2010	O
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m79	B-code
.	I-code
7	I-code
.	O

the	O
cohort	O
consisted	O
of	O
patients	O
diagnosed	O
with	O
systemic	B-phenotype
sclerosis	I-phenotype
according	O
to	O
the	O
acr	B-coding_system
/	I-coding_system
eular	I-coding_system
classification	O
criteria	O
.	O

this	O
study	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
polycystic	B-phenotype
ovary	I-phenotype
syndrome	I-phenotype
(	I-phenotype
pcos	I-phenotype
)	I-phenotype
based	O
on	O
the	O
rotterdam	B-coding_system
criteria	I-coding_system
.	O

participants	O
were	O
required	O
to	O
have	O
a	O
diagnosis	O
of	O
psoriasis	B-phenotype
according	O
to	O
the	O
pasi	B-coding_system
score	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l40	B-code
.	O

the	O
patient	O
cohort	O
included	O
individuals	O
with	O
a	O
diagnosis	O
of	O
chronic	B-phenotype
kidney	I-phenotype
disease	I-phenotype
according	O
to	O
the	O
kdigo	B-coding_system
guidelines	O
and	O
icd	B-coding_system
-	I-coding_system
9	I-coding_system
code	O
585	B-code
.	O

this	O
study	O
focused	O
on	O
patients	O
with	O
a	O
diagnosis	O
of	O
narcolepsy	B-phenotype
based	O
on	O
the	O
icsd	B-coding_system
-	I-coding_system
3	I-coding_system
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
7a21	B-code
.	O

participants	O
were	O
required	O
to	O
have	O
a	O
confirmed	O
diagnosis	O
of	O
endometriosis	B-phenotype
according	O
to	O
the	O
rasrm	B-coding_system
classification	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
n80	B-code
.	O

this	O
study	O
included	O
patients	O
diagnosed	O
with	O
cystic	B-phenotype
fibrosis	I-phenotype
using	O
the	O
cystic	B-coding_system
fibrosis	I-coding_system
foundation	I-coding_system
(	O
cff	O
)	O
guidelines	O
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
restless	B-phenotype
legs	I-phenotype
syndrome	I-phenotype
according	O
to	O
the	O
icsd	B-coding_system
-	I-coding_system
2	I-coding_system
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g25	B-code
.	I-code
81	I-code
were	O
included	O
in	O
the	O
study	O
.	O

the	O
cohort	O
consisted	O
of	O
patients	O
with	O
hereditary	B-phenotype
angioedema	I-phenotype
according	O
to	O
the	O
orphanet	B-coding_system
code	O
orpha91378	B-code
.	O

patients	O
diagnosed	O
with	O
primary	B-phenotype
biliary	I-phenotype
cholangitis	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
5a20	B-code
were	O
included	O
in	O
the	O
analysis	O
.	O

the	O
study	O
focused	O
on	O
patients	O
diagnosed	O
with	O
irritable	B-phenotype
bowel	I-phenotype
syndrome	I-phenotype
using	O
the	O
rome	B-coding_system
iv	I-coding_system
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k58	B-code
.	O

this	O
study	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
acromegaly	B-phenotype
,	O
as	O
indicated	O
by	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
e22	B-code
.	I-code
0	I-code
.	O

the	O
cohort	O
consisted	O
of	O
individuals	O
with	O
a	O
diagnosis	O
of	O
post	B-phenotype
-	I-phenotype
traumatic	I-phenotype
stress	I-phenotype
disorder	I-phenotype
(	O
ptsd	B-coding_system
)	O
based	O
on	O
the	O
dsm	B-coding_system
-	I-coding_system
5	I-coding_system
criteria	O
and	O
309	B-code
.	I-code
81	I-code
code	O
.	O

participants	O
were	O
required	O
to	O
have	O
a	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
according	O
to	O
both	O
the	O
modified	O
new	O
york	O
criteria	O
and	O
the	O
asas	B-coding_system
classification	O
criteria	O
.	O

this	O
study	O
included	O
patients	O
diagnosed	O
with	O
pyoderma	B-phenotype
gangrenosum	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
l88	B-code
.	O

the	O
cohort	O
consisted	O
of	O
individuals	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
chronic	B-phenotype
pancreatitis	I-phenotype
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k86	B-code
.	I-code
1	I-code
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
amyotrophic	B-phenotype
lateral	I-phenotype
sclerosis	I-phenotype
(	O
als	B-phenotype
)	O
based	O
on	O
the	O
el	B-coding_system
escorial	I-coding_system
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
g12	B-code
.	I-code
20	I-code
were	O
included	O
in	O
the	O
study	O
.	O

this	O
study	O
examined	O
patients	O
diagnosed	O
with	O
nonalcoholic	B-phenotype
steatohepatitis	I-phenotype
(	O
nash	B-phenotype
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
ka40	B-code
.	I-code
22	I-code
.	O

participants	O
were	O
required	O
to	O
have	O
a	O
confirmed	O
diagnosis	O
of	O
primary	B-phenotype
sclerosing	I-phenotype
cholangitis	I-phenotype
using	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k83	B-code
.	I-code
01	I-code
.	O

the	O
study	O
focused	O
on	O
patients	O
diagnosed	O
with	O
ulcerative	B-phenotype
colitis	I-phenotype
based	O
on	O
the	O
montreal	O
classification	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
k51	B-code
.	O

this	O
research	O
included	O
patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
frontotemporal	B-phenotype
dementia	I-phenotype
(	O
ftd	B-phenotype
)	O
according	O
to	O
the	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
5a04	B-code
.	O

the	O
study	O
population	O
consisted	O
of	O
individuals	O
with	O
a	O
diagnosis	O
of	O
hodgkin	B-phenotype
lymphoma	I-phenotype
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
c81	B-code
and	O
subtype	O
classification	O
according	O
to	O
the	O
who	B-coding_system
classification	I-coding_system
of	I-coding_system
tumours	I-coding_system
of	I-coding_system
haematopoietic	I-coding_system
and	I-coding_system
lymphoid	I-coding_system
tissues	I-coding_system
.	O

patients	O
with	O
a	O
confirmed	O
diagnosis	O
of	O
chronic	B-phenotype
fatigue	I-phenotype
syndrome	I-phenotype
(	O
cfs	B-phenotype
)	O
according	O
to	O
the	O
fukuda	B-coding_system
criteria	I-coding_system
were	O
included	O
in	O
the	O
study	O
.	O

this	O
study	O
focused	O
on	O
individuals	O
diagnosed	O
with	O
non	B-phenotype
-	I-phenotype
hodgkin	I-phenotype
lymphoma	I-phenotype
(	O
nhl	B-phenotype
)	O
based	O
on	O
the	O
icd	B-coding_system
-	I-coding_system
11	I-coding_system
code	O
2a83	B-code
and	O
who	B-coding_system
classification	I-coding_system
of	I-coding_system
tumours	I-coding_system
of	I-coding_system
haematopoietic	I-coding_system
and	I-coding_system
lymphoid	I-coding_system
tissues	I-coding_system
.	O

patients	O
with	O
a	O
diagnosis	O
of	O
osteoarthritis	B-phenotype
according	O
to	O
the	O
acr	B-coding_system
criteria	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m15	B-code
-	I-code
m19	I-code
were	O
included	O
in	O
the	O
analysis	O
.	O

participants	O
were	O
required	O
to	O
have	O
a	O
diagnosis	O
of	O
ankylosing	B-phenotype
spondylitis	I-phenotype
according	O
to	O
the	O
modified	O
new	O
york	O
criteria	O
,	O
asas	B-coding_system
classification	O
criteria	O
,	O
and	O
icd	B-coding_system
-	I-coding_system
10	I-coding_system
code	O
m45	B-code
.	O

